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Abstract
The mitochondrial zinc finger protein Zim17 belongs to a newly identified class of
cochaperones that maintain the function of Hsp70 proteins in mitochondria and
plastides of eukaryotic cells, presumably by preventing the aggregation of their
respective chaperone partners. However, while its aggregation-preventive function is
well demonstrated in vitro, little is known about the influence of the Zim17 interaction
on the chaperone activity of mitochondrial Hsp70s (mtHsp70s) and its concurrent
effects in the cellular context.
Due to the aggregation-protective character of Zim17, recombinant co-expression
with the zinc finger protein allowed the purification of the main yeast mtHsp70 Ssc1
from E.coli cells under native conditions. The purified proteins were used to analyse
the influence of Zim17 on the solubility of Ssc1 as well as the character and stability
of its binding to the chaperone. Zim17 interacted with Ssc1 as a single molecule but
tended to form dimers in the absence of the Hsp70 chaperone. Though the presence
of Zim17 improved the solubility of recombinant Ssc1 in E.coli cells, substantial
amounts of the Hsp70 chaperone still aggregated, even when Zim17 was expressed in
saturated amounts.
To study the effects of a loss of Zim17 function in the cellular environment, novel
conditional mutations within the ZIM17 gene of the model organism Saccharomyces
cerevisiae were generated. Yeast cells carrying these mutations showed a temperature-
sensitive growth phenotype and a tendency to develop respiratory deficits. On
fermentable growth media, the mutant cells were prone to loose their respiratory
competence and were inviable at elevated temperatures. In these cells, a strong
aggregation of the mitochondrial Hsp70 Ssq1 together with a concomitant defect
in Fe/S protein biogenesis was observed. In contrast, under respiring conditions,
the mitochondrial Hsp70s Ssc1 and Ssq1 exhibited only a partial aggregation. The
induction of the zim17 mutant phenotype by subjection to a high temperature
iv
treatment lead to a strong import defect for Ssc1-dependent matrix-targeted precursor
proteins that correlated with a significantly reduced binding of newly imported
substrate proteins to Ssc1. Both in vitro and in vivo approaches point to the
conclusion that Zim17 is not primarily required for the maintenance of mtHsp70
solubility. Instead, a functional analysis of the chaperone cycles of Ssc1 and Ssq1
shows that Zim17 directly assists the functional interaction of mtHsp70 with substrate
proteins in a J-protein cochaperone-dependent manner.
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11. Introduction
1.1. Mitochondria
Mitochondria are ubiquitous eukaryotic cell organelles that play crucial roles in many
cellular functions including respiration and energy production, Fe/S cluster assembly,
metabolism of amino acids and lipids and apoptosis.
Mitochondria origin from an endosymbiontic event that occured over 1.5 billion years
ago and most likely derive from an α-protobacterial ancestor that was assimilated
by a host cell of eukaryotic or prokaryotic origin (Dyall, Brown and Johnson 2004;
Gray, Burger and Lang 2001). As a result of a symbiotic relationship between the
two organisms, a conversion of the proto-mitochondrium to an organelle took place.
During this evolutionary process, the genome of mitochondria was reduced and genes
were transferred to the nuclear genome of the host cell (Adams and Palmer 2003;
Gabaldón and Huynen 2004). A machinery for the transport of proteins from the
cytosol to the organelle and presequences to target the mitochondrial precursor
proteins to their destination developed co-evolutionary (Adams and Palmer 2003;
Dyall, Brown and Johnson 2004). The mitochondrial proteome of yeast and other
organisms thus mainly consists of two sets of proteins: those that are of prokaryotic
origin and have bacterial homologues and those that occur only in eukaryotes (Gray,
Burger and Lang 2001).
Though mitochondria are not sustainable outside the cellular environment, they
are considered autonomous organelles that have kept the ability to self-replicate
and to synthesise a subset of their proteins. Moreover, mitochondria constitute
an intra-organellar environment isolated from the cytosol. Protein homoeostasis
in mitochondria thus has to be strictly maintained and is autonomously controlled
by i) a regulated import machinery that guides nuclear-encoded precursors to their
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subcompartmental destination, ii) an autonomous protein quality control system
that consists of a set of molecular chaperones and proteases.
1.1.1. Mitochondrial protein import
As most mitochondrial proteins are encoded in the nucleus and synthesised as
precursor forms in the cytosol, they must be imported into the organelle. Almost
all precursor proteins enter the mitochondria through the translocase of the outer
membrane (TOM). Mitochondrial precursor proteins carry a signal peptide at their N-
terminus that consists of 15-80 amino acids (Neupert and Herrmann 2007; Roise and
Schatz 1988). The signal peptide forms an amphipathic α-helix with one hydrophobic
and one positively charged face and is recognized by the receptor protein Tom20 at the
cytosolic side of the outer mitochondrial membrane (Abe 2000; Saitoh 2007). Tom20
forms a complex with Tom22 that connects it to the central translocation pore, which
consists of the channel protein Tom40 and a number of small Tom proteins (Tom 4,5
and 6, figure 1.1) (Neupert and Herrmann 2007; Schmidt, Pfanner and Meisinger
2010). In the special case of hydrophobic membrane destined precursor proteins, an
additional TOM-component, Tom70 interacts with Hsp70 and Hsp90 chaperones
that are bound to the precursor to protect it from aggregation in the hydrophilic
environment of the cytosol (Young, Hoogenraad and Hartl 2003). The interaction of
Tom70 with the presequence and the bound chaperones makes sure that the protein
is immediately transferred to the Tom20-Tom22 receptor and inserted into the Tom40
channel (Schmidt, Pfanner and Meisinger 2010). After passing the TOM complex,
the precursor proteins are distributed to the mitochondrial subcompartments (the
intermembrane space, the inner and outer membrane and the matrix) via different
pathways.
1.1.1.1. TIM23-mediated import pathways for matrix- and inner membrane proteins
Matrix-destined preproteins are imported via the translocase of the inner membrane
(TIM) in a membrane potential (∆Ψ) -dependent manner. The positive charge
of its N-terminal signal peptide directs the preprotein along the proton gradient
over the inner mitochondrial membrane through the TIM23 channel into the matrix
compartment (Martin, Mahlke and Pfanner 1991; Roise and Schatz 1988).
The TIM23 complex is composed of the channel proteins Tim23 and Tim17 (figure 1.1).
A third component, Tim50, consists of a transmembrane segment and a domain
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that reaches into the intermembrane space where it is able to interact with the
TOM-complex and transmit the information about the entrance of a preprotein
from TOM to TIM (Geissler 2002). The Tim50-mediated transient interaction
between the two complexes induces the closure of the Tim23 channel to prevent a
leakage of ions across the inner membrane (Meinecke 2006). On the matrix-side the
presequence translocase associated import motor (PAM), consisting of the proteins
Pam16, Pam17 and Pam18, and a mitochondrial Hsp70 protein assist in completion
of the import into the matrix compartment by exerting an ATP-dependent reaction
(section 1.2.1.1). In this composition, the TIM complex is also called TIM23PAM
or TIM23MOTOR (Laan, Hutu and Rehling 2010). When the precursor has reached
the matrix, its presequence is cleaved off by proteases. The main protease of the
mitochondrial matrix is the matrix processing peptidase (MPP) that removes the
targeting sequence of almost all entering precursors. Besides, the proteases Icp55
and Oct1 are found in the mitochondrial matrix. While Icp55 is thought to remove
single amino acid residues as a component of the ’N-end-rule’ pathway, the functional
significance of Oct1, that removes segments of 8 amino acids, is unknown (Gakh,
Cavadini and Isaya 2002; Mossmann, Meisinger and Vögtle 2012).
Mitochondrial inner membrane proteins can be inserted into the membrane via the
TIM23-complex, the TIM22-complex or the OXA-complex. Inner membrane proteins
that are imported via the Tim23 complex carry an N-terminal target signal followed
by a hydrophobic sorting sequence that induces an arrest of the import. Subsequently,
the protein is released into the inner membrane via an unknown mechanism. Recent
studies suggest that during this so-called sorting pathway, the TIM23 complex
seems to be free of the PAM module but includes an additional Tim-protein, Tim21.
According to its function, this form of the complex has been termed Tim23SORT
(Chacinska 2005, 2010; Laan 2007). Tim21 interacts with the TOM-complex via
Tom22 in the intermembrane space (Mokranjac 2005). Additionally, it seems to be
connected with the respiratory chain, most likely via complex III (cytochrome bc1
complex) and complex IV (cytochrome C oxidase, Laan 2006). This interaction is
thought to contribute to the ∆Ψ-dependent process of the inner membrane sorting.
However, its precise role remains to be elucidated. Furthermore, the existance of
two functionally fully separated TIM23 modules is still discussed (Mokranjac and
Neupert 2010; Popov-Celeketić 2008). Recent studies indicate that TIM23 is found in
the Tim23SORT form at the initial phase of the import of matrix-destined precursors
before it switches to the PAM-attached TIM23MOTOR complex during the import
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process and are thus in a dynamic interaction with each other (Chacinska 2010;
Wiedemann 2007).
1.1.1.2. Tim23-independent import pathways
1.1.1.2.1. Import into the inner and outer mitochondrial membrane
Mitochondrial inner membrane proteins are either encoded by the mitochondrial
genome or by nuclear genes. Proteins encoded by the mitochondrial genome are
translated on ribosomes in the mitochondrial matrix and are integrated into the
inner membrane via the OXA-complex (Stuart 2002, figure 1.2). Though some
nuclear encoded inner membrane proteins can also use the OXA-pathway their
majority is integrated into the inner mitochondrial membrane by the TIM23 complex
(section 1.1.1.1) or the TIM22 complexes. Proteins that are imported via the TIM22
complex are recognized by the receptor Tom70 as described above (section 1.1.1.1)
and enter the intermembrane space via the TOM-complex. In the intermembrane
space (IMS), the precursor proteins are bound by the small Tim-proteins TIM9 and
Tim10. Tim9 and Tim10 form hexameric complexes in the intermembrane space
(Lu 2004; Webb 2006) and transfer the incoming precursor proteins to TIM22. The
TIM22 complex consists of the inner membrane proteins Tim22, Tim18 and Tim54.
Part of Tim54 is exposed to the IMS and probably provides an interaction site for
the small Tim proteins (Wagner 2008).
Similarly, β-barrel precursors of the outer membrane are guided by the small Tim-
proteins Tim9-Tim10 and the homologuous proteins Tim8-Tim13 to the sorting
and assembly machinery (SAM) complex. The SAM complex consists of the outer
membrane proteins Sam35, Sam37 and Sam50. Sam35 interacts with a C-terminal
signal of the precursor protein and initializes its membrane insertion by the channel-
forming Sam50 in a process that is not fully understood (Kutik 2008). The insertion
of complex-forming outer membrane proteins like Tom40 is additionally promoted
by the protein Mdm10 (mitochondrial distribution and morphology), a component
the MDM complex (Meisinger 2004). The MDM complex is also found at junctions
between the outer mitochondrial membrane and the ER and seems to play a role in
the transport of lipids and Ca2+. For proteins with α-helical transmembrane segments
a second mechanism for the insertion of outer membrane proteins exists. This poorly
characterized pathway involves the outer membrane protein Mim1 (mitochondrial
import1) (Schmidt, Pfanner and Meisinger 2010).
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Figure 1.1.: Tim23-mediated import pathways, adapted from Schmidt (2010). Precursor proteins
with an N-terminal mitochondrial targeting sequence are recognized by Tom20 and Tom22 and imported
by the translocase of the outer membrane (TOM) complex. After passing the outer membrane, the
precursors are further imported by two modules of the translocase of the inner membrane (TIM) complex.
TIM23SORT mediates the release of precursors with an additional sorting sequence into the inner
membrane and comprises Tim23, Tim17, Tim50 and Tim21. Tim21 interacts with the TOM complex
and transiently binds to complexes of the respiratory chain. TIM23MOTOR lacks Tim21 but interacts
with Tim44 and the presequence-translocase associated motor (PAM) that assists in the import of
matrix-destined proteins. Precursor-import into the matrix is powered by the membrane potential (∆Ψ)
and an ATP-driven reaction of mtHsp70 that is recruited to the translocase by Tim44. After reaching
the matrix compartment, the presequence is cleaved off by the mitochondrial processing peptidase
(MPP). Some proteins are further processed by the peptidases Icp55 or Oct1 before they are folded into
their final conformation. OM, outer membrane; IM, inner membrane; IMS, intermembrane space.
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1.1.1.2.2. Import into the intermembrane space
Proteins of the intermembrane space can be imported via the Tim23 sorting pathway
if they contain a bipartite signal sequence composed of an N-terminal matrix signal
followed by a hydrophobic sorting sequence. Import is arrested and the protein is
inserted into the inner membrane as described above (section 1.1.1.1). After import,
the matrix-targeting signal and the sorting sequence are removed by proteolytic
cleavage and the protein is released into the IMS (Neupert and Herrmann 2007).
Another way for the import of proteins into the IMS is provided by a specialised
system applying the inner membrane protein Mia40 (mitochondrial intermembrane
space assembly 40) (Chacinska 2004). This special import pathway applies to
a group of small IMS proteins that have no cleavable presequences but contain
cysteine residues as a common characteristic (Longen 2009). After passage into
the intermembrane space via the TOM-complex, the newly imported proteins
need to be folded into their functional state. Despite of the reducing environment,
cysteine-containing proteins in the IMS generally occur in their oxidized form. Mia40
functions as an oxidoreductase that induces disulfide bonds between cysteine residues
by forming a transient disulfide bridge with its client proteins. The disulfide bond is
then transferred to the target protein, while Mia40 itself becomes reduced. After
release of the target protein, Mia is probably re-oxidized by its interaction partner
Erv1, a sulphhydryl-oxidase that also plays a role in the biogenesis of iron sulphur
cluster proteins. According to the role of Mia40, this import pathway was named the
’disulfid relay’(Hell 2008; Mesecke 2005). The small Tim proteins Tim9 and Tim10
are examples for proteins that are imported via the Mia40 pathway (Müller 2008).
1.1.2. Mitochondrial protein homoeostasis
Protein homoeostasis in mitochondria is controlled via a network of proteases and
chaperones (Voos 2013, figure 1.3). Briefly, chaperones of the mitochondrial matrix
fulfil two important tasks: the de novo folding of newly imported precursors and the
recognition and refolding of misfolded proteins. Chaperones of the Hsp70 class play
a key role in these processes. Hsp70 proteins consist of a peptide binding domain
(PBD) and a nucleotide-binding domain (NBD) and interact with substrate proteins
in a nucleotide-dependent manner. Their function is based on their intrinsic ATPase
activity that confers conformational changes from the NBD to the PBD and thus
allows the chaperone to work on its substrate. Mitochondrial Hsp70 chaperones
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Figure 1.2.: Tim23-independent import pathways. After passage through the TOM-complex,
proteins that lack an N-terminal matrix-targeting signal can use different sorting pathways. The Tim9-
Tim10 complex transfers hydrophobic precursor proteins through the IMS to either the TIM22 complex
in the inner membrane (1) or the sorting and assembly machinery (SAM) in the outer membrane (2),
that mediates the release of β-barrel proteins and the assembly of the Tom40 channel with the help of
Mdm1. The mitochondrial intermembrane space assembly machinery (MIA) drives the import of many
IMS proteins by mediating an oxidative folding process that also involves the sulphhydryl-oxidase Erv1
(3). Inner membrane proteins that are synthesised on mitochondrial ribosomes and a few proteins that
enter the mitochondrial matrix via the TIM23 complex are integrated into the inner membrane by the
OXA-complex (4). The precursors of α-helical outer membrane proteins are not imported via the TOM
complex but are inserted into the outer membrane by alternative pathways involving the newly identified
mitochondrial import 1 (Mim1)(5).
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interact with incoming precursor proteins at the import channel and assist in the
import reaction itself. After import, the Hsp70 chaperone stays attached to the
precursor and promotes the folding into its final conformation. Similarly, it stabilises
misfolded polypeptides in the mitochondrial matrix and assists in their refolding.
In yeast mitochondria, the main Hsp70 chaperone that assists in both import and
folding processes is called Ssc1 (Stress-Seventy subfamily C1, Kang 1990; Rowley
1994). Ssc1 interacts with exposed hydrophobic segments of the unfolded precursor
protein. A second mitochondrial Hsp70 protein, Ssq1, fulfils a more specialised
function in the biogenesis of mitochondrial iron-sulphur-cluster (Fe/S)-proteins (see
section below). While the functions of Ssc1 and Ssq1 are well characterized, the
role of the third yeast mitochondrial Hsp70 chaperone Ecm10 (Ssc3) remains to be
determined.
Hsp70 proteins are not the only chaperones that assist in the folding and refolding
of proteins in the mitochondrial matrix. A second class of chaperones that pro-
mote the folding of newly imported proteins are Hsp60 proteins (Cheng 1989). The
yeast mitochondrial Hsp60 chaperone is an orthologue of the E.coli protease GroEL.
Chaperones of the Hsp60 class form large complexes consisting of 14 monomers that
oligomerize into two heptameric rings with a hydrophobic substrate-binding cavity
in their center. Hsp60 interacts with unfolded polypeptides to a size of 50 kDa. The
cofactor Hsp10 covers the cavity and allows the substrate protein to fold into a native
conformation. The isolation of the substrate during the folding process protects it
from aggregation through interaction with other unfolded proteins (Walter 2002).
Hsp60-assisted folding is promoted by ATP hydrolyses. The induced conformational
change renders the interface of substrate-binding cavity more hydrophilic and forces
the protein to fold into a soluble state. Mitochondrial Hsp60 acts chronologically
after Hsp70 in the folding of newly imported matrix proteins (Heyrovská 1998) and
is probably also involved in the refolding of endogenous proteins (Bender 2011).
Besides the folding-promoting chaperones of the Hsp60 and Hsp70 classes, the pro-
tein quality control system of the mitochondrial matrix contains a set of proteins
which resolubilize aggregated proteins or remove polypeptides that are irreparably
damaged. In yeast mitochondria, Hsp78, a chaperone of the Hsp100 or Clp (Ca-
seinolytic peptidase protein homolog) class that belongs to the AAA+ protein family
(ATPases associated with diverse cellular activities), plays an important role in the
disaggregation and degradation of misfolded proteins (Janowsky 2006; Rottgers 2002).
Hsp78, like its E.coli homologue ClpB, forms large oligomeric ring-complexes and act
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together with Hsp70 chaperones in the refolding of substrates (Germaniuk, Liberek
and Marszalek 2002; Leidhold 2006). Hsp78/ClpB chaperones exist in bacteria and
yeast mitochondria but are not found in higher eukaryotes, where their roles are
probably taken over by proteins of the Hsp70 class.
In yeast mitochondria, the removal of irreparably damaged proteins as a last instance
is finally taken over by the Pim (proteolysis in mitochondria)/LON protease (Major
2006; Van Dyck, Pearce and Sherman 1994). LON proteases are serine peptidases
that consist of a catalytical domain, an ATPase domain and an N-terminal domain
that is involved in the binding of substrates.
In bacteria, a second protease, ClpP, forms a ring-shaped hexameric complex that
degrades polypeptides with certain signal sequences. ClpP can interact with the
cofactors ClpA, ClpX or ClpC that perform substrate-recruiting functions (Voos
2013). In yeast mitochondria, a ClpP protease-system does not exist. However,
mitochondria contain the protein Mcx1 (Dyck 1998), a ClpX-homologue of unknown
function and with no identified binding partner.
For the proteolysis of membrane-integrated substrate proteins, two mitochondrial
proteases have been identified. Both consist of a zinc metallo-protease of the AAA-
family and an integral membrane domain. The m-AAA-protease consists of the two
subunits Yta10 and Yta12 with its ATPase domain pointing to the mitochondrial
matrix. The protease domain of the i-AAA-protease Yme1 is exposed to the IMS and
represents the only known protease in the intermembrane space of yeast mitochondria
so far. Its functional significance for the degradation of soluble IMS proteins still
has to be determined. In higher eukaryotes a soluble IMS protease, Htr2A, has been
identified. However, its function remains unknown.
1.1.3. The mitochondrial Fe/S cluster assembly machinery
The mitochondrial Fe/S (ISC) cluster assembly machinery is an essential process of
particular importance as it affects the biogenesis of cytosolic Fe/S cluster-containing
proteins and thus draws a direct connection between mitochondrial and cytoplasmatic
processes (Lill 2012). Fe/S cluster proteins occur throughout the cell and fullfill
important roles in electron transfer, enzyme catalysis and regulatory processes (Lill
2006). The general importance of an intact iron-sulphur cluster assembly machinery is
mirrored by the fact that defects in this process lead to diseases like Friedreichs ataxia
or different forms of myopathies (reviewed in Sheftel, Stehling and Lill 2010). A key
component for the biogenesis of Fe/S cluster-containing proteins is the mitochondrial
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Figure 1.3.: The mitochondrial protein quality control system, adapted from Voos (2013). After
import via the TIM23 complex, matrix proteins are folded by the mitochondrial Hsp70 and Hsp60 systems.
Misfolded proteins are degraded with the help of Hsp78, a protein of the Hsp100 class of chaperones or
the Pim/LON-protease. Hsp78 also assists in the solubilisation and degradation of aggregated proteins,
a process that also involves the mtHsp70 chaperone system. The role of Mcx1, a homologue of the
bacterial ClpXP protease-component ClpX, is unknown. The m-AAA and i-AAA proteases assist in the
degradation of membrane-integrated substrate proteins. A homologue of Htr2A, a protease of unknown
function in the IMS of higher eukaryotes has not been identified in yeast yet. OM, outer membrane, IM,
inner membrane, IMS, intermembrane space.
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protein Isu1, on which the Fe/S cluster is built up before it is transferred to its
apoprotein (Knieszner 2005). For the synthesis of the [2Fe-2S]-cluster on Isu1, iron
is transported from the cytosol into the mitochondrial matrix via the carriers Mrs3
and Mrs4 that use the pH gradient over the inner membrane as a driving force
(Froschauer, Schweyen and Wiesenberger 2009, figure 1.4). During the assembly of
Fe/S clusters on Isu1, the protein Nfs1 serves as a sulphur donor. Nfs1 is part of
the cysteine desulfurase Nfs1-Isd11 (Adam 2006; Wiedemann 2006) that releases a
sulphur from free cysteine and transfers it to Isu1 (Lill 2006, 2012). Iron is integrated
into the complex with the help of frataxin (Yfh1 in yeast) that probably serves
as an iron donor (Gerber, Mühlenhoff and Lill 2003; Mühlenhoff 2003). Besides
Nfs1-Isd11 and frataxin, an electron transfer chain composed of ferredoxin (Yah1),
ferredoxin reductase (Arh1) and NAD(P)H plays an important, yet unresolved role in
the assembly of the Fe/S cluster on Isu1. Ferredoxin is an Fe/S protein that requires
the mitochondrial Fe/S assembly machinery for its own biogenesis and is essential in
yeast (Lill 2012). Upon its assembly on the scaffold protein Isu1, the Fe/S cluster is
transferred to its apo-protein, a process that involves the Hsp70 protein Ssq1, the
J-protein Jac1 and the monothiol glutaredoxin Grx5 in yeast. Ssq1 and Jac1 are
thought to destabilise the binding of the Fe/S cluster to Isu1, thereby facilitating its
transfer (Dutkiewicz 2006). Grx5 might assist in the transfer by transiently binding
the Fe/S cluster, however, its precise role remains elusive (Rodríguez-Manzaneque
2002). While the previously described steps are common for the biogenesis of all
mitochondrial Fe/S cluster proteins, further steps are dependent on the individual
target protein. In yeast mitochondria, the proteins Isa1, Isa2 and Iba57 are involved
in the assembly of [4Fe-4S]-cluster proteins, for example aconitase (Mühlenhoff 2007,
2011). Further, specialised components of the ISC assembly machinery assist in the
biogenesis of individual proteins. Nfu1 transiently binds to the [4Fe-4S]-cluster and
is involved in its transfer to lipoate synthase and respiratory chain complex II (SDH)
(Navarro-Sastre 2011). Another [4Fe-4S]-interacting protein, Ind1 is involved in the
biogenesis of complex I (Lill 2012).
As depletion of components of the mitochondrial Fe/S cluster machinery, for example
Nfs1 or ferredoxin, also compromises the cytosolic Fe/S cluster assembly machinery
(CIA), the two processes must be connected to each other. Presumably, a yet
unidentified component synthesised in the mitochondria is exported to the cytosol
where it is utilized in the CIA machinery. The ABC transporter Atm1 of the inner
mitochondrial membrane seems to be involved in the export. Interestingly, the
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function of Atm1 is probably dependent on the sulphydryl oxidase Erv1 that is also
involved in the Mia40-dependent import of IMS proteins (Lill 2012).
In mitochondria, proteins of respiratory metabolism like components of the respiratory
chain complexes I and II as well as the citric acid cycle protein aconitase carry Fe/S
clusters. Besides, Fe/S cluster proteins take part in the biogenesis of amino acids and
cofactors and play important roles in the mitochondrial and cytosolic Fe/S cluster
assembly machineries themselves (Lill 2006). It has been reported that yeast cells
with defects in the ISC assembly machinery show a substantial downregulation of
proteins of the respiratory chain and the citric acid cycle (Foury and Talibi 2001;
Hausmann 2008; Lill 2012). The downregulation of iron-responsive genes could be
part of a transcriptional response that resembles the response to iron starvation and
is achieved by constitutive activation of the transcription factors Aft1 and Aft2. Aft1
and 2 activate the transcription of the iron regulon, a set of genes that are involved in
cellular iron uptake and intracellular iron distribution. This process also leads to the
transcriptional regulation of iron-responsive genes, for instance by the degradation of
mRNA (Lill 2012). In the cytosol and nucleus, Fe/S cluster proteins play important
roles in nucleotide metabolism, protein translation and tRNA modification. Nuclear
Fe/S cluster proteins are involved in the synthesis and repair of DNA and in the
assembly of ribosomes (Lill and Mühlenhoff 2008). Hence, defects in the cytosolic
and mitochondrial ISC assembly machinery can lead to nuclear genome instability
(Netz 2012; Veatch 2009). This link between mitochondrial function and nuclear
DNA and RNA metabolism may contribute to the essentiality of mitochondria for
most eukaryotic cells (Lill 2012).
1.2. Hsp70 proteins and their cochaperones
Hsp70 (heat shock protein of 70 kDa) proteins are important members of the
mitochondrial protein quality control system and compose an ubiquitous family of
chaperones whose members occur throughout all species (except archea). The main
function of Hsp70 proteins is the stabilization and aggregation prevention of misfolded
or unfolded substrate proteins via an interaction with exposed hydrophobic residues
(Frydman 2001). Due to this property, Hsp70s are involved in a multitude of cellular
processes. These include the folding of newly synthesised proteins, the assistance
in intercellular protein sorting, but also the refolding of denatured polypeptides, a
characteristic that becomes especially important under stress conditions (Bukau,
1. Introduction 13
Figure 1.4.: The mitochondrial Fe/S protein biogenesis system, adapted from Lill (2012). Iron
is transported over the mitochondrial inner membrane via the transporter Mrs3/4. The Fe/S cluster
in the mitochondrial matrix is built up on the scaffold protein Isu1, a process involving frataxin as
a potential iron donor and the desulfurase complex Nfs1-Isd11 as a sulphur donor. Additionally, an
electron transfer chain consisting of NAD(P)H, ferredoxin reductase (Arh1) and ferredoxin (Yah1) plays
a role in the cluster assembly. Upon assembly on Isu1, the Fe/S cluster is labilized and transferred to its
apoprotein with the help of the monothiol glutaredoxin Grx5. Labilization of the Fe/S cluster in yeast
involves a Hsp70 chaperone system consisting of the Hsp70 protein Ssq1, the J-protein Jac1 and the
nucleotide exchange factor Mge1. While these steps are common for all mitochondrial Fe/S cluster
proteins, specialised components involving the proteins Isa1, Isa2 and Iba57 catalyse the generation
of [4Fe-4S]-clusters. The assembly of lipoate synthase and complex II of the respiratory chain (SDH)
involve the protein Nfu1 while Ind1 assists the assembly of complex I. The connection between the
mitochondrial and the cytosolic Fe/S assembly machineries is established by the export of an unidentified
component via the transporter Atm1 in the inner mitochondrial membrane.
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Weissman and Horwich 2006; Frydman 2001; Hartl, Bracher and Hayer-Hartl 2011;
Mayer and Bukau 2005; Voos and Röttgers 2002; Young 2004). The biochemical
activity of Hsp70 proteins is based on their ATPase-activity that determines the
affinity for its client proteins. The initial interaction with substrate polypeptides
occurs in the ATP-state, where the overall substrate affinity of the chaperone
is low and its conformation is characterized by an opened substrate-interaction
site exhibiting high on-off binding rates. After ATP hydrolysis, intramolecular
conformational changes allow a closure of the SDB and the chaperone shows a high
substrate-affinity. Only after exchange of the bound ADP to ATP, the client protein
is released and a new substrate can bind (Mayer and Bukau 2005; Saibil 2008).
This apparently simple mechanism, however, needs to be carefully adjusted for each
individual member of the Hsp70 family. For this reason, Hsp70 proteins interact
with numerous specific protein factors, termed cochaperones. In many cases the
cochaperones determine the specific cellular function of their cognate Hsp70 chaperone.
There are two main groups of cochaperones that influence the activity of Hsp70
proteins. Firstly, almost all Hsp70 proteins need nucleotide-exchange factors (NEFs)
that destabilise the binding to ADP and allow the interaction with fresh nucleotides
after ATP hydrolysis and the folding of the client protein have occurred. In yeast
mitochondria, Mge1 (mitochondrial GrpE homolog1) serves as a nucleotide exchange
factor for the two main Hsp70s Ssc1 and Ssq1 (Miao, Davis and Craig 1997; Schmidt,
Pfanner and Meisinger 2010). Mge1 is named after GrpE, the nucleotide exchange
factor of the E.coli Hsp70 protein DnaK.
Secondly, all Hsp70s depend on the activity of J-proteins. J-proteins are a diverse
class of Hsp70 cofactors. The common feature of all J-proteins is their ability to
stimulate the ATPase activity of substrate-bound Hsp70s and thus facilitate the
folding of the client protein. This function is exerted by interaction of the J-protein
with the ATPase domain of Hsp70s through a conserved motif consisting of a His-
Pro-Asp tripeptide (HPD) that is located in the N-terminal part of the J-protein,
called J-domain. While the J-domain is a mutual element of all J-proteins, additional
domains and motifs divide the J-proteins into three classes. The J-domain of class I
J-proteins is followed by a flexible Gly-Phe-rich region and a C-terminal extension.
The C-terminus of class I J-proteins contains a cysteine-rich domain forming two
zinc-binding motifs (zinc center I and II) and a hydrophobic substrate-binding pocket.
The namesake of the J-protein family is the E.coli DnaJ, a typical class I J-protein.
Class II J-proteins lack the zinc-binding regions and do not interact with substrate
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proteins. Moreover, some members of classes I and II of the J-protein family are
known to dimerize via a poorly conserved domain at their C-terminus (Kampinga
and Craig 2010; Langer 1992). E.coli DnaJ and the yeast cytosolic J-proteins
Ydj1 (class I) and Sis1 (class II) belong to the dimeric J-proteins. Residues that are
involved in the dimer formation have been identified for E.coli DnaJ and for the
yeast cytosolic class II J-proteins Ydj1 and Sis1 (Sha, Lee and Cyr 2000; Wu 2005).
For Ydj1, the yeast DnaJ homologue, a crystal structure of the substrate-bound
dimer is available (Li, Qian and Sha 2003). The class III J-proteins, a third group of
DnaJ-like cochaperones, does not resemble class I or class II except for the J-domain.
However, class III J-proteins can contain additional motifs that differ from the classic
J-protein components (Kampinga and Craig 2010; Kelley 1999; Walsh 2004). The
intrinsic substrate-binding activity of class I J-proteins is thought to keep unfolded
or misfolded Hsp70 client proteins soluble and deliver them to the chaperone, where
the J-protein eventually assists the Hsp70 chaperone by stimulating its ATPase
activity. There are hints that the two zinc centers of the C-terminal domain are
probably involved in the interaction with Hsp70 substrates (Linke 2003; Lu and
Cyr 1998; Szabo 1996). While only class I J-proteins contain zinc-binding motifs,
the ability to interact with substrates is not restricted to this group. Some class II
and many class III J-proteins have substrate-binding domains that strongly differ
from those of the class I J-proteins but have the same importance for their function.
Those proteins can show selective binding properties for single distinct substrates or
substrate-groups or promiscuous client binding like class I J-proteins (reviewed in
Kampinga and Craig 2010).
1.2.1. Mitochondrial Hsp70 proteins
1.2.1.1. The role of Ssc1 in the import and folding of preproteins
During the import of proteins into the mitochondrial matrix, the negatively charged
presequence of the precursor protein enters the preprotein translocase and is directed
into the matrix by the electric potential (∆Ψ) across the inner mitochondrial mem-
brane. ATP-bound Ssc1 is recruited to the import channel by the scaffold protein
Tim44, a component of the Tim23-translocase of the inner mitochondrial membrane
where it interacts with the incoming precursor and the J-protein complex consisting
of the proteins Pam16 and Pam18 (D’Silva 2003; D’Silva 2005; Frazier 2004; Truscott
2003). While Pam18 consists of a C-terminal transmembrane domain and a J-domain
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that is facing the mitochondrial matrix, Pam16 contains a J-like domain but lacks
the characteristic HPD motif. The ATPase-enhancing function of Pam18 is thought
to be negatively regulated by Pam16 (D’Silva 2008; Li 2004). Pam17, a recently
discovered component of the PAM complex, might induce the interaction of Pam18
with Pam16 and stabilise their binding to the translocase (Van Der Laan 2005). Upon
binding to the incoming precursor protein, Pam18 induces ATP hydrolysis and Ssc1
is released from Tim44 simultaneously. The binding of the nucleotide exchange factor
Mge1 induces exchange of the bound ADP with a fresh ATP. Upon ATP-binding,
Mge1 is released from the chaperone followed by dissociation of the precursor and a
concomitant dissociation of Ssc1 from Pam18 and the import channel. While the
binding of Mge1 is transient, the interaction of J-proteins with mtHsp70 proteins is
relatively stable. FRET-based in vitro experiments with purified components of the
Ssc1 chaperone system, showed that the dissociation of Mge1 from the chaperone
occured in milliseconds, while Mdj1, the J-protein of Ssc1 in the mitochondrial
matrix, was released only after seconds (Mapa 2010).
The precise role of Hsp70 proteins in the import reaction has been discussed exten-
sively. It is widely believed that the conformational changes caused by ATP-hydrolysis
exert an inward directed force (’pulling’) on the incoming substrate and thus facilitate
its translocation through the import channel (Lim 2001; Voisine 1999; Voos 1996).
On the other hand, it is also possible that binding of the Hsp70 protein fulfils only a
passive trapping function and simply prevents the precursor from sliding backwards
through the import channel (Neupert and Herrmann 2007). However, as precursor
proteins have to enter the TIM23-channel in an unfolded conformation, the ’pulling’
activity of Hsp70 is of particular importance during the import of long substrates
that are probably partially folded in the cytosol while it is dispensable for the import
of short, unfolded preproteins (Glick 1993; Krayl 2007; Voos 1993). Besides its
function during the import reaction, Ssc1 assists in folding and refolding of unfolded
or denatured substrates in the mitochondrial matrix. The interaction partners of
Ssc1 during the folding reaction are Mge1 and the class I J-protein Mdj1 (Rowley
1994; Westermann 1996). Like all class I J-proteins, Mdj1 is able to bind to client
proteins and delivers them to Ssc1. Furthermore, Mdj1 appears to possess an intrinsic
chaperone function independent of Ssc1 (Duchniewicz 1999).
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1.2.1.2. The role of Ssq1 in the biogenesis of mitochondrial Fe/S cluster proteins
The second, less abundant mtHsp70 protein, Ssq1, fulfils a highly specialised task
in the mitochondrial Fe/S cluster assembly machinery (Dutkiewicz 2003; Knight
1998). The only known substrate of Ssq1 is Isu1, the scaffold protein on which the
Fe/S cluster is built up before it is transferred to its apo-protein. Ssq1 is believed to
facilitate this transfer by inducing conformational changes on Isu1 (Dutkiewicz 2006).
Upon its assembly on Isu1, the [2Fe-2S]-cluster is transferred to its apo-protein
with the help of Ssq1 and its partner protein Jac1. Jac1 belongs to the class III
of J-proteins that lack the typical class I substrate interaction site. Instead, the
J-protein specifically binds to holo-Isu1 through a region in its C-terminal domain
and delivers it to the chaperone (Ciesielski 2012). Ssq1 interacts with Isu1 through
a conserved LPPVK motif. A conformational change induced by ATP hydrolysis
stimulated by Jac1 may weaken the binding of Isu1 to the Fe/S cluster and induces
the transfer of the Fe/S cluster to its apo-protein. Concomitantly, the binding
between Ssq1 and Isu1 is stabilised. The specialised Ssq1-system only exists in
S. cerevisae and a few other funghi, while in higher eukaryotes, a single mtHsp70
chaperone takes over both Ssc1 and Ssq1 functions. Jac1, the specialised J-protein
partner of Ssq1 has co-evolved with the chaperone (Pukszta 2010). The binding
of Ssq1 to Isu1 via a defined interaction site is far more specific than the more
general substrate interaction of Ssc1. Moreover, as also Jac1 selectively interacts
with Isu1, it strongly contributes to this specifity. Notably, the nucleotide exchange
factor for Ssq1, Mge1, is the same as for the Ssc1 chaperone system, underlining the
importance of J-proteins for the Hsp70-substrate interaction.
1.3. Zinc finger proteins and cellular zinc
The first zinc-binding protein motif was identified in the transcription factor TFIIIA
from Xenopus laevis and belonged to the classical C2H2 family of DNA-binding zinc
fingers (Miller, McLachlan and Klug 1985). Today, over 20 classes of zinc fingers
with a high structural and functional diversity are known (Krishna, Majumdar
and Grishin 2003). Besides their classical functions in transcriptional regulation
by recognition of specific DNA sequences, zinc finger motifs can play important
roles in structural stabilization or serve as protein-recognition motifs (Gamsjaeger
2007; Namuswe and Berg 2012). Roughly, the major role of the bound zinc ion
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can be catalytic, cocatalytic or structural (McCall, Huang and Fierke 2000). In
catalytic zinc sites, that often contain histidine, glutamic acid and aspartic acid as
zinc-chelating ligands, the zinc atom is directly involved in the enzymatic reaction
and binds at least one water molecule. The zinc atom in structural zinc-binding
sites, is ususally chelated by four cysteines. The stabilising properties of zinc ions
derive from secondary interactions of the chelating ligands with other groups in the
protein via hydrogen bonds that support its structure (Namuswe and Berg 2012).
Moreover, structural zinc sites contain no water molecule, a characteristic that is
diagnostic for catalytic zinc-binding motifs (McCall, Huang and Fierke 2000).
Zinc binding proteins occur throughout the cell. As many zinc finger proteins fulfil
classical roles in transcriptional regulation, they play important roles in processes
involved in stress tolerance. For instance, the transcription factors Atf1 and Atf2 that
induce the expression of genes of the iron regulon, contain zinc-binding motifs. Other
zinc finger proteins that are involved in yeast stress tolerance are the transcription
factors Msn2 and Msn4 (Multicopy suppressor of SNF1 mutation 2 and 4) that
bind to the stress-responsive element (SRE) in S. cerevisiae. Also zinc finger
proteins that are not involved in the transcriptional regulation, for instance members
of the J-protein family, have functions that are crucial for cellular survival. In
mitochondria, zinc finger proteins are involved in several metabolic functions, such as
alcohol oxidation (Adh3, Adh4), respiration (CoxIV) or leucine biosynthesis (Leu9).
Furthermore, they include a series of zinc-binding metalloproteases such as Yta10,
Yta1 and Yme1. The small Tim-proteins Tim9 and Tim10 that are involved in the
import of proteins by the Tim22 import pathway are able to bind zinc ions (Pierrel,
Cobine and Winge 2007). Furthermore, the homodimeric IMS protein Sod1 that
plays an important role in the cellular defense against oxidative stress is stabilised
by the binding of a copper and a zinc ion (Ding and Dokholyan 2008; Zhao and Bai
2012). Finally, some J-proteins, important cofactors of Hsp70 chaperones, carry zinc
finger motifs, among them the yeast mitochondrial J-protein Mdj1. Recently, the
zinc-chelating mtHsp70 interacting protein Zim17 has been discovered (Burri 2004).
1.4. Zim17, a newly identified mtHsp70 cochaperone
The yeast mitochondrial zinc finger protein Zim17 (Zinc finger motif protein of 17 kDa)
belongs to a newly identified class of mtHsp70 cochaperones that are characterized
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by a central zinc ribbon domain (Krishna, Majumdar and Grishin 2003) consisting
of two CXXC motifs flanked by several ß-sheets (Momose 2007). Homologues of
Zim17 have been identified in chloroplasts and mitochondria of funghi as well as
plants and higher eukaryotes (Kluth 2012). However, there are no Zim17 proteins
known in bacteria or archea. Zim17 has also been termed Tim15 (Translocase of the
inner mitochondrial membrane 15) and Hep1 (Hsp70 escort protein 1). The name
Hep1 refers to the ability of Zim17 to prevent the aggregation of Hsp70 chaperones
in mitochondria of eukaryotic cells (Sichting 2005) while the name Tim15 derives
from an observed import defect in Zim17-depletant cells (Yamamoto 2005). However,
as it has been shown that Zim17 is not a part of the inner membrane translocase
(Sanjuán Szklarz 2005; Sichting 2005) it does not belong to the Tim proteins.
Cells lacking Zim17 (zim17∆) show severe phenotypic defects like the inability to
grow at elevated temperatures. Furthermore, it was observed that the loss of Zim17
leads to a respiratory-deficient phenotype (Sichting 2005). However, a tetrad analysis
of a newly generated zim17∆ strain yielded spores that were respiratory-competent
initially but showed a high frequency to generate a petite phenotype (Sanjuán Szklarz
2005). Zim17 is known to interact with both Ssc1 and Ssq1 in the mitochondrial
matrix of S. cerevisiaeand its binding site is most likely located in the mtHsp70
ATPase domain (Blamowska 2010; Zhai 2008). The binding of Zim17 seems to be
ATP-dependent and occurs preferably in the absence of nucleotides (Sichting 2005).
It has been demonstrated that the human and chloroplast Zim17 orthologues Hep1
and HEP2 are able to interact with their mtHsp70 partners also in the presence of
ATP, however, the binding under ATP-free conditions was much stronger (Goswami,
Chittoor and D’Silva 2010; Willmund 2008; Zhai 2008). Moreover, it was shown
that the human Zim17 orthologue Hep1 is able to enhance the ATPase activity of
Hsp70 proteins (Goswami, Chittoor and D’Silva 2010; Zhai 2008) a function that
was not observed for yeast Zim17 (Blamowska 2010; Sichting 2005). Though the
Hsp70-interaction site of human Hep1 has been confined to the region around a
highly conserved Asp-Asn-Leu (D111 N112 L113) motif close to the zinc-binding
residues, the exact nature of its interaction with Hsp70s is still unclear (Momose
2007; Zhai 2011). It has been reported, that the conserved aspartate at position 111
(D111) and a histidine residue at position 107 (H107) are probably part of the Hsp70
binding site (Momose 2007; Zhai 2011). In particular, H107 has been shown to be
essential for the ATPase-stimulating function of human Hep1 (Zhai 2011).
Because the highly conserved DNL motif is in close proximity to the zinc-binding
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residues, the cysteine rich region of Zim17 has been classified as DNLZ-type zinc
finger (Zhai 2011). The relevance of the zinc finger domain for the function of
Zim17 remains to be determined. It was shown that binding of the zinc atom has
a stabilising role in both yeast Zim17 and human Hep1. Yeast cells expressing
Zim17 mutants that are deficient in the binding of zinc were inviable (Yamamoto
2005). Furthermore, recombinantly expressed Zim17 zinc finger mutants formed
insoluble aggregates (inclusion bodies) in E.coli cells (Momose 2007). A recent study
showed that the binding of the zinc atom promotes stabilising effects through the
coordinating cystein residues C75 and C110 that particularly influence the region
around the residues R106, H107 and D111 (Fraga 2012). Furthermore, purified Zim17
seems to tend to form oligomers in solution that are, like the monomeric protein,
stabilised in the presence of zinc (Dores-Silva 2013). Dimeric forms of the chloroplast
Zim17-orthologue HEP2, as well as dimers of human Hep1 were observed before
(Willmund 2008; Zhai 2008), however, their functional significance remains to be
clarified.
In organello-experiments revealed that loss of Zim17 results in aggregation of the two
main mitochondrial Hsp70 chaperones Ssc1 and Ssq1 (Momose 2007; Sichting 2005).
An aggregation-preventive function has also been observed for the human Zim17
orthologue Hep1. It was thus suggested that the nucleotide-free form of mtHsp70
is prone to aggregation and that the primary function of Zim17 is to maintain its
solubility (Blamowska 2010). In support of this thesis, further studies indicated
that Zim17 participates in the de novo folding of the main yeast mitochondrial
Hsp70 chaperone Ssc1 while components of the mitochondrial protein quality control
system (Hsp60, Hsp78 and Hsp70 itself) did not seem to be involved in this process.
Furthermore, Zim17 was able to promote the re-folding of Ssc1 in vitro (Blamowska,
Neupert and Hell 2012). Conclusively, the aggregation-preventive character of Zim17
has been claimed to be its primary function (Blamowska, Neupert and Hell 2012;
Sanjuán Szklarz 2005). The aggregation of mtHsp70 proteins presumably leads to
other observed defects in zim17∆ cells, for instance an impaired import of matrix
destined preproteins (Burri 2004; Yamamoto 2005) and a loss of Fe/S enzymes
such as aconitase (Sichting 2005). These defects would consequently result in an
enrichment of disfunctional mitochondria and an instable respiratory competence
(Sanjuán Szklarz 2005). As a long-term consequence a nuclear genome instability
of zim17∆ cells that is possibly induced by the functional loss of the mitochondrial
Fe/S assembly machinery has been reported (Díaz de la Loza 2011). However, it has
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also been observed that other Hsp70 cochaperones can have stabilising effects as well
(Momose 2007). Furthermore, Zim17 orthologues from other species show functions
that differ from a simple aggregation prevention mechanism. While recombinant
Ssc1 tends to aggregate in the absence of Zim17, its orthologue in chloroplasts of
Chlamydomonas reinhardtii, HEP2, is rather needed to keep the chaperone HSP70B
in an active state (Willmund 2008). The human Zim17 orthologe Hep1, prevents the
aggregation of mtHsp70. However, Hep1 also shows the propensity to enhance the
ATPase activity of its chaperone partner (Zhai 2008). This data raises the question
if the prevention of mtHsp70 aggregation is the primary function of Zim17.
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1.5. Research objectives
The aim of this thesis was to gain further insight into the functional cooperation of
Zim17 with its Hsp70 binding partners. Recent studies suggest that the main function
of Zim17 is given by its aggregation-preventive influence on mtHsp70 proteins.
Phenotypic effects like a defect in the mitochondrial iron sulphur cluster assembly
machinery (Sichting 2005) or the import of preproteins into the mitochondrial matrix
(Burri 2004; Sichting 2005) were considered to derive secondarily due to a loss of
soluble Hsp70 chaperones. However, as the aggregation of mitochondrial Hsp70
chaperones in Zim17 defiecient yeast cells is not complete (Sichting 2005) and other
Hsp70 cochaperones seem to have a similar aggregation-preventive effect (Momose
2007), the question arises if the aggregation of mtHsp70 proteins alone can lead to
the prominent effects listed above.
One objective of this work was to study the role of the aggregation-preventive func-
tion of Zim17 and its interaction mechanism with Ssc1 in a biochemical approach.In
particular, the influence of Zim17 on the solubility of Ssc1 as well as the character
and stability of its binding to the chaperone were intended to be analysed. As the
zinc ligand of Zim17 was suggested to have a stabilizing character (Momose 2007),
recombinant Zim17 mutants that were unable to chelate the zinc ligand should
further be generated and analysed with regard to their effect on the solubility of
Zim17.
A second aim was the classification of the precise cochaperone function of Zim17
and its effects in a cellular context in vivo. A deletion of ZIM17 in S.cerevisiae
leads to a pleiotropic phenotype that makes it difficult to define the primary
effects of a Zim17 loss. To avoid the accumulation of secondary effects, condi-
tional Zim17 mutants with a temperature-sensitive behaviour were intended to
be generated. To clarify if the prevention of mtHsp70 aggregation is the main
function of Zim17, its influence on mtHsp70 solubility and on mtHsp70-dependent
processes should be examined. Specifically, the Ssc1-dependent import of precursor
proteins into the mitochondrial matrix and the Ssq1-dependent biogenesis of
Fe/S cluster-containing proteins were destined to be analysed in detail to identify
possible direct effects of the Zim17 loss of function on the mtHsp70 chaperone activity.
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2. Materials and Methods
2.1. Yeast and E.coli strains
Table 2.1.: E.coli strains
strain genotype origin
NEB-5α
fhuA2∆(argF-lacZ)U169 phoA glnV44 Φ80∆ (lacZ)
M15 gyrA96 recA1 relA1 endA1 thi-1 hsdR17
New England Biolabs
BL21 Codon plusr
(DE3)-RP
B F−B ompT hsdS(r
−
B m
−
B) dcm+ Tetr gal λ(DE3)
endA Hte [argU proL Camr]
Stratagene
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Table 2.2.: Yeast strains I
strain genotype origin
YPH499
MATa, ura3-52, lys2-801, ade2-101, trp1-∆63,
his3-∆200, leu2-∆1
EUROSCARF
BY4742 MATalpha, his3∆1, leu2∆0, lys2∆0, ura3∆0 EUROSCARF
PK82 Mat alpha, his4-713 lys2 ura3-52 leu2-3,112 trp1 Kang1990
PK81 (ssc1-2 )
Mat alpha, ade2-101 lys2 ura3-52 leu2-3,112 trp1,
ssc1-2(LEU2)
Kang1990
BGY-Fomp3-20-2
(zim17-2 )
Mat a, ade2-101, his3-∆200, leu2-∆1, ura3-52,
trp1-∆63, lys2-801 zim17::ADE2
pFLzim17-Ts2-CEN
S. Szklarz 2005
BGY-Fomp3-C1
(zim17-3 )
Mat a, ade2-101, his3-∆200, leu2-∆1, ura3-52,
trp1-∆63, lys2-801 zim17::ADE2
pFLzim17-Ts3-CEN
S. Szklarz 2005
BGY-Fomp3-6-4
(zim17-4 )
Mat a, ade2-101, his3-∆200, leu2-∆1, ura3-52,
trp1-∆63, lys2-801 zim17::ADE2
pFLzim17-Ts4-CEN
S. Szklarz 2005
yBG∆-Fomp3-2
(zim17∆)
Mat a, ade2-101, his3-∆200, leu2-∆1, ura3-52,
trp1-∆63, lys2-801 zim17::ADE2
S. Szklarz 2005
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Table 2.3.: Yeast strains II - strains generated in this study
strain genotype origin
ILY01
MATa, ura3-52, lys2-801, ade2-101, trp1-∆63, his3-∆200,
leu2-∆1 pFLzim17-corrWT-CEN
this work
ILY02
MATa, ura3-52, lys2-801, ade2-101 trp1-∆63, his3-∆200,
leu2-∆1 ZIM17∆ :: ADE2 pFLzim17-corrWT-CEN
this work
ILY08
MATa, ura3-52, lys2-801, ade2-101, trp1-∆63,
his3-∆200,leu2-∆, ZIM17-wt (LEU2)
this work
ILY09
MATa, ura3-52, lys2-801, ade2-101, trp1-∆63,
his3-∆200,leu2-∆, ZIM17-3a (LEU2), respiratory
incompetent
this work
ILY10
MATa, ura3-52, lys2-801, ade2-101, trp1-∆63,
his3-∆200,leu2-∆, ZIM17-3b (LEU2), respiratory
incompetent
this work
ILY20
MATa/alpha leu2∆0/leu2∆, lys2-801/lys2-∆0,
URA3/ura3-∆0, ade2-101/ADE2, trp1-∆63/TRP1,
his3-∆200/HIS3, zim17::LEU2/ZIM17
this work
ILY21
MATa/alpha leu2∆0/leu2∆, lys2-801/lys2-∆0,
URA3/ura3-∆0, ade2-101/ADE2, trp1-∆63/TRP1,
his3-∆200/HIS3, zim17-3a::LEU2/ZIM17
this work
ILY22
MATa/alpha leu2∆0/leu2∆, lys2-801/lys2-∆0,
URA3/ura3-∆0, ade2-101/ADE2, trp1-∆63/TRP1,
his3-∆200/HIS3, zim17-3b::LEU2/ZIM17
this work
ILY24 leu2, trp1-∆63, ZIM17::LEU2, respiratory-competent this work
ILY27 leu2, trp1-∆63, zim17-3a::LEU2, respiratory-competent this work
ILY28 leu2, trp1-∆63, zim17-3b::LEU2, respiratory-competent this work
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2.2. Plasmids
Table 2.4.: Plasmids used in this work
Vector purpose origin
pCRbluntIITOPO blunt end cloning Invitrogen
pGEM-4z
Cloning of proteins for in vitro translation,
SP6 and T7 promotor, Ampicillin
resistance
Promega
pETDuet
Procaryotic expression of proteins (E.coli),
T7-promotor, Ampicillin resistance
Novagen
pET28
Procaryotic expression of proteins (E.coli),
T7-promotor, Kanamycin resistance
Novagen
pDB10
Procaryotic co-expression of Ssc1 and
Zim17 in pETDuet
D. Becker,
unpublished results
pIL1/ pIL2
Procaryotic co-expression of Ssc1 and
Zim17 in pETDuet
this work
pIL4
Procaryotic expression of Zim17 in
pETDuet
this work
pIL1/ pIL2 Procaryotic expression of Ssc1 in pET28 this work
pIL6/ pIL7
Procaryotic expression of Zim17 zinc finger
mutants in pETDuet
this work
pIL8, pIL9, pIL10
Cloning of pre-Zim17 wt and zinc finger
mutants in pCRbluntII TOPO for in vitro
translation
this work
pFL39
Eukaryotic protein expression
(S.cerevisiae), modified pUC19
Bonneaud 1991
pFL-Zim17-ts2-CEN,
pFL-Zim17-ts3-CEN,
pFL-Zim17-ts4-CEN
Eukaryotic expression of Zim17-2, -3,
and -4 in pFL39
S.Szklarz 2005
pFL-Zim17-corrWT-CEN Eukaryotic expression of Zim17-wt this work
pRS415 Amplification of LEU2 Sikorski 1989
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2.3. Growth media
Table 2.5.: Growth media
Medium composition
yeast
YPD 10 g/l yeast extract, 20 g/l bacto peptone, 2% glucose, pH 5.0
YPG 10 g/l yeast extract, 20 g/l bacto peptone, 3% glycerol, pH 5.0
SD 6.7 g/l yeast nitrogen base w/o amino acids (Roth),
addition of amino acid supplements
(CSM -Trp/ -Leu/ -LeuTrp or CSM -URA), MP bio
presporulation medium 0.8% yeast extract, 0.3% bacto peptone, 10% glucose
sporulation medium 0.1% yeast extract, 1% Kaliumacetat,
CSM complete supplement mix (MP bio, Eschwege)
SOS 50% YPD, 1M sorbitol, 6.5mMCaCl2
bacteria
LB 5 g/l yeast extract, 10 g/l tryptone, 10 g/l NaCl
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2.4. Molecular biological methods
2.4.1. Polymerase chain reaction
2.4.1.1. Phusion-polymerase system
The polymerase chain reaction (PCR, Saiki 1985) was used to amplify DNA-fragments
from yeast genomic or plasmid DNA with the Phusion High-Fidelity DNA Polymerase
system (Thermo Scientific). PCR reaction mixes with a total volume of 50µl were
composed according to the instructions of the supplier and generally contained 1-fold
concentrated PHUSION-HF-buffer, 0.02U/µl polymerase, 200µM dNTP, 25pmol of
each oligonucleotide and 1-5 ng of plasmid DNA or 50-100 ng of genomic yeast DNA
respectively. Cycle conditions are shown in table table 2.6. Melting temperatures for
the annealing part of the applied oligonucleotides were calculated using the formular
Tm = 69.3 ◦C + (0.41 ◦C ∗ (G+ C)%)− 650/bp (2.1)
Generally, an annealing temperature 3-5 ◦C above the lower calculated melting
temperature was used.
Table 2.6.: Cycling conditions for PCR
Step Temperature Duration
Initial denaturation 98 ◦C 60 s
Denaturation 98 ◦C 10 s
Annealing Tm + 3 ◦C 15 s 35 cycles
Extending 72 ◦C 30 s per kb
Final Extending 72 ◦C 10min per kb
2.4.1.2. In vitro mutagenesis by overlap-extension PCR
The overlap extension PCR method (Higuchi, Krummel and Saiki 1988; Ho 1989)
was used to insert point mutations into DNA fragments. In a first step, two PCR
reactions were carried out to induce the desired mutation into the target sequence.
The first PCR applied a flanking forward primer in combination with an internal
reverse primer that contained the mismatched base pairs. For the second PCR, an
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internal forward primer and a flanking reverse primer were used. As the two inner
primers are reverse complementary to each other, two overlapping PCR fragments
were amplified. The PCR fragments act as primers for each other and thus were
combined via a primer extension reaction in a third PCR applying the two flanking
primers from step one.
2.4.2. Agarose-gelelectrophoresis
Depending on the size of the analysed DNA fragments, 1-2% agarose in TAE buffer
with 1 µg/µl Ethidiumbromid was used for the preparation of agarose gels. 1-10 µl
DNA samples were mixed with loading dye (10mM Tris/HCl, pH 7.6, 60% glycerol,
60mM EDTA, 0.03% Xylene Cyanol FF, 0.03% bromphenolblue) before loading on
the gel. Adequate markers from New England Biolabs (e.g. Quick load™1kb ladder
or Quick load™100bp ladder) were used as size standards. DNA fragments were
separated by applying an electric tension of 120-200V depending on the size of the
gel. Gels were analysed with the Bio doc analyze Biometra system (Analytik Jena).
To isolate DNA from a gel, bands were cut out under UV-light with a scalpel and
DNA was purified via a column using the innu PREP Gel extraction Kit (Analytik
Jena).
2.4.3. Restriction digest of DNA
For cloning of PCR fragments into plasmids, restriction sites were added via the
applied oligonucleotides. For restriction digests, enzymes and buffers from Fermentas
were used (Fermentas/ Thermo Scientific).
2.4.3.1. Analytical restriction digest
For a standard restriction digest for control purposes and analysis of vectors and
PCR fragments, 1µl DNA (between 200 ng and 1µg) was mixed with 1U enzyme,
1µl of the appropriate 10 x buffer and H2O in a total volume of 10µl. Samples were
incubated for 1h at 37 ◦C and subsequently analysed by agarose gelelectrophoresis.
2.4.3.2. Preparative restriction digest
To extract PCR products or cloned DNA fragments, approximately 10 µg DNA were
digested with 5U of the appropriate restriction enzymes as described above and
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incubated at 37 ◦C for several hours or over night. After gelelectrophoresis, DNA
fragments were extracted from the agarose gel as described in section 2.4.2.
2.4.4. Ligation
DNA fragments prepared by restriction digest were cloned into plasmids that were
cut with the same restriction enzymes (cloning via cohesive ends). Ligations were
performed using the Rapid DNA dephos. and ligation kit (Roche). For a 10µl
ligation reaction, 50-100 ng vector DNA were mixed with 1µl dilution buffer (Roche)
and water. The amount of insert was calculated using the formular
ng insert = ng vector ∗ kb insert
kb vector
(2.2)
1 µl T4 Ligase (Roche) was added and samples were incubated 20-25min at 25 ◦C.
5µl of the ligation preparation was used for the transformation of 50µl competent
E.coli cells (section 2.4.5).
2.4.5. Transformation of competent bacteria
Transformation of E.coli cells with plasmid DNA was performed using the strain
BL21cp for the expression of recombinant proteins (section 2.4.7). E. coli cells from
the strain NEB 5α (New England Biolabs) were used for cloning and replication
of plasmid DNA. 50µl of frozen competent E.coli cells were mixed with 10-100 ng
plasmid DNA. Cells were incubated 30min on ice, subjected to an 80 s heat shock
at 42 ◦C in a water bath and directly transferred to ice for 5min. 1ml of room
temperature LB medium was added and cells were incubated for 1h at 37 ◦C. 100µl
of each sample were plated directly on solid LB medium containing the appropriate
antibiotics to select successfully transformed cells. If the transformation efficiency was
low, the sample volume was reduced by collecting the cells with a 5min centrifugation
step at 4 500 rpm. Cell pellets were resuspended in 100µl LB medium and the whole
amount of transformed cells was distributed to selective LB medium. The plates
were incubated over night at 37 ◦C. Single colonies were picked and incubated in
liquid medium for further analyis.
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2.4.6. DNA isolation from E.coli
To isolate small amounts of plasmid DNA (for sequencing and control digests) or
large amounts of plasmid DNA (for instance for the transformation of yeast cells)
the GeneJETr Plasmid Miniprep or Midiprep Kits (Fermentas/ Thermo Scientific)
were used. DNA was isolated according to the manufacturers specifications and
resuspended in water (for sequencing) or in TE buffer (10mM Tris/HCl, 1mM EDTA,
pH8.0). The purity and concentration of DNA was determined photometrically
by measuring the absorption at 260nm and 280 nm with a BioPhotometer plus
(Eppendorf). DNA has an absorption maximum at 260 nm with an extinction E260
=1 at a concentration of 50 µg/µl double strand DNA. Measurement of the absorption
at 280 nm allows an estimation of the of contaminating proteins. A solution containing
pure DNA displays an E260/E280 ratio of 1.9.
2.4.7. Expression of recombinant proteins in E.coli
For the recombinant expression of proteins, the vector pETDuet from Novagen
was used. Transformed E.coli BL21cp were grown over night at 37 ◦C in 5ml LB-
medium containing the appropriate antibiotics. On the next day, the culture was
transferred into 50ml fresh medium and further incubated at 37 ◦C till an OD600 of
0.6-0.8 was reached. Protein expression was induced after 1h by addition of 0.1M
Isopropylβ-D-1-thiogalactopyranoside (IPTG). After 3-5h, the cells were harvested
by centrifugation at 4 500 rpm. Cell pellets were stored at −20 ◦C. Samples were
taken before and after the induction of protein expression and analysed by SDS-PAGE
(section 2.5.1) and Western blot (section 2.5.2).
2.4.8. Transformation of S. cerevisiae
For the transformation of yeast, cells were grown in YPD medium to an OD600 of
0.6-0.8. Cells were harvested by centrifugation at room temperature for 5min at
4 000 rpm, washed and resuspended in 1ml LiTE buffer (100mM LiOAc, 10mM
Tris/HCl, pH 7.4, 1mM EDTA, 1.2M Sorbitol). After 1h incubation at 37 ◦C, 2-10µg
plasmid DNA were added to 100 µl of cell suspension. After addition of 235 µl of 50%
PEG-4000, the cells were subjected to a 15min heat shock at 42 ◦C. After the heat
treatment, the cells were spun down, resuspended in 500µl SOS medium (table 2.5)
and incubated at 30 ◦C for 15min. 200µl of the cell suspension were distributed on
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selective medium lacking the appropriate amino acid to select successfully transformed
cells.
2.4.9. DNA isolation from yeast
2.4.9.1. Quick isolation of plasmid and genomic DNA
A method according to Hoffman and Winston (1987) was used to isolate plasmid
DNA from yeast cells , e.g for subsequent E.coli transformations. The same method
was used for yeast colony screening after in vitro mutagenesis. 5ml cultures were spun
down and resuspended in 400µl TSTES (2% Triton-X-100, 1%SDS, 10mM Tris/HCl
pH8.0, 100mM NaCl, 1mM EDTA). 200µl glass beads and 200µl phenol/chloroform
were added and the mixture was vortexed in short intervalls for 5-10min. After
centrifugation for 10min at 14 000 rpm, the aqueous phase was transferred to a fresh
tube and DNA was extracted two times with chloroform. 2.5Vol. ethanol were added
and precipitates were spun down 10min at 14 000 rpm. After two washing steps with
70% ethanol, DNA-pellets were dried and resuspended in 50µl aqua bidest.
2.4.9.2. Small scale isolation of genomic DNA for PCR and sequencing
To isolate genomic DNA from yeast for subsequent PCR and sequencing, cells were
grown in 1ml YPD to an OD600 of 0.5-0.7. Cells were harvested by centrifugation
at room temperature and 4 500 rpm for 5min. Cell pellets were put on ice and
resuspended in 150µl solutionA (50mM Tris/HCl pH7.5, 10mM EDTA, 0.3% β-
mercaptoethanol,0.5mg/ml Zymolase). After incubation at 37 ◦C for 1 h, 20 µl 10%
SDS and 100µl ammoniumactetate were added to precipitate proteins. The mixture
was vortexed and incubated at −20 ◦C for 15min. After a 15min clarifying spin
at 14 000 rpm and 4 ◦C, 180 µl of the supernatant fraction were mixed with 120µl
isopropanol. After a second centrifugation step, the DNA pellet was washed with
70% ethanol, dried and resuspended in 20-30µl TE buffer. 2µl of isolated genomic
DNA were used in a PCR reaction.
2.4.10. Whole cell yeast extracts for Western blot
To prepare protein extracts from yeast, 1OD of cells was spun down 5min at
4 000 rpm and resuspended in 1ml water. After addition of 148µl 2M NAOH and
12 µl β-mercaptoethanol, cells were vortexed and incubated for 10min on ice. 160µl
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50% trichloroacetic acid (TCA) were added and cells were incubated for another
10min. Precipitates were spun down 10min at 14 000 rpm and 4 ◦C and resuspended
in 35 µl 2 x Laemmli. 15 µl 1M Tris/HCl pH8.0 were added to neutralize residual
TCA. 5-10 µl of the cell extracts were analysed by SDS-Page and Western blot.
2.4.11. Subcellular fractionation of yeast cells
To separate mitochondria from the cytosolic fraction of yeast cells for Western blot
analyis, 1ml cultures of yeast cells were grown to an OD600 of 0.8-1.0. 1OD of cells
was harvested and resuspended in 1ml TEB-buffer (200mM Tris/HCl pH8,0, 20mM
EDTA, 1% β-mercaptoethanol). Cell suspensions were shaken for 10min at room
temperature, spun down for 5min at 4 000 rpm and resuspended in 1ml SPM-buffer
(1.2mM sorbitol, 50mM KPi, pH7.3, 1mM MgCl2). 150 µl of 10mg/ml Zymolase
dissolved in SPM buffer were added and cells were incubated for 60min at 37 ◦C.
Cells were spun down 5min at 4000 rpm, 4 ◦C, washed 3 x with SPM-buffer and put
on ice. Cell lysis was performed in SET-buffer (50mM Tris/HCl pH7.5, 200mM
Sorbitol, 1mM EDTA, 1 x PI) by pipetting up and down 20 times with a yellow
tip. After a clarifying spin for 5min at 500 x g and 4 ◦C, 1/10 of the supernatants
was taken as a total sample and mixed with 50 µl 2 x Laemmli. Mitochondria were
separated from the cytosolic fraction by a 10min centrifugation at 13 000 x g, 4 ◦C.
1/10 of the supernatant fraction containing cytosolic proteins was taken and mixed
with 50µl 2 x Laemmli. The mitochondria pellet was resuspended in 100 µl 1 x
Laemmli. 10-20µl of all fractions were analysed by SDS-PAGE and Western blot.
2.4.12. Isolation of mitochondria from S. cerevisiae
To gain high culture volumes of S. cerevisiae for a preparative isolation of mitochon-
dria, yeast cells were initially grown in 5ml of the appropriate growth medium (YPD,
YPG or in some cases selective medium) at 25 or 30 ◦C. After 3-5 days, the whole
culture volume was transferred into 200ml fresh medium and further incubated for
2-4 days. In case of slow growing yeast strains, the cells were grown in 50ml fresh
medium for 2-3 days before the whole culture was transferred to 200ml fresh medium.
Depending on the growth rate of the individiual yeast strains, 2 l cultures were
inoculated to an OD600 of 1.5-2.0 after growth over night. For wild type yeast cells a
doubling time of approximately 5h in YPG and 4h in YPD was assumed. However,
the doubling times can differ largely depending on growth medium, temperature or
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mutations and thus must be determined individually for each yeast strain. After
an OD600 of 1.5 was reached, cells were harvested by a 5min centrifugation step at
4 000 rpm in weighed centrifuge tubes at room temperature. Cell pellets were washed
with water and wet weight of the pellets was determined. After resuspension in 2ml
DTT-buffer(100mM Tris/H2SO4 pH9.4, 10mM Dithiothreitol (DTT)) per g wet
pellet weight, the cell suspensions were gently shaken at 25 or 30 ◦C for 20min. Cells
were harvested by 5min centrifugation at 4 000 rpm, washed with 100ml prewarmed
zymolase-buffer (20mM Kpi pH7.4, 1.2M sorbitol) and resuspended in 7ml zymolase
buffer per g wet pellet weight. 4mg/ml Zymolase were added and the cell suspension
was incubated for 1 h at 30 ◦C or for 2h at 25 ◦C respectively. The cells were spun
down, washed 1 x with zymolase buffer and were resuspended in homogenization
buffer(0.6M sorbitol, 4mM Tris/ HCl pH7.4, 1mM EDTA, 0.2%BSA). Cells were
put on ice immediately and disrupted in a homogenisator (’potter’). Lysates were
centrifuged 3min at 1 500 rpm directly followed by 4min at 3 000 rpm and 4 ◦C to
precipitate cellular debris. Supernatants were centrifuged at 4 000 rpm for 5min and
subjected to a 15min centrifugation step at 12 000 rpm. Mitochondria pellets were
resuspended in SEM-buffer (200mM sucrose, 1mM EDTA, 10mM MOPS/KOH
pH7.2) and subjected to another centrifugation step at 4 000 rpm. Supernatants
were collected and spun down 15min at 12 000 rpm. Pellets were resuspended in
SEM buffer, frozen in liquid nitrogen and stored at −80 ◦C.
2.4.13. Genomic integration
Zim17-mutants were inserted into the genome of S.cerevisiae through replacement
of the endogenous ZIM17 gene by homologous recombination. Mutant and wild
type (wt) ZIM17 genes were amplified from pFLzim17-Ts3-CEN and pFLzim17-Ts4
(obtained from the yeast strains BGY-Fomp3-C1 and BGY-Fomp3-6-4) and the
corresponding wild-type plasmid. For zim17-3a, zim17-4 and the corresponding
wt a forward primer annealing 88 nucleotides downstream the ZIM17 start codon
was chosen (A1-fw, table 2.8). To exclude the mutation at residue 79, a second
forward primer with an annealing sequence at position 217 in the ZIM17 ORF
was used to amplify the zim17-3b fragment (A1b-fw). The reverse primer for all
constructs, A2-rev, has an annealing side 115 bp downstream of the ZIM17 ORF. The
LEU2 gene was amplified from the vector pRS415 (Sikorski and Hieter 1989) using
the antisense-primer B2-rev and the sense-primer B1-fw that has a 20 nucleotide
extension complementary to the zim17 reverse primer sequence. Annealing parts of
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the oligonucleotides for amplification of the LEU2 marker were chosen as suggested
by Brachmann (1998). The LEU2 marker was fused to the mutant and wt ZIM17
fragments by overlap extension PCR (section 2.4.1.2) employing the forward primers
A1-fw and A1b-fw and the antisense oligonucleotide C-rev that contains a 55–bp
extension reverse complementary to a region of the 3’UTR of the ZIM17 gene. PCR
products were preserved by cloning into the vector pSC-B using the pSC-B blunt
cloning Kit (Stratagene). For insertion into the genome of S.cerevisiae, freshly
prepared PCR-products were transformed into YPH499 yeast cells containing a 2µ
URA3-containing plasmid Yep352 with the ZIM17 open reading frame between the
MET25 promoter and the CYC1 terminator (pGB8233, provided by Dr. Bernard
Guiard, Centre de Génétique Moléculaire, Université Pierre et Marie Curie, Gif-
sur-Yvette, France). Integrants were grown on minimal dropout medium lacking
leucine and uracil and subsequently replica-plated to the same medium containing
1 g/l 5-FOA to allow loss of the Yep-ZIM17 plasmid.
2.4.14. Random spore analysis
Genomic integrants were crossed with the wild-type strain BY4742 and diploid cells
were selected by growth on minimal dropout medium without leucine and tryptophane.
Diploid cells were grown on presporulation medium (table 2.5) and sporulation was
induced by subsequent subjection to sporulation medium. Sporulation was carried
out at 25 ◦C for 5-10 days until a sporulation rate of 50 % or higher was reached.
Tetrades were treated with 50 mg/ml zymolase at 30 ◦C. Asci and remaining diploid
cells were disrupted with glass beads and the remaining spores were plated out on
YPD medium. A random spore analysis was carried out by replica plating to drop-out
media lacking Leucine, Tryptophane or both. Temperature sensitivity and respiratory
competence of spores carrying the mutant zim17 alleles were assayed by subjection
to non-permissive temperature on both fermentable (YPD) and non-fermentable
(YPG) conditions. An overview of the yeast strains generated in this work is listed
in table 2.3.
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Figure 2.1.: In vitro mutagenesis of ZIM17.. Mutant and wt zim17 alleles were amplified from
the plasmids pFL-Zim17-ts3-CEN and pFL-Zim17-ts4-CEN (PCRA). LEU2 gene was amplified from
the vector pRS415 (PCRB). The products of PCRA and PCRB were fused via overlap-extension
PCR (PCRC) and inserted into the genome of S.cerevisiae via homologous recombination (genomic
integration).
2.5. Protein-biochemical and immunological methods
2.5.1. SDS-polyacrylamid-gelelectrophoresis (SDS-PAGE)
Proteins were separated by discontinuous SDS-polyacrylamid-gelelectrophoresis as
initially described by Laemmli (1970). Depending on the sizes of the proteins
of interest, 8-16% polyacrylamid (Rotiphoreser Gel30 (37.5:1), Roth) were used
for the preparation of gel mixtures according to table 2.7. The running buffer
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was composed of 50mM Tris/HCl pH8.3, 384mM Glycin and 0.1% SDS. As not
otherwise stated, samples were resuspended in 20µl 1 x Laemmli buffer (2% SDS,
5% β-mercaptoethanol 10% v/v Glycerin, 60mM Tris/HCl pH6.8 and 0.02% w/v
Bromphenol blue) and boiled for 5min at 37 ◦C. Large gels (125 x 140 x 1mm) were
subjected to an electric current of 20-35mA. For minigels (Biorad) a constant electric
tension of 200V was used. Gels were further analysed by Western blot (section 2.5.2)
and immunodetection (section 2.5.3) or stained and dried with a Model 543 geldrier
(Biorad, Munich). For staining, gels were incubated for 30min with Coomassie
stainer (10% v/v acetic acid, 30% v/v methanol, 0.1% w/v Coomassie brilliant
blue R-250) destained for 2-3 h in 10% v/v acetic acid and 30% v/v methanol.
Radioactively labelled proteins were detected by digital autoradiographie using the
FLA-5100 imaging system (FUJIFILM Life Science). Signals were quantified using
the programme Multi Gauge Version 3.2 (FUJIFILM Life Science).
Table 2.7.: Composition of polyacrylamid gels for SDS-PAGE
Component Resolving gel Stacking Gel
% Polyacrylamid 16 12.5 10 8
Rotiphoreser Gel30 (37.5:1) [ml] 9 6.9 5.7 4.6 0.83
1.857M Tris pH8.8 [ml] 3.5 3.5 3.5 3.5
0.6M Tris pH6.8 [ml] 0.5
10% SDS [µl] 170 170 170 170 50
aqua bidest [ml] 4.2 6.3 7.5 8.6 3.55
TEMED [µl] 100 100 100 100 50
10% APS [µl] 10 10 10 10 10
total Vol.[ml] 17 5
2.5.2. Western blot
For analyis via immunological methods, proteins were immobilized on polyvinylidene
difluoride (PVDF) membranes. Proteins separated by SDS-PAGE were transferred
to the membrane via semi-dry Western blot (Renart, Reiser and Stark 1979). Gels
were applied onto the PVDF membranes between several layers of Whatmann paper
(Rotilabor blotting paper 1mm, Roth) that was soaked in blotting buffer (20mM
38 2. Materials and Methods
Tris, 150mM Glycin, 0.02% SDS, 20% methanol) and proteins were transferred by
applying a constant electric current of 1mA/cm2 for 90min. After the transfer, the
membranes were stained with Coomassie stainer (section 2.5.1) and analysed by
immunodetection.
2.5.3. Immunodetection of immobilized proteins
For immunodetection, the PVDF membranes with immobilized proteins were blocked
45min in 5% milk powder that was dissolved in DEKO-SALT (50mM Tris, 150mM
NaCl, 0.05% Tween). Incubation with primary antibodies diluted 1 : 500-1 : 10 000
in DEKO-SALT was carried out for 1 h at room temperature or over night at
4 ◦C. To remove excess antibodies, the membranes were washed three times for
10min in DEKO-SALT. Incubation with the secondary antibody (peroxidase-coupled
anti-rabbit) was carried out for 45min. After three further washing steps, bound
antibodies were detected via a chemiluminescence reaction using the Lumi lightPLUS
reagent (Roche) according to the manufacturers specifications. Signals were detected
by applying a Super RX Medical X-Ray film (FUJIFILM Life Science) or with the
LAS-4000 Mini system (FUJIFILM Life Science).
2.5.4. Precipitation of proteins with trichloroacetic acid (TCA)
For the precipitation of proteins in a sample, 1/5 volumes 72% TCA were added to
the samples and incubated for 30min at 4 ◦C. Precipitates were spun down 30min at
14 000 rpm and 4 ◦C and washed with acetone. After a second 15min centrifugation
step, pellets were dried and resuspended in 1 x Laemmli buffer for SDS-PAGE and
Western blot analyis.
2.5.5. Purification of recombinant proteins via affinity tags
2.5.5.1. Purification under native conditions via a deka-histidine-tag
Recombinant proteins that were expressed in E.coli cells from pET-plasmids (sec-
tion 2.4.7) were purified via their histidine or Strep-tags respectively. All purification
steps were carried out on ice or at 4 ◦C respectively.
Histidine-tagged proteins were purified via Nitrilo-Tri-Acetic-Acid (NTA)-Agarose.
Frozen bacteria pellets from 100ml E.coli cultures (section 2.4.7) were thawed 15min
on ice and resuspended in 2ml lysis-buffer (50mM Tris/HCl pH7.4, 100mM KCl, 5%
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Glycerol, 2mM ATP, 5mM MgCl2, 1mM DTT, 1 x cOmplete EDTA-free Protease
Inhibitor Cocktail (Roche) 10mM imidazole, 1mg/ml Lysozyme) per gram wet pellet.
Cells were lysed for 30min and sonicated 5-10 times for 10 s on ice with a 10 s cooling
period between each burst. Lysates were centrifuged for 20min at 10 000 x g and
supernatants were subjected to Ni-NTA columns using 0.5ml 50% Ni-NTA slurry in
washing buffer (50mM Tris/HCl pH7.4, 100mM KCl, 5% Glycerol, 5mM MgCl2,
1mM DTT, 1 x protease-inhibitor coctail, 20mM imidazole) per 1ml cleared lysate.
The columns were incubated for at least 1 h at 4 ◦C on an end-over-end shaker. After
three washing steps with 3 x 2 column volumes washing-buffer, bound proteins were
eluted from the column with 4 column volumes elution buffer (50mM Tris/HCl
pH7.4, 100mM KCl, 5% Glycerol, 5mM MgCl2, 1mM DTT, 1 x protease-inhibitor
coctail, 20mM imidazole). Eluates were collected in 500µl fractions and analysed
by SDS-PAGE and Western blot. Fractions with the highest amounts of purified
proteins were combined, desalted by centrifugation at 6 000 rpm using centricons
(10 000 NMWL, Millipore)and further analysed by FPLC (section 2.5.6).
2.5.5.2. Purification under native conditions via a Strep-tag
For the purification of Strep-tagged proteins, pellets from 100ml E.coli cultures
were resuspended in 5ml of a buffer composed of 50mM NaH2PO4 pH8.0, 300mM
NaCl, 5% Glycerol, 5mM DTT, 1mg/ml Lysozyme and protease-inhibitors. After
30min incubation on ice, cells were sonicated 5-10 times for 10 s and subjected to
a clarifying centrifugation step as described above. Lysates were applied to a 5ml
Streptactin-Sepharose colum and incubated at least 1h at 4 ◦C on an end-over-end
shaker. Unbound material was removed by rinsing the column with 20ml washing
buffer (50mM NaH2PO4 pH8.0 300mM NaCl, 5% Glycerol, 5mM DTT) and elution
was carried out by applying 5ml washing buffer containing 2.5mM desthiobiotin.
Eluates were collected and desalted as described above and subjected to FPLC
analyis.
2.5.6. Fast protein liquid chromatography (FPLC)
Proteins that were purified from E.coli cells via Ni-NTA or Streptactin-Sepharose
were subjected to size exclusion chromatography. FPLC was carried out with
the ÄKTATM FPLCTM system (Amersham/ GE healthcare) using a Sephadex 75
column with 24ml total volume (Vt). A buffer composed of 30mM Tris/HCl, pH 7.4,
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50mM KCl, 5% Glycerol and 1mM DTT was used as running buffer. For FPLC
analyis of Zim17 30 µM ZnSO4 was added to the buffer. Chromatography runs were
programmed and analysed with the UNICORN softwarepackage (GE Healthcare),
Version 5.0.
2.5.6.1. Calibration of the Sephadex 75 column
Calibration of the Sephadex 75 column (figure 2.2) was done with the low molecular
weight gel filtration calibration kit (GE healthcare) consisting of conalbumin (75
kDa), carbonic anhydrase (29 kDa) ribonuclease A (13.7 kDa) and apronitin (6.5
kDa). The mobile phase volume (void volume) of the column was determined by
applying dextran blue, a substance that is not retained by the column material. The
kD value of each protein was calculated using the formular .
KD = VE − V0/Vt − V0 (2.3)
in which VE, Vt and V0 are defined as the elution volume, the total bed volume
and the void volume of the column. The KD values of each standard protein were
plotted against the logarithm of its molecular weight and the equation of the resulting
regression line was used to determine the molecular weight of proteins or protein
complexes of unknown size.
Figure 2.2.: Calibration of the Sephadex 75 column.
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2.6. Biochemical in-vitro and in-organello assays
Biochemical in-vitro and in-organello assays were intended to analyse specific func-
tions and interactions of proteins with substrates, nucleotides or binding partners in
an environment resembling the conditions in a living cell. As not otherwise stated,
all experiments were done at 4 ◦C. Analytical reagent grade chemicals (p.A) and
ultrapure water (Millipore quality) were used for all following experiments.
2.6.1. In-vitro translation of radiolabelled proteins in reticulocyte lysate
Radioactive labelling of proteins for in organello import assays was done with
the TNTr-coupled reticulocyte lysate systems (Promega). Proteins of interest
were either cloned into the Vector pGEM-4Z or directly translated from PCR
products by applying primers with a T7-promotorsequence. For a 50 µl translation
reaction applying Vector DNA as a template, 25µl TNTr rabbit reticulocyte lysate
(Promega, #4610) were mixed with 2 µl TNTr reaction buffer, 2 µl amino acid
mixture minus methionine, 1.5µl 40U/µl RNAsin and 1µg circular template DNA.
2 µl [35S]-methionine (EXPRE35S35S Protein Labelling Mix, 2mCi, 74MBq, Perkin
Elmer) and 2 µl TNTr RNA polymerase (SP6 or T7) were added and the reaction
mixture was filled up with RNAse-free water to a total volume of 50 µl. For a
translation reaction applying PCR products as a template, 40 µl TNTr PCR Quick
Master Mix were added to 2.5µl unpurified PCR product and 2µl [35S]-methionine.
RNAse-free water was added to a total volume of 50µl. All reaction mixtures were
incubated 90min at 30 ◦C for transcription and translation of the precursor proteins.
Ribosomes and aggregates in the samples were spun down by a 30min centrifugation
step at 45 000 rpm. Supernatants were mixed with 12.5µl 2.5% sucrose and analysed
by SDS-PAGE and digital autoradiographie. Samples were frozen in liquid nitrogen
and stored at −80 ◦C.
2.6.2. In-organello import of radiolabelled precursor proteins
2.6.2.1. Import into respiratory-competent mitochondria
To asses the import efficiency of different mutants, isolated yeast mitochondria
were incubated with radiolabelled preproteins in a time-course experiment. As not
otherwise stated, the artificial protein Su9(86)-DHFR, that consists of the N-terminal
pre-sequence and the first 20 mature residues of the Fo subunit9 of the F1Fo-
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ATPase from Neurospora crassa fused to the entire mouse dihydrofolate reductase
(DHFR) molecule was used as a model precursor. 50µg isolated mitochondria
per sample were taken and resuspended in p80 import buffer (250mM sucrose,
10mM MOPS/KOH pH7.2, 80mM KCl, 5mM MgCl2) containing 3% w/v BSA
(p803%) to a concentration of 0.25 µg/µl. 20mM Kpi, 2mM ATP, 2mM NADH
and 5mM MOPS/Met (0.2M MOPS/KOH pH7.2, 0.1M methionine) were added.
One sample containing 1% (v/v) AVO-Mix (50 µM valinomycin, 800 µM antimycin,
2mM oligomycin) to disrupt the inner membrane potential was pipetted for control
purposes. Depending on the individual translation efficiency, 1-10µl lysate containing
radiolabelled preproteins (section 2.6.1) was added and import reactions were carried
out for 20-40min depending on the experiment. As not otherwise stated, samples
containing 50µg mitochondria were taken at different time points and the import
reaction was stopped by addition of 0.5µM Valinomycin. Samples were put back on
ice, divided into halves and subjected to a 15min treatment with 100 µg/µl proteinase K
(PK). The PK reaction was stopped by addition of 100mM PMSF. Mitochondria were
spun down 10min at 14 000 rpm and washed 1 x with SEM-PMSF (250mM sucrose,
1mM EDTA, 10mM MOPS/KOH pH7.2). Mitochondrial pellets were resuspended
in 20µl 1 x Laemmli and analysed by SDS-PAGE and digital autoradiography.
2.6.2.2. Import into respiratory-deficient mitochondria
As the membrane potential (∆Ψ) of respiratory-deficient mitochondria is generally
low due to a lack of H+ ions deriving from oxidative phosporylation, excess ATP was
added to the import reaction to generate an artificial membrane potential. At low
levels of protons and high levels of ATP, the ∆Ψ-dependent ATP-generating reaction
that is catalysed by the F1Fo-ATPase can be reversed by using ATP to generate
a proton gradient over the inner mitochondrial membrane. 5mM ATP, 10mM CP
(creatine phosphate) and 10 µg/µl CK (creatine kinase) were added to the import buffer
(section 2.6.2.1). As the proton gradient generated by the reverse ATPase reaction is
usually not as stong as the gradient generated by the electron transport reactions of
the respiratory chain, the preproteins were denatured in a buffer containing 7M urea,
30mM MOPS/KOH pH7.2 and 1mM DTT to facilitate the import. Preproteins
were added to isolated mitochondria to a final urea-concentration of 2-4% and import
reactions were carried out as described above.
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2.6.3. Assessment of an inward-directed translocation force (’pulling’)
To test the pulling activity of Ssc1, another standard preprotein, b2(167)∆DHFR, was
imported into Zim17rc mitochondria in the presence of the DHFR ligand methrotrex-
ate (MTX). b2(167)∆DHFR consists of the pre-sequence and the first 89 N-terminal
residues of the mature cytochrome b2 fused to the entire mouse DHFR molecule. In
contrast to wild type cytochrome b2, the fusion protein b2(167)∆DHFR is targeted to
the mitochondrial matrix due to a deletion of the intermembrane space sorting signal
(amino acids 49 to 65). MTX binds to the DHFR domain of b2(167)∆-DHFR, thereby
stabilising its folding state and arresting the preprotein in the import channel. The
amino-terminal segment of the preprotein can reach the matrix compartment and
interacts with the translocation machinery. When Ssc1 is able to generate an intact
inward-directed force (’pulling’), the MTX-stabilised DHFR domain is pulled tightly
to the surface of the outer mitochondrial membrane and remains largely resistant to
externally added proteases. 25µl b2(167)∆DHFR were incubated with 5 µM MTX
for 5min at 25 ◦C prior to the import reaction. Import was carried out for 20min.
After the import reaction was stopped by addition of valinomycin, all samples were
treated with proteinase K as described above (section 2.6.2.1). To assess the total
import rate, one sample omitting the PK treatment was assayed for each mutant.
Samples were analysed by SDS-PAGE and digital autoradiography.
2.6.4. Assessment of the Ssc1 folding activity
To estimate the folding capacity of Ssc1, the propensity of the DHFR domain to
assume a tightly folded form inside the mitochondrial matrix was utilized in a special
assay applying proteinase K. The DHFR domain of Su9(86)DHFR becomes resistant
against low amounts of the protease after it has acquired its native conformation
in the matrix compartment. Thus, the amount of protease-resistant DHFR domain
after import into mitochondria is directly proportional to the folding activity of
Ssc1. Radiolabelled Su9(86)DHFR was denatured with 7M urea as described above
(section 2.6.2.2) and imported into isolated zim17rc mitochondria at 25 ◦C. After the
import reaction was stopped, mitochondria were washed with SEM-PMSF and lysed
in a buffer composed of 0.5% Triton x-100, 30mM Tris pH 7.4 and 200mM KCl and
5mM EDTA with or without 180 µg/ml proteinase K. Protease resistant proteins were
detected by SDS-PAGE and digital autoradiography, quantified and set in relation
to the overall amount of imported protein as described in section 2.6.3.
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2.6.5. Analysis of protein-interactions by pulldown experiments
2.6.5.1. Ssc1-pulldown with immobilised Zim17
To analyse the interaction of Ssc1 from mitochondrial lysates with immobilized
Zim17, 25 µg FPLC-purified Zim17-Strep (section 2.5.5.2 and section 2.5.6) was
immobilized on 50µl 50% Streptactin-Sepharose in solubilization buffer (30mM
Tris/HCl, pH7.4, 50mM KCl, 5% glycerol, 5mM MgCl2,1mM Zn-acetate, 1mM
PMSF and 1 x cOmplete EDTA-free Protease Inhibitor Cocktail, Roche) for 1 h at
4 ◦C. The column was washed 3 times in solubilitzation buffer, sealed and set aside.
320µg isolated mitochondria were spun down 10min at 14 000 rpm and resuspended
in a buffer composed of 5mM MgCl2 and 20mM Kpi in p80 buffer containing 0.1%
BSA. To create ATP-regenerating conditions, 2mM ATP, 4mM NADH and an
ATP-regenerating system consisting of creatine phosphate (10mM CP) and creatine
kinase (10 µg/µl CK) that transfers the phosphate group from creatin phosphate to
ADP, were added to the reaction. To deplete ATP from the samples, the uncoupler
Oligomycin (20µM) and 0.1u/µl apyrase, an enzyme that catalyses the hydrolysis
of ATP, were used. Samples were incubated for 15min at 25 ◦C. Mitochondria were
spun down, washed with SEM-PMSF and lysed under native conditions in 300 µl lysis
buffer (0.03% Triton-X-100 in solubilisation buffer) with or without 2mM ATP by
pipetting 20 x up and down with a yellow tip. Mitochondrial lysates were incubated
1 h at 25 ◦C with the prepared Zim17-Sepharose or with empty Streptactin Sepharose
as a control. Samples were spun down 2min at 1 000 x g. The supernatants were
removed and the columns were washed 5 times with 100 µl solubilization buffer.
Bound proteins were eluted with 25 µl 2 x Laemmli and samples were analysed by
SDS-PAGE and Western blot.
2.6.5.2. Ssc1-His pulldown via Ni-NTA
To analyse the binding of Zim17 to Ssc1 in its native environment, pull down
His-tagged Ssc1 from mitochondrial lysates were precipitated via Ni-NTA. 200 µg
mitochondria were resuspended in p80 buffer containing 0.1% BSA to a concentration
of 1 µg/µl. To generate nucleotide-free conditions, Apyrase and Oligomycin were added
to the samples in the concentrations described in section 2.6.5.1. Mitochondria were
incubated for 15min at 25 ◦C, spun down and lysed in 50 µl of a buffer composed of
1% Triton-x-100, 30mM Tris/HCl, pH7.4, 50mM KCl, 10% glycerol, 2mM MgCl2,
0.5mM Zn-acetate, 50mM imidazole, 1mM PMSF and 1 x cOmplete EDTA-free
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Protease Inhibitor Cocktail (Roche). ATP and NADH or Apyrase and Oligomycin
were added as described above. Samples were filled up to a volume of 200 µl with the
same buffer and transferred to a 50 µl Ni-NTA column. After 1h incubation at 4 ◦C
on an end-over-end-shaker, samples were spun down 2min at 3 000 rpm and washed
3 times with 100 µl ATP-free buffer. Bound proteins were eluted from the column
with 200µl of the same buffer containing 250mM imidazole. Proteins in the samples
were TCA-precipitated and analysed by SDS-PAGE and Western blot.
2.6.6. In vitro-analysis of Ssc1 substrate and nucleotide-binding properties
2.6.6.1. Binding of Ssc1 to immobilized ATP
2.6.6.1.1. Binding of purified Ssc1 to ATP-Agarose
To assess the ability of the purified Ssc1-His to bind and release nucleotides, 1µg
protein was diluted 1:10 in a buffer composed of 30mM Tris/HCl, pH7.4, 50mM
KPi, pH 7.4, 200mM KCl, 5mM MgCl2, 5% glycerol, 1mM PMSF and 1 x cOmplete
EDTA-free Protease Inhibitor Cocktail, Roche. The protein suspension was subjected
to 25 µl ATP-Agarose (Sigma) and incubated for 90min at room temperature on an
end-over-end shaker. Samples were spun down for 1.5min at 7 000 rpm and washed
3 times with 200µl buffer. Bound proteins were eluted by a 30min incubation at
room-temperature in the same buffer containing 2mM ATP followed by a second
elution step with 25µl 2 x Laemmli. All fractions were collected, TCA-precipitated
and analysed by SDS-PAGE and western botting.
2.6.6.1.2. Binding of Ssc1 from isolated mitochondria to ATP-Agarose
To test the nucleotide-binding properties of native Ssc1, 50 µg mitochondria were
spun down and resuspended in lysis buffer (100mM KCl, 100mM NaCl, 50mM KPi,
pH 7.4, 5mM MgCl2, 0.1% Trito-X-100, 5% glycerol, 1mM PMSF and 1 x cOmplete
EDTA-free Protease Inhibitor Cocktail). Samples were subjected to ATP-Agarose
and incubated 90min at room-temperature followed by 3 washing steps applying the
same buffer. Bound proteins were eluated with 2 x Laemmli.
2.6.6.2. Binding of Ssc1 to immobilized model substrate
2.6.6.2.1. Preparation of reduced carboxy-methylated α-lactalbumin (RCMLA)
To generate the permanently unfolded Ssc1 model substrate reduced carboxy-
methylated α-lactalbumin (RCMLA), 10.5mg (1.3mM α-lactalbumin were incu-
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bated in 1ml reducing buffer (200mM Tris/HCL, pH 8.7, 7M guanidiunium-chloride,
20mM DTT, 2mM EDTA for 90min at room temperature. Iodoacetic acid was
added to a final concentration of 100mM and the protein was further incubated for
20min under dark room conditions. The reaction was quenched with an with an ex-
cess of reduced glutathione (0.2M reduced glutathione in 200mM 0,2 M Tris, pH 7.5).
The sample was dialysed against 20mM KPi, pH 7.5 using a SpectraPor Dialysis
Membrane (MWCO 8000, Spectrum Labs) and applied to cyanogenbromide-activated
sepharose.
2.6.6.2.2. Coupling of RCMLA to Cyanogen bromide (CNBr)-activated Sepharose
0.5 g activated Sepharose (Cyanogen bromide-activated-Sepharoser 4B, Sigma) were
suspended in 1mM HCl on a glass filter. Sepharose was washed by repeated rinsing
with a total volume of 100ml 1mM HCl and and transferred into a fresh 15ml
Falcon tube. 10mg RCMLA were added in a volume of 2.5ml coupling buffer
(0.1mM NaHCO3, pH 8.3, 0.5M NaCl) and incubated 2 h at room temperature in
an end-over-end shaker. Sepharose beads were washed 1 x with coupling buffer and
residual active sites were blocked by 2 h incubation at room temperature in 0.1M
Tris/HCl pH8.0. Beads were washed three times in 0.1M sodium acetate, pH4.0
and subsequently three times in a buffer composed of 0.1M Tris/HCl pH8.0 and
0.5M NaCl. The RCMLA-Sepharose was stored in 0.1% sodium azide.
2.6.6.2.3. Binding of Ssc1 from isolated mitochondria to RCMLA-Sepharose
To analyse the binding of Ssc1 to RCMLA-sepharose, isolated mitochondria were
activated by a 15min incubation in a buffer consisting of 20mM Kpi pH7.4, 3mM
ATP and 3mM NADH in p80 buffer containing 3% BSA. Mitochondria were collected
by 10min centrifugation at 14 000 rpm for 10min and immediately resuspended in
lysis buffer (section 2.6.6.1.2). Samples were incubated with 50µl 1:3 RCMLA-
Sepharose in lysis buffer for 60min at room temperature, washed 3 times and eluted
with 3mMATP in the same buffer. Total and elution fractions were TCA-precipitated
and analysed by SDS-PAGE and Western blot.
2.6.7. Aggregation assay
Mitochondria were centifuged and lysed with 1 µl of a buffer composed of 30mMTris,
pH7.5, 200mM KCl, 5mM EDTA; 0.5% Triton; 5mM PMSF and 1 x cOmplete
EDTA-free Protease Inhibitor Cocktail per µg mitochondria. A 25µl total-sample
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was taken and the remaining lysate was subjected to a a high-velocity spin at
125 000 x g for 30min at 4 ◦C. Supernatants were removed and 25µl were taken as
a sample for SDS-PAGE. The pellets were re-extracted by vigorous shaking with
100µl lysis buffer and then centrifuged again at 125 000 x g for 30min at 4 ◦C. The
supernatants were discarded. Total, supernatant, and pellet samples were analysed
by SDS–PAGE, Western blot and incubation with specific antibodies. To assess
the aggregation of newly imported mtHsp70s, radiolabelled Ssc1 was imported into
isolated mitochondria. The import reaction was stopped after 15min by addition of
valinomycin. Mitochondria were re-isolated, treated with proteinase K as described
in section 2.6.2.1 and subjected to the aggregation assay as described above. Samples
were analysed by SDS-PAGE and digital autoradiography.
2.6.8. Assessment of Aconitase activity
To determine enzymatic activity of aconitase in mitochondrial lysates, isolated
mitochondria were centrifuged and lysed in homogenisation buffer (50mM Tris
pH7.4 and 0.2% laurylmaltoside). Mitochondrial lysates were then added to 1.4ml
quartz cuvettes containing 1ml of pre-warmed (30 ◦C) reaction buffer (50mM Tris
pH7.4 5mM sodium citrate; 0.6mM MnCl2, 0.2mM NADP+) followed by thorough
mixing. After addition of 0.1mg/ml isocitrate dehydrogenase, the aconitase activity
was measured in a GeneSys 10s UV-Vis Spectrophotometer (Thermo Scientific) by
following the increase in NADPH.
2.6.9. Assessment of the mitochondrial inner membrane potential ∆Ψ
The electric membrane potential (∆Ψ) of isolated mitochondria was assessed by
use of the potential-sensitive fluorescent dye 3,3’-dipropylthiadicarbocyanine iodide
(diSC3(5)) as described Waggoner (1976). Measurements were performed with a
fluorescence spectrometer (Aminco-Bowman) at 25 ◦C (excitation at 622 nm, emission
at 670 nm) in a buffer composed of 0.6M sorbitol, 0.1% (w/v) bovine serum albumin,
10mM MgCl2; 20mM KPi, pH 7.4; 5mM malate; 10mM glutamate.
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2.7. List of primers and oligonucleotides
Table 2.8.: List of primers and oligonucleotides used in this work
oligonucleotide sequence
pDB10-IL1-f 5’-CTG TTG CCG GTT CTT CTG GT-3’
pDB10-IL1-r+rbs 5’-TTT CAT ATG ATA CCT CCT GGA TTA TGC GGC CGT GTA CAA-3’
pDB10-IL2-r 5’-TTT CAT ATG CGC AAG CTT AGT GAT GAT GA-3’
pIL4-C78S-f 5’-GCA AGA AAT CTA ACA CCC GAT CGT CAC ACA-3’
pIL4-C78S-r 5’-TGT GTG ACG ATC GGG TGT TAG ATT TCT TGC-3’
pIL4-C100S-f 5’-GAA AGG TAC CGT CTT GAT CTC TTC TCC GCA CTG-3’
pIL4-C100S-r 5’-CAG TGC GGA GAA GAG ATC AAG ACG GTA CCT TTC-3’
pIL4-Zim17-f 5’-GGG AAT TGT GAG CGG ATA AC-3’
pIL4-Zim17-r 5’-TAA AGC TGC GCT AGT AGA CG-3’
gen-Zim17-f 5’-GGC GCC ACC ATG ATT CCG AGG ACT AGA AC-3’
gen-Zim17-r 5’-TCA TTT CTG GGA AAG GGT GAA GG-3’
Zim17-corrWT-f 5’-TAG CAG AAG CCC TGC GAG TA-5’
Zim17-corrWT-r 5’-GCG AAG CTT AGC ACA GCC CTC TTC CTC TT-3’
A1-fw 5’-ACG-TGT-GCC GTA CTC TAC CC-3’
A1b-fw 5’-TCA CCT GCA AGA AAT GTA ACA CC-3’
A2-rev 5’-AAT CTT CTG CTG GTT ATC GC-3’
B1-fw 5’-GCG ATA ACC AGC AGA AGA TTA GAT TGT ACT GAG AGT GCA C-3’
B2-rev 5’CTG TGC GGT ATT TCA CAC CG-3’
C-rev 5’-TGC GGT TCA ACT TTT CAT ATC TAG CAG TGG CTC ATC TTT ATG
TAC TCT AGT CCT ACT GTG CGG TAT TTC ACA CCG-3’
K-fw 5’-ATG ATT CCG AGG ACT AGA ACA-3’
K-rev 5’-GGT TGA CCC TAT CGC CAC TA-3’
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2.8. List of antisera
Table 2.9.: Antisera used in this study
Antiserum internal number dilution origin
AcoI 945 1:20 000 G
Cit1 208 1:1 000 F
CoxIV 577 1:500 G/F
GroEL 80322 1:1 000 M
Isu1 724 1:500 G
Jac1 228 1:500 F
Mge1 23210 1:1 000 W
Mdh1 1088 1:1 000 G
Mdj1 121 1:1 000 F
mrpL40 - 1:500 K
Pam18 752 1:500 G/F
Rip1 543 1:1 000 G/F
Sod2 1051 1:1 000 G
Ssc1 41756 1:5 000 M
Ssq1 213 1:1 000 F
Tim23 133 1:1 000 F
Tim44 128 1:1 000 F
Tom40 168 1:1 000 F
Zim17 554 1:500 G/F
Antisera were kindly provided by:
F = AG Pfanner, University of Freiburg, Germany; M = AG Neupert, Ludwig
Maximilians-University, Munich, Germany; W = E. Craig, University of Wisconsin-
Madison, Wisconsin, USA; K = S. Gruschke, University of Kaiserslautern, Germany
G = Antisera purchased from Gramsch Laboratories, Schwabhausen, Germany
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2.9. List of chemicals
AMS Bio, Abingdon, UK
zymolyase 20T
FUJIFILM Life Science, Düsseldorf
Super RX Medical X-Ray film
MP Bio, Eschwege
CSM -Leu, CSM -Leu/-Trp, CSM -URA
Qiagen, Hilden
Ni-NTA-Agarose, Strep-Tactin Superflow
Roche, Mannheim
adenosine triphosphate (ATP), cOmplete EDTA-free Protease Inhibitor Cocktail,
creatine kinase, creatine phosphate, Lumi LightPLUS Western blotting substrate
Roth, Karlsruhe
acetic acid, ammonium actetate, ammonium persulfate (APS), bacto peptone, bovine
serum albumine, bromophenol blue, calcium chloride, Coomassie brilliant blue R-250,
dextrose (glucose), dipotassium phosphate, dithiothreitol, dodecyl-β-D-maltoside
(laurylmaltoside), ethylenediaminetetraacetic acid (EDTA), ethanol, L-glutamic acid
(glutamate), glycerol, guanidinium chloride, hydrogen chloride, imidazole, iodoacetic
acid, isopropyl-β-D-1-thioglacatopyranoside (IPTG), lysozyme, magnesium chloride,
DL-malic acid (malate), manganese(II) chloride, methanol, β-mercaptoethanol,
3-(N-morpholino)propanesulfonic acid (MOPS), nicotinamide adenine dinucleotide
phosphate (NADPH and NADP+, PEG-4000, potassium acetate, potassium chloride,
potassium dihydrogen phosphate, 2-propanol, Rotilabor blotting paper 1mm,
Rotiphoreser Gel30, Rotir-phenol/ choroform/ isoamylaclohol, Rotir-PVDF,
sodium acetate, sodium azide, sodium chloride, sodium citrate, sodium dihydrogen
phosphate, sodium dodecyl sulfate, sodium hydrogen carbonate, sodium hydroxide,
sorbitol, dialysis membrane SpectraPor 7 MWCO 8000, sucrose, sulfuric acid,
trichloroacetic acid, Tris, Triton-X-100, tryptone, Tween-20, xylene cyanol, yeast
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extract, yeast nitrogen base, zinc acetate, zinc sulfate
Sigma, St. Louis, Missouri, USA
antimycin A, apyrase from potato, 5’ATP-Agarose 4B, Cyanogen bromide-activated-
Sepharoser 4B, D-desthiobiotin, 3,3’-dipropylthiadicarbocyanine iodide, glutathione,
oligomycin, peroxidase conjugate-goat anti-rabbit IgG, valinomycin
Thermo Scientific, Waltham, Massachusetts, USA
Phusion High-Fidelity DNA Polymerase
2.10. List of kits
Analytik Jena, Jena
innu PREP Gel Extraction Kit
GE Healthcare, Munich
Low molecular weight Gel filtration calibration Kit
Promega, Mannheim
TNTr-coupled Reticolocyte Lysate System
Roche, Mannheim
Rapid DNA Dephos & Ligation Kit
Stratagene, La Jolla, California, USA
StrataClone blunt PCR cloning Kit
Thermo Scientific, Waltham, Massachusetts, USA
Fermentas GeneJETr Plasmid Mini and Midiprep Kits, PHUSION high fidelity
PCR Kit
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2.11. List of laboratory instruments
Analytik Jena, Jena
Bio doc analyze Biometra System and associated software, Thermomixer TMix
Beckman Coulter, Krefeld
Avantir J-E centrifuge; Rotors: JA-10, JA-25.50
Biometra, Göttingen
Thermocycler (Trioblock)
Biorad, Munich
Model 534 Gel drier
Eppendorf, Hamburg
BioPhotometer plus, Centrifuge 5417-R, Centrifuge 5804-R; Rotors: A-4-44, F-34-6-
38, New Brunswick Scientific innovar Incubator shaker series, Thermomixer comfort
series
FUJIFILM Life Science, Düsseldorf
FLA-5100 imaging system and associated software, LAS-4000 Mini system and
associated software
GE Healthcare, Munich
Amersham ÄKTATM FPLCTM system and Sephadex 75 column
Thermo Scientific, Waltham, Massachusetts, USA
Aminco-Bowman fluorescence spectrometer, GeneSys 10s UV-Vis Spectrophotometer,
Varioklavr steam sterilizer
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2.12. List of software
Adobe, San Jose, California, USA
Adobe Illustrator CS2 and CS3, Adobe Photoshop CS6
Apple, Cupertino, California, USA
MAC OS X 10.6 Snow Leopard
FUJIFILM Life Science, Düsseldorf
Multi Gauge Version 3.2
GE Healthcare, Munich
UNICORN softwarepackage; Version 5.0
GraphPad Software, Inc., La Jolla, California, USA
GraphPad Prism; Version 5
Microsoft, Redmond, Washington, USA
Microsoft Office 2010, Windows 7 Home Premium
Free and Open Source Software
BioEdit Sequence alignment editor, Gimp Version 2.0, Libre Office 3.5.7.2, Linux
(Fedora 17 and 18), Mendeley Desktop Version 1.7.1, Serial Cloner Version 2.5,
LaTEX (TeX Life pdfTEX Version 3.14)
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3. Results
3.1. Co-purification and in vitro analysis of recombinant Ssc1 and Zim17
Zim17 is known to maintain the function of Hsp70 chaperones in mitochondria
of S. cerevisiae, most likely by preventing their aggregation in the mitochondrial
matrix. Deletion of ZIM17 in yeast cells leads to severe growth defects such as
temperature-sensitivity and respiratory deficiency, underlining its importance for
the functional integrity of mitochondrial Hsp70 systems. Because of the innate
tendency of mtHsp70 proteins to aggregate (Blamowska 2010), Ssc1, the main Hsp70
chaperone in the matrix of yeast mitochondria, is prone to form inclusion bodies
upon its recombinant expression in E.coli cells. As the aggregation is impeding its
purification under native conditions, recombinant Ssc1 has to be purified from yeast
mitochondria - a time consuming process with generally low yields of protein. Due
to its aggregation-preventive character, Zim17 was co-expressed with Ssc1 in E.coli
cells to allow a more efficient purification of the fully functional chaperone.
3.1.1. Co-expression of Ssc1-His and Zim17-Strep in E. coli
3.1.1.1. Generation of the expression vectors pIL1 and pIL2
The plasmid pDB10 (D.Becker, unpublished results) was used for the recombinant
expression of Ssc1 and Zim17 in E.coli cells. pDB10 derives from the vector pETDuet-
1 (Novagen). The original pETDuet-1 plasmid contains two multiple cloning sites
(MCS1 and MCS2) for the co-expression of proteins in E. coli cells (section A.2.1). In
case of pDB10, a copy of the SSC1 gene with a C-terminal 10-histidine tag and a copy
of the ZIM17 gene with a C-terminal Strep tag were cloned into MCS1 and MCS2 via
the NcoI/HindIII (MCS1, SSC1 ) and NdeI/XhoI (MCS2, ZIM17 ) restriction sites
respectively (section A.1.1). Expression of Ssc1-His and Zim17-Strep from pDB10
in the E. coli strain BL21cp resulted in a high overexpression of Zim17-Strep while
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the expression levels of Ssc1-His were low (figure 3.1, lane 2). In attempt to gain
comparable amounts of Ssc1 and Zim17, the original pDB10 plasmid was altered
to reduce the amounts of expressed Zim17. MCS1 and MCS2 of the pETDuet-1
vector contains two separate T7 promotors, each followed by a ribosome binding
site. The T7-promotor of MCS2 was removed by a restriction digest employing
the enzymes MfeI and NdeI to generate a single mRNA encoding both the SSC1
and the ZIM17 genes. The MfeI restriction site is located in the SSC1 coding
sequence 311 nucleotides upstream of the stop codon while the NdeI restriction site
lies at the 5’end of the ZIM17 insert. The 311 nucleotides at the 3’end of SSC1 -His
that were removed by the digest were amplified using the primer pair pDB10-IL1-f
and pDB10-IL1+rbs-r (table 2.8). The PCR product was digested with MfeI and
NdeI and re-inserted into the plasmid (section A.1.1). A new ribosome binding site
upstream of the ZIM17 -gene was added via the reverse primer pDB10-IL1+rbs-r
that contains a Shine Dalgarno sequence (5’-AGGAGG-3’). In a second approach,
the reverse primer pDB10-IL2-r without the Shine Dalgarno sequence was used,
resulting in the plasmid pIL2 that lacks both the T7 promotor and the ribosome
binding site of MCS2. pIL1 and pIL2 were transformed into E. coli BL21cp cells
and protein expression was induced by IPTG. A Western blot analyis of E. coli cell
lysates showed that in case of pIL1 the expression levels of Zim17-Strep were similar
to its expression levels when the plasmid pDB10 was used. In case of pIL2 the
expression levels of Zim17-Strep were considerably reduced and comparable to the
levels of Ssc1-His (figure 3.1, lanes 6 and 10). However, a third translation product
with a size of approximately 21 kDa (Zim17*) occurred during the expression from
pIL2. Zim17* is translated from an additional ATG close to the 3’end of the SSC1
gene that is in frame with the ZIM17 insert. Zim17* thus represents a Zim17 protein
with a 25 amino acid extension at its N-terminus (see section A.1.1). A solubility
test showed that 100% of the Zim17*-artefact was found in a nonsoluble, aggregated
form (figure 3.1, lanes 11 and 12). It therefore can be assumed that Zim17* is most
likely non-functional and does not interfere with Zim17 or Ssc1 in the E. coli cell.
3.1.1.2. Limited Ssc1 solubility in E. coli in the presence of Zim17
To assess the aggregation behaviour of the co-expressed proteins in the cytosol of
E. coli, cells were collected, lysed and inclusion bodes were separated from soluble
proteins by centifugation at 14 000 rpm as described in section 2.6.7. Samples
were analysed via SDS-PAGE and Western blot followed by immunodecoration with
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Figure 3.1.: Expression levels of Ssc1-His and Zim17-Strep in E. coli. Zim17-Strep and Ssc1-His
were expressed in E. coli cells from the vectors pDB10, pIL1, pIL2 and pIL5. Cells were lysed and
soluble material was separated from insoluble inclusion bodies by a high velocity centrifugation step.
Cell extracts before (-) and after (+) induction of protein expression with IPTG, supernatant (S) and
pellet (P) fractions were analysed via SDS-PAGE, Western blot and decoration with antibodies against
the indicated proteins. Zim17* = Zim17-artefact derived from an additional ATG in the SSC1-His gene
(see text).
specific antibodies against Zim17 and Ssc1. To compare the aggregation behaviour of
Ssc1 in the presence of Zim17 to its aggregation behaviour in the absence of Zim17,
the plasmid pIL5 that was generated by cloning Ssc1 into the vector pET28 (Novagen)
was used as a control. Upon expression in E. coli BL21cp from pIL5, almost 100%
of the soluble fraction of Ssc1 was found in insoluble inclusion bodies (figure 3.1,
pIL5, lane 13 and 14). Approximately 50% of the recombinant Ssc1 aggregated in
all three E. coli strains that were co-expressing Ssc1-His and Zim17-Step (figure 3.1,
pIL1, pIL2 and pDB10, lanes 4, 8, 12), even in the presence of saturating amounts of
Zim17 (pIL2, figure 3.1, lanes 3, 4, 7, 8, 11, 12). Similarly, about 50% of Zim17-Strep
was found in the form of insoluble aggregates (inclusion bodies). In summary, only a
part of the total Ssc1 amount was efficiently protected from aggregation upon its
co-expression with Zim17 in the cytosol of E. coli cells.
3.1.2. Purification and FPLC analysis of Ssc1-His in the presence of Zim17
To examine the interaction between Ssc1 and Zim17 more closely and to gain highly
purified proteins for further in vitro assays, Ssc1-His was purified and analysed via
FPLC (section 2.5.6). After co-expression from pIL1 and pIL2 in E. coli BL21cp,
cells were lysed and applied to Ni-NTA-Agarose. Subsequent FPLC analysis of the
purified Ssc1-His using a Sephadex75 column was performed by W. Tomberg at the
Institute for Biochemnistry and Molecular Biology in Bonn.
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3.1.2.1. FPLC analysis in presence of high Zim17 amounts
When expressed from pIL1, Ssc1 and Zim17 eluted at volumes corresponding to
molecular weights of approximately 90.3 and 30.6 kDa (figure 3.2A). A Western
blot analysis showed that the fraction that eluted at a volume corresponding to a
molecular weight of 90.3 kDa contained a mixture of Ssc1 and Zim17 (figure 3.2B,
lanes 1-3). Zim17, together with small amounts of remaining Ssc1, was detected in
the fractions containing a protein species of 30.6 kDa (figure 3.2B., lanes 4-6). As
this molecular weight represents the mass of approximately two Zim17 molecules,
the results strongly suggest that Zim17 might occur as a dimer during its interaction
cycle with Ssc1. In support of this idea, decoration with the Zim17 antibody showed a
second Zim17 signal at a size of approximately 36 kDa in all Ssc1-containing fractions,
probably representing remaining dimers in the samples that were not solubilized
by the SDS in the Laemmi buffer. However, the calculated molecular weight of
90.3 kDa in the Ssc1-containing fractions corresponds to the molecular weight of
an Ssc1 molecule with only a single Zim17 molecule attached, implying that Zim17
interacts with Ssc1 in its monomeric form. A third peak at a molecular weight
of 8.3 kDa (figure 3.2B, lanes 7-10) most likely represents the translation-product
deriving from one of the in-frame ATG codons in the Zim17 sequence (section A.1.1).
Monomeric Zim17 was also detected in these fractions, probably due to an overload
of the column.
3.1.2.2. FPLC analysis in presence of low Zim17 amounts
In case of pIL2, the expression levels of Zim17 are much lower than in case of pIL1
and thus more likely to resemble the in vivo situation in yeast mitochondria. When
expressed from pIL2, two main peaks corresponding to molecular weights of 92.6 and
7.6 kDa were observed in the FPLC (figure 3.3A). In a Western blot analysis, both
Ssc1 and Zim17 were detected in the fractions that eluted at a volume corresponding
to a molecular weight of 92,6 kDa (figure 3.3B, lanes 1-6) while hardly any Zim17
remained in the fractions containing a protein species of 7.6 kDa. These results are
in consistence with the observations made for pIL1. A third peak, that eluted at a
volume corresponding to a molecular weight 29 kDa and thus most likely represents a
dimeric form of Zim17 (section 3.1.2) was hardly visible. In a Western blot analysis
of the appendant fractions, Zim17 and remaining Ssc1 were detected (figure 3.3B,
lanes 7-10). While the Ssc1 signal most likely derives from a column overload, the low
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Figure 3.2.: FPLC analysis of
Ssc1 in the presence of high
Zim17 amounts. FPLC analy-
sis of Ssc1-His purified from pIL1.
(A) FPLC result (B)Western blot
analyis of the FPLC fractions.1 µg
protein from protein-containing
FPLC fractions were applied on
a 15% SDS-Gel and analysed
via Western blot and incubation
with antibodies against Zim17 and
Ssc1. Due to an overexposure,
parts of the Zim17 signal appear
as a white area.** putative Zim17-
dimer.
abundance of dimeric Zim17 supports the theory that the cochaperone interacts with
Ssc1 in its monomeric form while it tends to form dimers in solution. In contrast to
pIL1, where Zim17 was expressed in saturated amounts and a large moiety of its
unbound form remained, almost all Zim17 was associated with Ssc1 molecules when
the proteins are co-expressed from pIL2.
3.1.2.3. ATP-binding properties of FPLC-purified Ssc1
To test the functionality of the purified recombinant Ssc1, its ability to interact with
ATP was determined. FPLC-purified Ssc1 expressed from pIL1 was taken and bound
to immobilized ATP as described in section 2.6.6.1.1. Bound protein was washed
from the coulumn with excess ATP followed by a second elution step with Laemmli
buffer to remove all remaining proteins from the column. Samples were analysed
via SDS-PAGE, Western blot and subsequent incubation with antibodies against
Ssc1. Approximately 50% of the total amount of applied Ssc1 was bound to the
immobilized ATP confirming that its general ability to interact with nucleotides
remained (figure 3.4). However, while Ssc1 could be eluted from the column with
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Figure 3.3.: FPLC analysis of
Ssc1 in the presence of low
Zim17 amounts. FPLC analy-
sis of Ssc1-His purified from pIL1.
(A) FPLC result (B)Western blot
analysis of FPLC fractions. 1 µg
protein from protein-containing
FPLC fractions was applied on a
15% SDS-Gel and analysed via
immunoblotting with antibodies
against Zim17 and Ssc1.
Laemmli buffer, the chaperone kept stably associated with the immobilized nucleotides
when an elution step with excess ATP was performed, indicating a diminished ability
to hydrolyse ATP or to release ADP from its nucleotide binding pocket after hydrolysis.
Furthermore, it was noted that a subset of the copurified Zim17 stayed attached to
the Hsp70 chaperone during its interaction with the immobilized nucleotides.
Figure 3.4.: ATP-agarose assay with purified Ssc1 Ssc1
was expressed in E. coli from pIL1 and purified via Ni-NTA
and FPLC. 1 µg total protein taken from FPLC-fraction A6
(figure 3.1) was bound to 100µl immobilized ATP. T Total,
fl. flow through, W1/W3 washing steps 1 and 3, E elution
with excess ATP, Lä elution with Laemmli
3.1.3. Purification and FPLC analysis of Zim17-Strep
Even after a purification via FPLC, Zim17 and Ssc1 could not be totally separated
from each other. To obtain highly purified Zim17, an E. coli expression vector that
solely carried the ZIM17 gene was generated. ZIM17 -Strep was taken from pDB10
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Figure 3.5.: FPLC analysis of
Zim17. FPLC analysis of Zim17-
Strep purified from pIL4. (A)
Coomassie-stain of E. coli BL21cp-
cell extracts before (-) and af-
ter (+) induction of protein ex-
pression from pIL4 with IPTG.
Overexpressed Zim17-Strep is in-
dicated by an arrow.(B) FPLC re-
sult (C) Western blot analysis of
FPLC fractions. 1 µg protein from
protein-containing FPLC fractions
was applied on a 15% SDS-Gel
and analysed via immunoblotting
with an antibody against Zim17.
** putative Zim17-dimers *** pu-
tative Zim17-multimers.
and cloned into MCS1 of the empty pETDuet plasmid via the NdeI/XhoI restriction
sites resulting in the plasmid pIL4. After expression in the E. coli strain BL21cp
(figure 3.5A) Zim17 was purified via StrepTactin-Sepharose and an FPLC analyis
was performed as described above. In consistence with the observations described
above (section 3.1.2.1) Zim17 eluted as a dimer at a volume corresponding to a
molecular weight of 32.2 kDa. Additionally, two small peaks corresponding to 89.7
and 7.6 kDa were detected (figure 3.5B). Western blot analysis and incubation with
a Zim17 specific antibody showed signals at the size of its monomeric (17 kDa) and
dimeric form (34 kDa) in the elution fractions that contained a protein species of
approximately 32.2 kDa (figure 3.5B, lanes 2-5). The elution of a protein species with
ab approximate molecular weight of 89.7 kDa probably derives from an interaction
of Zim17 with the E.coli Hsp70 protein DnaK. In a Western blot analysis of these
fractions, momomers, dimers and potential multimers with a molecular weight
>100 kDa were detected by the Zim17 antibody, the latter probably representing an
aggregated form of the protein.
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3.1.4. Nucleotid-dependency of the Zim17-Ssc1 interaction
The interaction of Hsp70 proteins with most of their cochaperone binding partners is
dependent on their nucleotide binding state. It has been shown that Zim17 interacts
with Ssc1 most likely in its nucleotide-free form (Sichting 2005). However, when
purified Ssc1 was applied to ATP agarose, Zim17 was found in the elution fractions,
indicating that it is also able to interact with Ssc1 in the presence of nucleotides
(figure 3.4, section 3.1.2.3). To assess the dependence of the Zim17 interaction on
the ATP binding state of Ssc1 in more detail, two different approaches of binding
experiments with native Ssc1 obtained directly from mitochondrial lysates were
performed.
3.1.4.1. Ssc1 interacts with immobilized Zim17 preferably in the absence of ATP
Ssc1-free Zim17-Strep that was purified upon expression from pIL4 was immobilized
on a Streptacin sepharose column. 300 µg mitochondria isolated from the wild
type yeast strain PK82 were incubated for 20min at 37 ◦C under ATP-depleting
or ATP-regenerating conditions. To deplete ATP from the samples the uncoupler
oligomycin and the enzyme apyrase were added. ATP regenerating conditions
were provided by addition of creatine kinase and its substrate creatine phosphate
(section 2.6.5.1). Mitochondrial lysates were prepared under native conditions in a
Triton-X100 containing buffer as described in section 2.6.5.1 and subjected to the
immobilized Zim17. Proteins in the total and elution fractions were TCA precipitated
and analysed via SDS-PAGE, Western blot and incubation with specific antibodies as
shown in figure 3.6 lane 5. Ssc1 seemed to interact with Zim17 preferably at ATP-free
conditions, while the binding to Zim17 in the presence of ATP was indistinguishable
from its binding to an empty Streptactin column (lanes 3 and 6). However, the
possibility that Ssc1 interacts with the immobilized Zim17 in a substrate-like manner,
cannot be excluded.
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Figure 3.6.: Binding of Ssc1 to immobilized Zim17.
25µg FPLC-purified Zim17-Strep (figure 3.5) were immo-
bilized on 50µl Streptacin sepharose. The binding of Ssc1
from mitochondrial lysates was assayed in the presence (lanes
2 and 5) and absence (lanes 3 and 6) of nucleotides. Pro-
teins were eluted from the column with Laemmli buffer and
analysed via immunoblotting with antibodies against Zim17
and Ssc1. Zim17-free Streptactin was used as a control
(lanes 1 and 4).
3.1.4.2. Ssc1 interacts with Zim17 in organello in the absence of ATP
To assess the interaction of Ssc1 with native amounts of Zim17 in organello, isolated
mitochondria of an S. cerevisiae strain carrying a copy of the SSC1 gene with
a C-terminal histidine tag were subjected to a Ni-NTA column as described in
section 2.5.5.1. Before lysis, all mitochondria were pretreated 15min at 25 ◦C under
ATP-depleating or ATP-regenerating conditions as described above. As the zinc-
binding properties of Zim17 make it prone to interact with the Ni-NTA itself,
high concentrations of imidazole (50mM) were used in the washing steps to elute
unspecifically bound protein from the column. As a control, mitochondria of the
S. cerevisiae PK82 wild type strain were used to exclude an unspecific binding of
Zim17 to the Ni-NTA matrix. Proteins in the elution fractions were precipitated with
TCA and subjected to SDS-PAGE and Western bot analysis followed by incubation
with specific antibodies against Ssc1 and Zim17. Immunoblotting with antibodies
against the Ssc1 cochaperones Mdj1 and Mge1 was carried out as positive controls.
While the binding of Ssc1 to the nucleotide exchange factor Mge1 is known to
be diminished by the addition of nucleotides (Miao, Davis and Craig 1997), its
interaction with the J-protein Mdj1 should be stable in the presence of ATP. Binding
of Ssc1 to the Ni-NTA matrix occurred in the samples containing the histidine-
tagged protein while no signal was detectable in the elution fractions of the control
samples containing wild type Ssc1. As expected, Mdj1 coeluted with Ssc1-His in the
presence of ATP (figure 3.7, lane 8) while Mge1 eluted in the absence of nucleotides
(figure 3.7, lane 6). Though the interaction of Zim17 with the Ni-NTA matrix is quite
strong, almost all background signals could be removed due to the stringent washing
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Figure 3.7.: Interaction of Zim17 with Ssc1-His. 200 µg mitochondrial lysates from an ssc1-his-yeast
strain were subjected to 50 µl Ni-NTA in the presence and absence of nucleotides. Proteins were eluted
from the column with 250mM imidazole and analysed via Western blot and incubation with antibodies
against the indicated proteins. Wild type mitochondria from the S. cerevisiae strain PK 82 were used as
a control.
conditions. As it was observed before (Sichting 2005), Zim17, similar to Mge1, was
coeluted with Ssc1 only under nucleotide-free conditions (figure 3.7, lane 8).
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3.2. Role of the zinc-chelating cysteine residues in Zim17
3.2.1. Generation of the zinc finger mutants zim17-C78S and zim17-C100S
The zinc-chelating residues in Zim17 are believed to be essential for the protein to
gain and maintain its native structure (Momose 2007). However, little is known
about the importance of the zinc-binding domain for the cochaperone function of
Zim17. In attempt to assess if a diminished binding of the zinc atom affects the Zim17
interaction with Ssc1, two zinc finger mutants were created by an exchange of the
cysteine residues at positions 78 and 100 with serines. The mutations were inserted
into the mature form of ZIM17 by overlap extension PCR (section 2.4.1.2) via the
internal primers pIL4-C78S-f/r and pIL4-C100S-f/r respectively. The plasmid pIL4
(section 3.1.3) was used as a template. The subsequent fusion PCR was performed
using the flanking primers pIL4-Zim17-f and pIL4-Zim17-r that anneal at the 5’- and
3’-end of ZIM17, omitting the residues of the presequence. The PCR products were
inserted into the empty pETDuet vector via the NdeI and XhoI restriction sites of
MCS2 resulting in the plasmids pIL6 (C78S) and pIL7 (C100S).
3.2.2. Solubility of Zim17 zinc finger mutants in E. coli
Protein expression from pIL6 and pIL7 was induced in E. coli BL21 cp cells and
a solubility test followed by SDS-PAGE and Western blot analysis was performed.
As already observed by Momose (2007), both Zim17-C78S and Zim17-C100S were
detected as insoluble aggregates in the E. coli cell lysates (figure 3.8). As the zinc
finger mutants were not able to achieve a native folding state, no further purification
or co-expression assays were performed in E. coli.
Figure 3.8.: Expression levels and solubility
of Zim17-C78S and Zim17-C100S in E. coli.
Zim17-C78S and C100S were expressed in E. coli
cells from the vectors pIL6 and pIL7. Cells were
lysed and soluble material was separated from
insoluble inclusion bodies as described in sec-
tion 3.1.1.2. - cell extracts before induction of
protein expression. + protein expression from
plasmids induced with IPTG. S Supernatant, solu-
ble proteins P Pellet, insoluble proteins (inclusion
bodies).
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3.2.3. Zim17 zinc finger mutants are soluble after import into isolated yeast
mitochondria
3.2.3.1. Generation of the preforms of the zinc finger mutants for in vitro translation
As the cytosol of E. coli cells provides a non-natural environment for the expression
of yeast proteins, the formation of insoluble aggregates may occur to a less severe
extent in the matrix compartment of yeast mitochondria. To estimate the solubility
of the zinc finger mutants in the mitochondrial matrix, precursor forms of the zinc
finger mutant proteins were generated and imported into isolated mitochondria of
the S. cerevisiae YPH499 wild type strain. The mutations were inserted into the
ZIM17 gene by overlap extension PCR, using the internal primers pIL4-C78S-f/r
and pIL4-C100S-f/r in combination with the flanking primers gen-Zim17-r and gen-
Zim17-f that anneal at the 5’- and 3’-ends of the ZIM17 ORF. For control purposes,
the precursor form of the wild type ZIM17 gene was amplified additionally. Genomic
DNA of the yeast strain BY4741 was used as a template. The forward primer
gen-Zim17-f that was used for the fusion PCR contains a KOZAK sequence at its
5’-end, that provides a ribosome binding site. The PCR products were inserted into
the pCR-BluntII-TOPO vector (Invitrogen) via blunt end cloning, resulting in the
plasmids pIL8 (pre-ZIM17 ), pIL9 (pre-zim17-C78S) and pIL10 (pre-zim17-C100S).
Radioactively labelled proteins were generated by in vitro translation (section 2.6.1)
using the SP6-promotor of pCR-BluntII-TOPO.
3.2.3.2. In organello import and solubility test of Zim17 zinc finger mutants
The radioactively labelled Zim17 wild type and zinc finger mutant proteins were
imported to isolated mitochondria as described in section 2.6.2.1. Samples were taken
at the time points indicated in figure 3.9A, treated with proteinase K and analysed via
SDS-PAGE and digital autoradiography. All three proteins were imported efficiently
to a protease-protected location. The precursor forms of the different Zim17 proteins
were not degraded by the externally added protease, indicating a slow processing
probably due to the short length of Zim17.
To assess the solubility of the imported zinc finger mutants, an aggregation test
was performed after a 30min import reaction. Mitochondrial lysates were prepared
directly after the import reaction and subjected to a high velocity centrifugation step
as described in section 2.6.7. In contrast to their aggregation behaviour in E. coli cells,
both zinc finger mutants were 100% soluble in the mitochondrial matrix (figure 3.9B),
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Figure 3.9.: Import and solubility of Zim17-C78S and C100S in yeast mitochondria. (A)
Radiolabeled Zim17-wt, -C78S and -C100S were imported into isolated YPH499 wild type mitochondria
for 30min. (B) Aggregation assay after 30min of import. Mitochondria were lysed in a Triton-X-100
containing buffer and subjected to an ultracentrifugation step at 45 0000 rpm as described in section 2.6.7.
Samples were taken at the time points indicated, treated with proteinase K and analysed via SDS-PAGE
and digital autoradiography. S Supernatant P Pellet.
suggesting that the structural role of the zinc finger domain is less important than
it has been assumed on the basis of experiments applying recombinantly expressed
proteins (Momose 2007, this study).
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3.3. Analysis of the temperature-sensitive mutants zim17-2, zim17-3 and
zim17-4
3.3.1. Expression of Zim17-2, -3 and -4 from plasmids in a zim17∆ genetic background
Zim17 is known to interact with mitochondrial Hsp70 chaperones. In vitro assays
using proteins that were overexpressed in E. coli could confirm that the interaction
of Zim17 with Ssc1 occurs in the abscence of nucleotides in mitochondrial lysates
(section 3.1.4). Moreover, binding of purified Ssc1 to immobilized ATP seemed to
occur while Zim17 was still associated with the chaperone under in vitro conditions
(section 3.1.2.3). Zim17 also appears to be able to dimerize, most likely when it is
not bound to a Hsp70 molecule (section 3.1.2).
To study the functional interaction of Zim17 with mtHsp70s in its natural environ-
ment, deletion mutants have been used in a number of studies in the past years
(Blamowska, Neupert and Hell 2012; Blamowska 2010; Díaz de la Loza 2011; Sanjuán
Szklarz 2005; Sichting 2005). However, zim17∆ strains seem to display a strong
tendency to develop a respiratory-deficient phenotype (Sanjuán Szklarz 2005). Thus,
it is likely that a deletion of the ZIM17 gene leads to an accumulation of secondary,
indirect effects over time. To study the direct, short-term consequences of a Zim17
loss of function on the main mtHsp70s Ssc1 and Ssq1 in their natural environment,
a set of zim17 mutants was generated by error-prone PCR in the laboratory of
Professor Dr. N. Pfanner at the University of Freiburg with the aim to gain con-
ditional mutations within the ZIM17 gene. The amplified mutant alleles together
with approximately 600 bp of the ZIM17 3’UTR and 300 bp of the ZIM17 5’UTR
were cloned into the vector pFL39 (Bonneaud 1991), allowing the expression of the
mutant Zim17s under the control of their own promotor (Sanjuán Szklarz 2005).
Plasmids carrying the mutations were named pFLzim17-tsx-CEN with x referring
to the number of the individual mutant and transformed into zim17∆ yeast cells
(Sanjuán Szklarz 2005).
Transformants were screened for a temperature-sensitive growth phenotype. In this
work, the mutants that showed the most severe temperature-sensitive phenotype (re-
ferred to as zim17-2 and zim17-3 and zim17-4 respectively) were selected for further
analysis. A subcellular fractionation (section 2.4.11) that was carried out to confirm
the expression and distribution of the mutant Zim17 proteins. Zim17-3 and Zim17-4
were located to the mitochondrial compartment of the yeast cells (figure 3.10A).
However, Zim17-3 was strongly overexpressed, while Zim17-4 seemed to be expressed
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Figure 3.10.: Subcellular fractionation of zim17-2,-3 and -4 mutant cells. (A) Subcellular
fractionation of zim17-3 and -4. Cells were grown for 5 days in YPG or selective medium as indicated.
Cells were lysed and subcellular fractionations were performed as described in section 2.4.11. (B)
Subcellular fractionation and mitochondrial isolation of zim17-2 mutants. Mitochondria were isolated
after growth at 25 ◦C (25), a 4h heat treatment at 37 ◦C (SH) or after a 16h heat treatment at 37 ◦C
(ON). S supernatant (cytosolic fraction), P pellet (mitochondrial fraction)
in low amounts. Unexpectedly, the mutant protein Zim17-2, that has been used in a
previous study on the function of Zim17, (Sanjuán Szklarz 2005) seemed to remain
in the cytosolic fraction of the cells (figure 3.10B).
3.3.2. Sequence analyis of zim17-2, -3 and -4
To identify the mutated residues in zim17-2, -3 and -4, a sequence analyis was
performed (figure 3.11). Zim17-2 showed mutations at residues 40, 59 and 107
of its amino acid sequence. At positions 40 and 59, two leucine residues were
exchanged with serines. At position 107, a histidine was replaced by a proline. As
the leucine at position 40 lies inside the predicted Zim17 pre-sequence, this mutation
potentially impairs its import to the mitochondrial matrix, leading to extremely low
mitochondrial levels of the mutant protein.
Sequencing of zim17-3 revealed a mutation at residue 111 where the aspartic acid in
the highly conserved DHL-motif was replaced by a neutral glycine. An additional
mutation was found at the less conserved residue 79 where an asparagine was replaced
with a serine.
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Figure 3.11.: Sequence alignment of wt and mutant Zim17 proteins. The positions of mutations
in one of the proteins are indicated by black bars. Mutated residues are indicated in gray.
In zim17-4 mutations were found at positions 113 and 115 where the hydrophobic
leucin and isoleucin were replaced with a heterocyclic proline and a neutral threonine.
A third mutation was found at residue 31 where valine was exchanged to alanine. The
mutation at position 31 in Zim17-4 also lies in the pre-sequence of Zim17 and thus
might explain its low mitochondrial levels in comparison to Zim17-3. In addition to
the mutations described above, all three mutants carried a number of silent mutations
and mutations in the 3’- and 5’UTRs of the mutants indicated in section A.1.2. Of
all three mutants, zim17-4 carried the largest number of silent mutations.
3.3.3. Generation of a corresponding wild type plasmid
As the mutant Zim17 proteins were expressed in a zim17∆ genetic background, a
correspronding wild type plasmid was generated for control purposes. The plasmid
pFLzim17-ts3-CEN carrying the Zim17-3 allele was digested with the restriction
enzyme HindIII (restriction sites indicated in section A.1.2) to remove all mutated
residues. One HindIII restriction site is found at position -332 upstream the ZIM17
ATG sequence. The second HindIII site belongs to the multiple cloning site of the
pFL39 vector and lies at the 3’end of the zim17 -insert. A PCR applying yeast
genomic DNA obtained from the BY4741 wild type strain as template was performed
using the primer pair Zim17-corrWT-f and Zim17-corrWT-r (table 2.8). The PCR
product was inserted into the empty pFLzim17-ts3-CEN vector via the HindIII
restriction sites, resulting in the new plasmid pFLzim17-corrWT-CEN.
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3.3.4. Growth phenotype of ZIM17-corrWT, zim17-3 and zim17-4
To analyse the growth phenotype of zim17-3 and zim17-4, serial drop dilution tests
at different temperatures were performed on growth media with two kinds of carbon
sources. YPD medium that contains glucose as a carbon source, allows the yeast
cells to switch from respiratory to fermentative metabolism if needed. On YPG
medium with non-fermentable glycerol as a single carbon source, the yeast cells
are restricted to respiratory metabolism and thus are unable to grow in case of a
respiratory deficiency.
Zim17-3, zim17-4 and corresponding wt cells were grown on YPD or YPG respectively.
After log phase was reached, the cells were spotted onto solid medium that contained
the same carbon source as the medium that was used for the precultures. All
three zim17 -strains were able to grow on both YPD and YPG medium, though the
cells that were grown on YPG grew slower than cells that were cultivated on YPD
(figure 3.12A). At 37 ◦C, zim17-3 displayed a strongly diminished growth on both
carbon sources while zim17-4 was not able to grow at all.
As both mutant and corresponding wild type cells grew poorly under non-fermentable
conditions, a second experiment was performed to assess the stability of their
respiratory competence. Precultures were grown in YPD until log phase and then
spotted onto YPG medium (figure 3.12B). After the shift from glucose to glycerol,
zim17-4 cells were not able to grow even at a permissive temperature of 25 ◦C while
zim17-3 cells formed few, slowly growing colonies. Surprisingly, the correspronding
wild type strain, like zim17-4, was not able to grow on a non-fermentable carbon
source at all after incubation in fermentable medium suggesting that the expression of
the wt plasmid was not able to completely restore a wild type-like growth phenotype
in zim17∆ cells.
3.3.5. Aggregation of Ssc1 in zim17-3 and zim17-4
MtHsp70 proteins are known to have the tendency to aggregate in the mitochondrial
matrix of yeast cells lacking Zim17 (Burri 2004). To measure the propensity of the
mutant Zim17s to keep mtHsp70s soluble, an aggregation analysis was performed.
Zim17-3, -4 and the corresponding wt cells were grown at a permissive temperature
of 25 ◦C to an OD600 of approximately 1.0. All cultures were grown in selective
medium lacking tryptophan in attempt to ensure maximal expression levels of the
mutated Zim17 proteins. As the mutant cells grew very slowly on selective medium
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Figure 3.12.: Growth phenotype of zim17-3 and -4 mutants in comparison to wt and zim17∆.
(A) Serial dilution droptests on fermentable (YPD) or non-fermentable (YPG) medium. (B) Switch
from fermentable conditions to non-fermentable conditions. Serial dilution drop test on YPG after
growth to log phase in liquid YPD.
containing glycerol as the sole carbon source, 2% glucose was added to the medium.
To distinguish between long term and short term effects of a heat treatment, one
third of the cultures was subjected to a short-term heat shock of 4h at 37 ◦C (SH)
while another third was treated for 16h at 37 ◦C (ON) as suggested in Szklarz (2005).
The remaining culture was kept at a permissive temperature of 25 ◦C. Mitochondria
were isolated, lysed and subjected to an aggregation test (section 2.6.7). Total and
pellet fractions were analysed via SDS-PAGE, Western blot and incubation with
the antibodies indicated in figure 3.13. Despite of the wild type-like growth of
both mutants at permissive temperature, Ssc1 in zim17-3 mitochondria aggregated
already at a permissive temperature of 25 ◦C (figure 3.13, lanes 15). Zim17-4 mutant
mitochondria showed a less severe Ssc1 aggregation at permissive temperature and
after a short-term heat shock. The amounts of aggregated Ssc1 in zim17-4 after
a long term heat treatment were similar to the amounts in the zim17-3 mutant
(figure 3.13, lanes 16, 20, 24). Surprisingly, the corresponding wild type mitochondria
displayed the most severe Ssc1 aggregation phenotype (figure 3.13, lanes 14, 18, 22)
while a YPH499 wt strain carrying the zim17-corrWT plasmid that was used as a
control showed no Ssc1 aggregation at all (figure 3.13, lanes 13, 17, 21). Decoration
with the Zim17 antibody showed that Zim17 was strongly overexpressed in the wt
3. Results 73
Figure 3.13.: Aggregation of Ssc1 in zim17-3, -4 and wt mitochondria. Isolated mitochondria
from heat-treated or non-heat-treated cells were lysed under native conditions in a buffer containing 0.5%
Triton-X100. To separate soluble proteins from insoluble aggregates, the lysates were subjected to a high
velocity spin. 25 ◦C, growth at 25 ◦C, SH, 4 h heat treatment at37 ◦C ON, 16 h heat treatment at 37 ◦C.
C, control; expression of zim17-corr-wt in S. cerevisiae YPH499, wt/3/4, expression of zim17-corrWT,
-3 and 4 in zim17∆.
and the zim17-3 strain (figure 3.13, lanes 2, 3, 6, 7, 10, 11), correlating with the high
Ssc1 aggregation in these samples. It was also noted that the levels of mrpL40, that
was used as an aggregation control, were diminished in all strains with a zim17∆
genetic background (figure 3.13, lanes 1-12).
Taken together, the zim17 mutants showed a mixture of phenotypic effects differing
from wild type like growth defects and aggregation of mitochondrial Hsp70s that
could derive from the mutated Zim17 protein or from its previous lack in the zim17∆
host strain.
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3.4. Novel conditional zim17 mutants
3.4.1. Generation of the mutants zim17-3a and zim17-3b
Expression of plasmid-encoded Zim17 wild type and mutant proteins in yeast cells
with a zim17∆ genetic background leads to a mixture of phenotypes that make it
impossible to distinguish between direct effects of the zim17 mutations and secondary
effects that derive from the previous lack of Zim17 in the cells. To overcome this
problem, the mutant proteins and their corresponding wild type were integrated into
the genome of S. cerevisiae.
The mutation at position 111 in the peptide sequence of zim17-3 (D111G) was
previously shown to lead to a reduced interaction between Zim17 and Ssc1 in
vitro, suggesting that the DHL-motif might be part of a potential Ssc1 binding
site (Momose 2007). To distinguish between the effects derived solely from the
D111G mutation and those derived from the combination of both D111G and
N79S, a second mutant carrying only the mutation at position D111 was created
in addition to the original zim17-3. In the following, the two new zim17-3 mu-
tants will be referred to zim17-3a (D111G/N79S) and zim17-3b (D111G) (figure 3.14).
Figure 3.14.: Generation of condi-
tional zim17 -mutants (A) Surface rep-
resentation of the Zim17 structure. The
locations of the amino acid changes
present in the zim17-3a and zim17-3b
mutants are indicated. The mutated
residues are indicated in red. (B) Magni-
fication into the molecular environment
of the amino acids D111 and N79 in
the three-dimensional structure of Zim17
(Protein Data Bank code 2E2Z (Mo-
mose 2007)). N79 and D111 are indi-
cated in green, neighbouring residues and
the four cysteines binding the zinc atom
(sphere) are indicated in purple. Struc-
tures were visualized using the program
Swiss-PdbViewer.
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3.4.2. Genomic integration of the mutated ZIM17 genes
ZIM17-wt, zim17-3a, -3b and zim17-4 were inserted into the genome of S. cerevisiae
under the addition of a LEU2 marker by PCR-mediated gene disruption (Baudin
1993; Lorenz 1995, section A.1.3, section 2.4.13). Colonies derived from cells that
were able to grow on leucine-free medium and thus likely to contain the integrated
zim17 -alleles were screened for a temperature-sensitive phenotype. While a large
number of wt, zim17-3a and 3b cells were able to grow in the absence of leucine,
only 5 zim17-4 colonies survived on the selective medium. Zim17-3a, -3b and -4
colonies that showed a temperature-sensitive behaviour and were unable to grow at
37 ◦C were picked and tested for successful integration of the mutant zim17 alleles by
colony PCRs applying the primer pair k-fw and k-rev (figure 3.15A). The antisense-
primer k-rev anneals inside the LEU2 gene. The sense-primer k-fw has an annealing
site in the part of the ZIM17 gene that is not replaced by the integrated PCR
fragment. The resulting PCR product of 1663 bp can only be amplified when the
insert was integrated into the genomic DNA successfully and at the right position.
The DNA of positive wt, zim17-3a and zim17-3b clones was sequenced to confirm
the presence of the appropriate mutations. While D111G/N79S and the D111G were
present in zim17-3a and zim17-3b, the two positive zim17-4 colonies (figure 3.15B,
zim17-4 #1 and #3) carried an insert containing the wild type ZIM17 gene. All
sequenced wt, zim17-3a and zim17-3b clones were tested for respiratory competence
by subjection to a non-fermentable carbon source. While wt cells were able to grow
on both fermentable and non-fermentable carbon sources, the original zim-3a and
-3b integrants were respiratory incompetent. The clones wt #5, zim17-3a #14 and
zim17-3b #15 (figure 3.15B) were preserved in glycerol stocks and used for further
experiments.
3.4.3. Random spore analysis of zim17-3a and zim17-3b integrants
An instable respiratory phenotype was observed in zim17-3a and -3b genomic inte-
grants as well as in zim17∆ cells (Sanjuán Szklarz 2005) and in the plasmid-originated
zim17-3 and zim17-4 mutants (section 3.3.4). Therefore, wt zim17-3a and zim17-3b
integrants were subjected to a random spore analysis (section 2.4.14) to asses if the
respiratory deficiency and the temperature-sensitivity were both directly related to
the mutations in the ZIM17 gene. Zim17 integrants were crossed with S.cerevisiae
BY4742 wild type cells. After sporulation and disruption of the tetrades, haploid
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Figure 3.15.: Colony-PCRs of wt, zim17-3a, -3b and -4 integrants. (A) Schematic illustration of
control PCRs used to identify positive mutant integrants. (B) DNA was isolated from cells that showed
a temperature-sensitive growth behaviour and were able to grow on leucine. The primers k-fw and k-rev
were used for control PCRs.
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Table 3.1.: Growth phenotypes of wt, zim17-3a and zim17-3b tetrades
tetrade wt zim17-3a zim17-3b
CFUs %petites %ts %rho- CFUs %petites %ts %rho- CFUs %petites %ts %rho-
total 138 205 226
SD -Trp 25 0 0 0 36 8.3 0 0 55 1.8 0 0
SD -Leu 41 0 0 0 41 95.1 100 36.6 54 98.1 98.1 74.0
SD -Leu/-Trp 38 nd nd nd 78 nd nd nd 62 nd nd nd
only YPG 34 nd nd nd 49 nd nd nd 55 nd nd nd
Figure 3.16.: Random spore analysis of wt, zim17-3a and zim17-3b integrants. (A) Growth of
tetrades on single and double dropout media. Bars show the percentage of total counted colony forming
units (CFUs). (B) Growth phenotype of wild type and zim17 mutant tetrades. Bars represent the
absolute numbers of counted CFUs.
cells deriving from single spores were grown on the appropriate single and double
dropout media (see table 3.1, figure 3.16A). As the TRP1 gene from BY4742 and
the LEU2 gene from the zim17 integrants are encoded on different chromosomes
and are thus completely unlinked, the ratio between cells that were able to grow only
on full medium or on dropout media lacking leucine, tryptophan or both was equal
(figure 3.16A). In case of zim17-3a the amount of cells that were able to grow on
-Leu/-Trp double dropout medium was slightly enhanced, probably due to diploid
cells remaining after the tetrade disruption.
As the integrated zim17 alleles are linked to the LEU2 gene, the phenotype of cells
that are only able to grow on leucine-free medium can be directly related to the
appropriate zim17 mutant. Therefore, all tetrades were tested for temperature-
sensitivity and respiratory deficiency (figure 3.16A). Over 95% of the zim17-3a and
zim17-3b integrants showed a temperature-sensitive phenotype, confirming that the
temperature-sensitivity derives from defects directly related to the zim17 mutations
78 3. Results
(table 3.1, figure 3.16B, right panel). In contrast, only 36.6% of zim17-3a integrants
and 74% of the zim17-3b integrants displayed a tendency to loose their respiratory
competence and hence were not viable when subjected to non-fermentable medium,
revealing that the loss of respiration is not a direct consequence of the loss of Zim17
function. As expected, all cells deriving from spores that were able to grow only
on -Trp dropout medium and thus carrying the BY4742 ZIM17 gene were able
to grow at elevated temperatures and showed a respiratory-competent phenotype
(table 3.1, figure 3.16B, left panel). Single colonies of respiratory-competent wt,
zim17-3a, and zim17-3b spores were selected and stored as glycerol stocks. DNA
of the respiratory-competent spores was isolated and tested for the presence of the
integrated sequences by PCR applying the primer pair k-fw/ k-rev (figure 3.15A).
A PCR with the primers k-fw and gen-zim17-rev (figure 3.15A) that amplify the
3’end of ZIM17 was performed as a control. Genomic DNA from BY4742 yeast
cells and from the wt integrant #5 (section 2.4.13) was used as a negative and
a positive control respectively. As shown in figure 3.17 all respiratory competent
spores contained the zim17/LEU2 inserts. The presence of the zim-3a and zim17-3b
mutations was confirmed by sequencing of the PCR products.
Figure 3.17.: Colony-PCRs of wt, zim17-3a and zim17-3b tetrades. Respiratory competent (rc)
and respiratory incompetent (ri) tetrades were grown on selective media (-leu) and cell extracts were
prepared as described in section 2.4.9.2. PCRs were carried out using the primers k-fw, k-rev and gen-rev
as described in figure 3.15A, section 3.4.2. A mock sample without DNA (M), genomic yeast DNA (g)
and DNA of the original genomic wt integrant #5 (wt-5, see figure 3.15) were used as controls.
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3.4.4. Zim17 mutant integrants show a temperature-sensitive respiratory instable
phenotype
3.4.4.1. Growth phenotype of zim17-3a and -3b
Spores carrying the mutated zim17 alleles were generally able to respire, however,
part of the populations seemed to loose their respiratory competence over time. To
study this instable respiratory-competent phenotype in more detail, the ability of
zim17 integrants to grow on different carbon sources was examined under specified
conditions. To examine the growth phenotype of the respiratory-competent spores,
serial dilution drop tests at 25 ◦C and 37 ◦C was performed. Cells derived from
respiratory-competent spores were grown in liquid cultures of fermentable (YPD)
or non-fermentable (YPG) medium 25 ◦C to an OD600 of 0.8-1.0 and subsequently
spotted on solid medium containing the same carbon source (figure 3.18). On YPG
the growth phenotype of zim17-3a and -3b was indistinguishable from the growth of
the wt at a permissive temperature of 25 ◦C. At 37 ◦C both zim17-3a and zim17-3b
showed a slow and diminished growth in comparison to wt. On YPD, both zim17
mutant integrants formed small, slow growing colonies at permissive temperature
that strongly resembled the petite phenotype and thus most likely display a reduced
ability to respire (Sanjuán Szklarz 2005). At an elevated temperature of 37 ◦C
zim17-3a and zim17-3b were not able to grow at all. Wt cells grew normally on YPD
under all examined conditions. To study the effects of a heat treatment and of the
carbon source on the respiratory competence of the zim17 mutants in more detail,
further growth experiments were performed.
Figure 3.18.: Growth phenotype of
respiratory-competent wt, zim17-
3a and zim17-3b mutant inte-
grants. Tenfold serial dilutions of cells
grown in liquid precultures of YPD or
YPG were spotted onto solid medium,
followed by incubation at the indicated
temperatures for 4 d.
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Figure 3.19.: Temperature sensi-
tivity of respiratory-competent wt,
zim17-3a and zim17-3b integrants.
Wt, zim17-3a and zim17-3b cells were
grown in liquid YPG medium at 25 ◦C
and subjected to non-permissive tem-
perature (37 ◦C) for 48 h. At the
indicated time points, samples were
taken, plated on solid YPG and incu-
bated for 5 days at 25 ◦C. CFUs were
counted and the viability of zim17-3a
and zim17-3b in relation to the wt was
determined. Cells were kept at the log-
arithmic growth phase (OD600 0.6 –
0.8) throughout the experiment. Values
shown are means ± SEM of 4 indepen-
dent experiments.
3.4.4.2. Temperature sensitivity of zim17-3a and -3b
To measure the general effect of a heat treatment on the survival of zim17 mutant cells,
a time course experiment was performed. Respiratory competent zim17 integrants
were grown in liquid non-fermentable medium at 25 ◦C. After an OD600 of 0.8-1.0 was
reached, cells were subjected to a heat treatment at 37 ◦C for 48h. Equal amounts
of cells were taken at the time points indicated in figure 3.19. and distributed onto
solid non-fermentable medium at 25 ◦C. Colony forming units (CFUs) were counted
and the number of wt cells was set to 100%. After a heat treatment of approximately
12 h the survival rate of zim17-3a and -3b cells began to drop rapidly in comparison
to the wt. After a 24 h heat treatment, the number of CFUs zim17-3a and -3b was
reduced to 40% and 60% of the wt respectively. In conclusion, the primary effects of
a 37 ◦C heat shock take place between 12 and 24 h of heat treatment.
3.4.4.3. Respiratory competence of zim17-3a and -3b
3.4.4.3.1. Effect of heat treatment
To examine if a heat treatment also influences the respiratory competence of zim17
mutant cells, respiratory-competent zim17 integrants were grown in liquid YPG and
subjected to a 48h heat treatment as described above. Equal amounts of cells were
taken at the time points indicated in figure 3.20A and spread out on solid YPD
and YPG at 25 ◦C. Colony forming units (CFUs) on both media were counted and
the number of CFUs that grew on YPD was set to 100%. The relative amount of
CFUs on YPD was determined to measure the respiratory competence of the cells.
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As shown in figure 3.20A, all zim17 itegrants showed a similar growth on both
carbon sources after the heat-treatment. Thus, even though both mutants exhibited
a temperature-sensitive behaviour, their respiratory competence was not affected by
the heat treatment under non-fermentable conditions.
3.4.4.3.2. Effect of carbon sources
To test the effect of different carbon sources on the respiratory competence of zim17-
3a and zim17-3b cells, precultures of respiratory competent zim17 mutant integrants
were grown in liquid YPG as described above. Cells were harvested, resuspended in
YPD and further incubated for 48h at a constant temperature of 25 ◦C. Samples
were taken at the time points indicated in figure 3.20B. Equal amounts of cells
were washed with water and spread on fermentable and nonfermentable medium
respectively. The relative amount of respiratory-competent cells was determined as
described above. While the wt cells were able to keep their respiratory competence,
the number of zim17-3a and -3b integrants that were able to grow on YPG began
to decrease rapidly after 6h growth on YPD. After an incubation time of 25h only
about 50% of the zim17 mutant integrants remained to be able to respire. After 48h
the number of cells that were able to form colonies on YPG was less than 10% of
those on YPD.
3.4.5. Differentiation between respiratory-competent (zim17rc) and incompetent
(zim17ri) mitochondria isolated from mutant integrants
As the respiratory competence of zim17 mutant integrants is dependent on the car-
bon source, further experiments distinguished between respiratory incompetent and
respiratory-competent mitochondria. To isolate respiratory-competent mitochondria,
zim17 integrants were grown on YPG at 25 ◦C to an OD600 of approximately 1.0.
Cultures grown in YPG were divided in two halfes and further grown at 25 ◦C and
37 ◦C respectively. According to figure 3.19 in section 3.4.4.2, a 16h heat treatment
was chosen for all further experiments.
To generate respiratory incompetent mitochondria, zim17 integrants were grown on
YPD at 25 ◦C. As a temperature of 37 ◦C was lethal for zim17-3a and zim17-3b cells
under those conditions (figure 3.18), the heat treatment was not performed.
Mitochondrial isolations were performed as described in section 2.4.12. In the
following, zim17 mutans will be referred to as zim17rc for respiratory-competent mi-
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tochondria isolated from cells grown on YPG and Zim17ri for respiratory incompetent
mitochondria isolated from cells grown on YPD.
Figure 3.20.: Respiratory competence of wt, zim17-3a and zim17-3b mutant integrants. (A)
Influence of heat treatment on respiratory competence. (B) Influence of a fermentable carbon source on
respiratory competence. Respiratory competent wt, zim17-3a and zim17-3b yeasts were grown in liquid
precultures in glycerol-containing medium (YPG) at 25 ◦C to an OD600 of 1. Cells were washed, diluted
with water to an OD600 of 0.6 and further incubated in glycerol-containing medium at 37 ◦C (A) or
in glucose-rich medium at 25 ◦C (B) for 48 h. At the indicated time points, samples were taken and
equal amounts of cells were plated on YPD and YPG solid medium. After a 5 d incubation at 25 ◦C,
colony forming units (CFUs) were counted and the ratio of CFUs on YPG compared to CFUs on YPD
was determined. Cells were kept at the logarithmic growth phase (OD 0.6 – 0.8) throughout the time
courses of both experiments. Values shown are means ±SEM of 4 independent experiments.
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3.5. Biochemical analysis of genomic Zim17 conditional mutants
3.5.1. Aggregation of Hsp70 chaperones
As it is known that a loss of Zim17 results in the aggregation of mitochondrial
Hsp70s, zim17 mutant integrants were tested for aggregation of the two main yeast
mtHsp70 chaperones Ssc1 and Ssq1. Zim17ri and Zim17rc mitochondria were isolated
and lysed in a buffer containing 0.5% Triton-X100. Soluble proteins were separated
from insoluble aggregates by a high velocity centrifugation step. Samples of total
mitochondrial lysates, supernatants and pellets were analysed via SDS page and
immunoblotting with specific antibodies as indicated in figure 3.21. To exclude an
unspecific aggregation behaviour, the soluble matrix protein Sod2 was probed as a
control.
3.5.1.1. Aggregation in respiratory-deficient zim17 integrants
In respiratory-incompetent Zim17ri mitochondria, both mtHsp70s were aggregating at
a permissive temperature of 25 ◦C (figure 3.21A). While Ssq1 showed an aggregation
between 70% and 100%, the aggregation of Ssc1 was 50% or higher in both mutants.
To differentiate between effects due to respiratory deficiency and effects due to the
zim17 -mutations, mitochondria obtained from a respiratory-deficient variant of the S.
cerevisiae YPH499 strain lacking mitochondrial DNA (rho-) were used as a control.
Ssc1 and Ssq1 were soluble in both YPH499 wt (rho+) and YPH499 rho- cells,
suggesting the mtHsp70 aggregation as a consequence of the loss of Zim17. It also
has to be noted that the levels of the control protein Sod2 were diminisished in
zim17ri-3a and zim17ri-3b (figure 3.21, lanes 4 and 5).
3.5.1.2. Aggregation in respiratory-competent zim17 integrants
3.5.1.2.1. Aggregation of mature Ssc1
Concerning respiratory-competent zim17rc mitochondria, both mtHsp70 proteins
were soluble at a permissive temperature of 25 ◦C (figure 3.21B, lanes 8 and 9).
After a 37 ◦C heat treatment, Ssc1 and Ssq1 were detected in the pellet fractions of
zim17rc-3a and zim17rc-3b (figure 3.21B, lanes 11 and 12). Additionally, the total
amounts of the less abundant mtHsp70 protein Ssq1 were decreased in both Zim17rc-
3a and Zim17rc-3b mitochondria (figure 3.21B, lanes 2, 3, 5, 6). Quantification of the
signals obtained from three independent experiments showed that 30% of total Ssc1
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and 70% of total Ssq1 were found in the aggregate pellet of Zim17rc-3a mitochondria.
In Zim17rc-3b mitochondria 13% of total Ssc1 and 6% of total Ssq1 were detected
in the pellet. However, considerable amounts of both heat shock proteins were not
affected by aggregation and remained in the supernatants.
3.5.1.2.2. Aggregation of newly imported Ssc1
To examine the effect of a loss of Zim17 function on the de novo folding of mtHsp70,
radiolabelled Ssc1 was generated by in vitro translation and imported into heat-
treated and non-heat-treated isolated Zim17rc mitochondria for 20min. Before
lysis, mitochondria were treated with proteinase K to remove unimported precursor
proteins. After a washing step, mitochondrial lysates were subjected to a high velocity
centrifugation step as described above and samples were analysed via SDS-PAGE,
Western blot and digital autoradiography. In contrast to mature mtHsp70s, less than
1% of newly imported Ssc1 was detected in the pellet fractions of heat-treated zim17
mutant mitochondria (figure 3.21B), pointing to the conclusion that the formation of
aggregates does not occur during the general biogenesis of mtHsp70s in the zim17-3a
and -3b mutants.
3.5.2. Relative abundance of mtHsp70s and their cochaperones in zim17 mutant cells
3.5.2.1. Expression levels of mutant Zim17s in zim17 integrants
Mutant and wild type Zim17 proteins showed a high overexpression when they were
encoded on plasmid DNA in a zim17∆ genomic background, probably as a reaction to
the previous lack of the protein in the mitochondrial matrix of those cells. To assess
the expression levels of Zim17 in zim17rc and zim17ri mitochondria, a Western blot
membrane with mitochondrial lysates was incubated with a Zim17 specific antibody
(figure 3.22). In comparison to YPH499 and YPH499 rho-, Zim17-3a and -3b levels
were elevated in zim17ri mutants while Zim17-wt was expressed normally. In zim17rc
mutant integrats the amounts of Zim17-3a were strongly reduced in comparison to
Zim17-wt. Zim17-3b showed a higher expression than Zim17-3a, however, it was still
expressed in lesser amounts than the wt protein.
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Figure 3.21.: Aggregation of mtHsp70s in zim17ri and zim17rc under fermentative and non-
fermentative conditions. Lysates of mitochondria isolated from yeast cells grown on YPD (zim17ri),
(A) and YPG (zim17rc), (B) were centrifuged at high velocity (45 000 rpm, 30min) and analysed via
SDS-PAGE and immunoblotting with specific antisera against the indicated proteins.
Figure 3.22.: Expression of Zim17-wt, -
3a and 3b in zim17ri and zim17ri mito-
chondria. 25 µg of mitochondria were lysed
in Laemmli buffer and analysed via SDS-
PAGE followed by Western blot and incu-
bation with specific antibodies
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3.5.2.2. Expression levels of mtHsp70 proteins and their cochaperones in
respiratory-competent zim17 integrants
The levels of Zim17 were diminished in both zim17rc-3a and zim17rc-3b mitochondria.
To examine if the expression levels of other key proteins of the two matrix chaperone
systems were affected as well, a Western blot analysis of zim17rc mitochondria
was performed. Equal amounts of mitochondria were lysed in Laemmli buffer and
subjected to SDS-PAGE. Proteins of interest were detected using specific antibodies.
The amounts of each protein were quantified and normalized to the citrate cycle
protein Mdh1. The protein amounts determined for wt mitochondria were set to
100% for each experiment. Figure 3.23 shows the results of at least 5 independent
experiments for each measured protein.
The levels of the main Hsp70 protein Ssc1 were slightly diminished in zim17rc-wt,
-3a and -3b mitochondria at a permissive temperature of 25 ◦C. After a 16h heat
treatment at 37 ◦C, Ssc1 showed a heat-stress induced upregulation that was stronger
in the mutants than in wt mitochondria. The J-protein partner of Ssc1 in the
mitochondrial matrix, Mdj1, showed a significant reduction in both mutants already
at 25 ◦C. At 37 ◦C the Mdj1 levels in zim17rc-3a and -3b were indistinguishable from
its levels in wt mitochondria. As Mdj1 is a heatshock protein itself, its levels were
probably restored by temperature-induced overproduction. The inner membrane
J-protein Pam18 that assists Ssc1 in fulfiling its function during the import reaction,
showed stable, wild type-like levels before and after the heat treatment.
As already observed in section 3.5.2.1, the levels of the second matrix Hsp70 Ssq1
were severely downregulated to less than 50% of wild type levels in zim17rc-3a and
zim17rc-3b mitochondria. An overproduction of Ssq1 after a 37 ◦C heat treatment
could not restore its amounts back to normal levels. Jac1, the J-protein partner of
Ssq1, showed consistent expression levels at 25 ◦C. However, after heat treatment,
its amounts were enhanced about 3-fold in both zim17 mutants. Similar to Jac1,
the levels of the Ssq1-interacting scaffold protein Isu1 remained constant at 25 ◦C
but were strongly elevated, in this case almost 10-fold, at 37 ◦C.
3.5.2.3. Expression levels of mtHsp70 proteins and their cochaperones in
respiratory-deficient zim17 integrants
As respiratory-competent zim17 mutants showed alterations in the expression levels
of mtHsp70 proteins and some of their key-interaction partners, the levels of mito-
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Figure 3.23.: Relative abundance of mtHsp70 proteins and their cochaperones in zim17rc
mutant integrants. Mitochondria isolated from respiratory-competent yeast cells grown on YPG were
lysed and assayed by SDS-PAGE, Western blot and incubation with antisera against the indicated
proteins. Values shown are means ± standard error of protein amounts in zim17rc-3a and -3b relative
to wt mitochondria of at least 5 independent experiments. All values were normalized to the amounts
of Mdh1.
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chondrial proteins isolated from respiratory-incompetent zim17 cells were examined
as a comparison. As described above, equal amounts of zim17ri mitochondria were
subjected to SDS-PAGE and Western blot and analysed via incubation with anti-
bodies as indicated in figure 3.24. Tim23 was decorated as a quantity control. As
already described in section 3.5.1.1 YPH499rho- and YPH499 mitochondria were
used as respiratory-deficient and respiratory-competent control wild type strains.
The levels of Ssc1 and its J-proteins Mdj1 and Pam18 remained stable in zim17ri-3a
and -3b mitochondria. In contrast to zim17rc- mitochondria, the Ssq1-levels in the
zim17ri-3a and -3b mutants were indistinuishable from its levels in in the wt. Also
the Ssq1 cochaperone Jac1 displayed constant levels in the mutants and in the wt.
As an exception, the levels of Isu1 were upregulated in zim17ri mitochondria already
at a permissive temperature of 25 ◦C.
Figure 3.24.: Abundance of mtHsp70 proteins and their cochaperones in zim17ri mutant inte-
grants. Mitochondria isolated from respiratory-competent yeast cells grown on YPD were lysed and
assayed by SDS-PAGE and immunoblotting with antisera against the indicated proteins.
3.5.3. Interaction of mutant Zim17 with Ssc1
The mutation D111G that is present in both zim17 mutants, was suggested to play a
role in the interaction of Ssc1 and Zim17. To test if the mutant Zim17 proteins were
still able to interact with mtHsp70s in the mitochondrial matrix, a co-fractionation ex-
periment was performed. To assay the interaction under true in organello conditions
and avoid a bias due to aggregated or misfolded Ssc1 caused by in vivo expression of
the Zim17 mutations, co-immunoprecipitation experiments with radiolabelled prepro-
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Figure 3.25.: Interaction of wt and mutant
Zim17s with mtHsp70s. Radiolabeled prepro-
teins (Zim17-wt, -3a, -3b and Mdh1) were im-
ported into isolated YPH499 wt mitochondria.
The import was terminated after 20min at 25 ◦C
and samples were further incubated at 25 ◦C for
30min. Mitochondria were lysed, and proteins
bound to Ssc1 were co-immunoprecipitated us-
ing antiserum against Ssc1. Precipitated pro-
teins Zim17 proteins were assayed by SDS-PAGE
and digital autoradiography. The co-precipitated
amounts were quantified and the respective total
amounts of imported proteins for each of the sam-
ples were set to 100%. The data represent the
mean values and standard errors of three indepen-
dent experiments.
teins were performed. [35S]-Zim17-wt, -3a and -3b precursor proteins were generated
by in vitro translation as described in section 2.6.1. Import into isolated mitochondria
was performed 20min at 25 ◦C. As Zim17 was reported to interact with Ssc1 in the
absence of nucleotides (Sichting 2005), ATP was depleted by addition of apyrase
and the uncoupler oligomycin after the import reaction was stopped. Mitochondria
were lysed in a Triton-X100-containing buffer and immunoprecipitations with specific
antibodies against Ssc1 were performed. To exclude that the signals were derived
from an import-related interaction, radiolabelled Mdh1 (malat-dehydrogenase), a
standard matrix-destined precursor that is transferred into the mitochondrial matrix
via the Tim-PAM complex and does not interact with Ssc1 after import and folding
has been completed, was used as a control. Precipitated proteins were analysed via
SDS-PAGE and Western blot followed by digital autoradiography. Co-precipitated
amounts of Zim17-wt, -3a and 3b and Mdh1 were quantified and total amounts of
imported proteins were set to 100% for each of the samples. About 2% of Zim17-wt
was co-precipitated with Ssc1 after 30minute of post-import incubation while only
1.3% of Zim17-3a and 1.6% of Zim17-3b were associated with Ssc1 under the same
conditions (figure 3.25). As less than 0.1% of Mdh1 was co-precipitated with Ssc1,
the possibility that the imported proteins were bound to Ssc1 as substrates could
be ruled out. In summary, Zim17-3a and Zim17-3a show a diminished, but not
completely abolished interaction with Ssc1 in its native state.
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3.5.4. Analysis of Ssq1-related processes in zim17 conditional mutants
3.5.4.1. Expression levels of the Fe/S cluster protein aconitase in zim17 mutants
The less abundant mitochondrial Hsp70 protein Ssq1 plays an important role in
the biogenesis of mitochondrial Fe/S cluster-containing proteins. To monitor the
effects of Zim17 on this process, the Fe/S cluster-containing citrate cycle component
Aco1 was chosen as a model protein. It was shown previously, that the expression
levels of Aco1 were strongly diminished in zim17∆ cells (Sichting 2005). Lysates of
zim17rc mitochondria were analysed via SDS-PAGE and Western blot. The aconitase
levels in zim17rc-3a and zim17rc-3b mitochondria remained constant in mitochondria
obtained from cells that were grown at permissive and non-permissive temperature
(figure 3.26A). In case of zim17rc-3b, a slight enhancement of the aconitase levels
could be observed after heat treatment.
As a shift to non-fermentable conditions resulted in a loss of respiratory competence
of zim17 mutants, the effect of a subjection to a fermentable carbon source on the
expression levels of aconitase was examined. Respiratory competent zim17 cells
grown in non-fermentable medium were tranferred to a fermentable carbon source for
48 h. The temperature was kept at 25 ◦C constantly and all cultures were maintained
at an OD600 of 0.8-1.0 during the whole experiment. Whole cell yeast extracts were
prepared and analysed via SDS-PAGE and Western blot. Aconitase was detected
with specific antibodies. Tom40, a protein of the outer mitochondrial membrane
translocase was used as a quantity control. After a 12h incubation on a fermentable
carbon source the levels of aconitase were reduced to non-detectable amounts in
zim17 mutant cells (figure 3.26B). The signals detected in wt mitochondria remained
constant.
3.5.4.2. Expression levels of citrate cycle and respiratory chain proteins
Iron sulphur cluster proteins like Aconitase are involved in many essential metabolic
pathways in the cell, including the electron transfer of the mitochondrial respiratory
chain or, in case of aconitase, the citrate cycle. It has been shown that a number
of genes encoding proteins of those metabolic pathways are substantially downregu-
lated in S. cerevisiae with a defective mitochondrial Fe/S synthesis (Andrew 2008;
Hausmann 2008; Lill 2012). Therefore, the levels of different proteins involved in
respiratory metabolism in Zim17rc and Zim17ri mitochondria were measured. The
proteins Rip1 (rieske protein of the cytochrome bc1 complex) and CoxIV (cytochrome
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Figure 3.26.: Aconitase levels in zim17rc mutant integrants. (A) Relative abundance of aconitase
in zim17rc mitochondria isolated from respiratory-competent yeast cells grown on YPG. Mitochondria
were lysed and assayed by SDS-PAGE, Western blot and incubation with specific antisera against the
indicated proteins as described in figure 3.23.(B) Loss of aconitase in respiratory-competent zim17
mutants after growth on non-fermentable medium. Wt, zim17-3a and zim17-3b yeasts grown in YPG
precultures were transferred to YPD medium 25 ◦C. Whole cell yeast extracts taken at the indicated
times were analysed via SDS-PAGE and immunoblotting with the indicated antisera.
c oxidase subunit IV) were decorated as examples of proteins of the respiratory chain.
Rip1 carries an iron sulphur cluster itself and thus, like aconitase, was expected to be
downregulated in respiratory-deficient Zim17ri mutants. MDH1 (malat dehydroge-
nase) and Cit1 (citrate synthase), represent components of the citrate cycle. Zim17ri
integrants showed an almost complete loss of all decorated proteins while the protein
levels of zim17rc mutants were indistinguishable from wt (figure 3.27). The strong
effect in the zim17ri is not solely due to a loss of respiration as mitochondria from
the comparable respiratory-deficient wt strain lacking mitochondrial DNA (rho−)
showed a less severe downregulation of all examined proteins.
3.5.4.3. Diminishment of aconitase activity in respiratory-competent zim17 mutants
While zim17ri mutant integrants showed a strong reduction of aconitase and other
proteins involved in respiratory metabolism, the levels of all measured proteins
were constant in zim17rc mutant mitochondria. However, it remained unclear if the
aconitase of zim17rc mutant mitochondria is still functional. To assess this question
the enzymatic activity of aconitase was photometrically measured by following the
increase in NADPH as desribed in section 2.6.8.
The activity of aconitase remained constant in zim17rc-wt, -3a and-3b mitochondria
obtained from yeast cells grown at permissive temperature (figure 3.28A). Aconitase
from heat-treated zim17rc-3a only displayed an activity of 44% in comparison to the
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Figure 3.27.: Loss of enzymes of the citric acid cycle and respiratory chain in zim17ri mito-
chondria. Isolated mitochondria of the indicated yeast strains grown on permissive temperature on
YPD and YPG were analysed as described in figure 3.24. rho+, YPH499-wt, rho-, respiratory-deficient
YPH499.
corresponding wt. In heat-treated zim17-3b mitochondria, the activity remained
equal to wt levels. To confirm that the diminished enzymatic activity of Aco1 did not
derive from an aggregation of the protein, zim17rc mutant and wild type mitochondria
were lysed and subjected to a high velocity centrifugation step. Isolated mitochondria
from the temperature-sensitive mutant ssc1-3 were heat-treated 15min at 37 ◦C and
used as an aggregation control (Bender 2011). Samples were analysed via SDS-PAGE
and immunoblotting with specific antibodies. The soluble matrix proteins Sod2 and
the ribosomal protein MrpL40 were decorated as loading controls for the supernatant
and pellet fraction respectively (Bender 2011). While aconitase was detected in the
pellet fraction of heat-treated ssc1-2 mitochondria, no aggregation could be observed
in mitochondria of heat-treated or untreated zim17rc mutant cells (figure 3.28B). In
consistence with these results, Fe-incorporation assays into aconitase from zim17rc
mutants that were performed by N. Rietzschel in the laboratory of Prof. Dr. R. Lill
in Marburg, Fe-incorporation into aconitase is diminished in respiratory zim17-3a
mutant cells (Lewrenz et.al. 2013, submitted for publication).
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Figure 3.28.: Aconitase activity and agggregation in zim17rc mitochondria. (A) Enzyme activity
assay of aconitase in zim17rc mitochondria isolated from zim17 mutant cells grown on YPG at permissive
and non-permissive temperature. (B) Aggregation of aconitase under non-fermentative conditions.
Lysates of zim17rc mitochondria isolated from yeast cells grown on YPG were centrifuged at high
velocity (45 000 rpm, 30min) and analysed via SDS-PAGE, Western blot and incubation with antisera
against the indicated proteins.
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3.5.5. Analysis of Ssc1-related processes in zim17 conditional mutants
3.5.5.1. Preprotein import into respiratory-deficient zim17 mitochondria
Zim17∆ mitochondria display defects in the import of matrix-destined preproteins.
Therefore the import phenotype of zim17 mutant integrants was assessed in or-
ganello. Radiolabelled Su9(86)DHFR was denatured with 7M urea and imported
into respiratory-deficient zim17ri mitochondria at 25 ◦C for 30min as described in
section 2.6.2.2. For control purposes, one sample applying native preprotein and
one sample where the membrane potential was interrupted using the uncoupler
valinomycin were assayed for each mutant. YPH499 rho- mitochondria were used
as a comparison. Samples were taken at the time points indicated in figure 3.29A
and analysed via digital autoradiography. Wt mitochondria showed a fast import
of denatured and native preprotein (figure 3.29A, lanes 6-9, 26-29). In comparison
to the wt, less protein was imported to the matrix of respiratory-deficient YPH499
rho- mitochondria (figure 3.29A, lanes 1-4, 21-24). The Fo subunit 9 of the N.crassa
F1Fo-ATPase has two MPP processing sites resulting in the formation of a transient
intermediate form of Su9(86)DHFR (i) during the import reaction. In YPH499
rho- mitochondria both the pre-form and the intermediate form were detected in
addition to the mature form of Su9(86)DHFR, showing the reduced import effciency
of respiratory-deficient mitochondria (figure 3.29A, lanes 1-3, 21-23). Zim17ri-3a
and -3b mitochondria showed a very low, almost undetectable import when native
preprotein was used (figure 3.29A, lanes 14, 19, 34, 39). The import rates employing
denatured preprotein were higher (figure 3.29A, lanes 12-13, 16-18, 31-33, 36-39),
however, in comparison to wt and YPH499 rho- mitochondria the import was still
reduced.
A membrane potential measurement (section 2.6.9) showed that the electrochemical
gradient at the inner membrane of zim17ri mitochondrial was depleated (figure 3.29B),
indicating that the observed import deficiency of the mutant cells is probably a
secondary effect due to the loss of respiratory competence of zim17ri-3a and -3b
mitochondria.
3.5.5.2. Preprotein import in respiratory-competent zim17 mitochondria
To assess the import rates of respiratory-competent zim17rc mitochondria, import
reactions were carried out for 40min as described in section 2.6.2.1 and analysed
via SDS-PAGE and Western blot followed by digital autoradiography. Signals were
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Figure 3.29.: Import phenotype of zim17ri mitochondria. (A) Import of Su9(86)-DHFR. The
[35S]-labeled preprotein Su9(86)-DHFR was denatured in urea and incubated with isolated zim17ri
mitochondria as described in section 2.6.2.2. Samples were taken at the indicated time-points, divided
into halves and treated with proteinase K (+PK) or water (-PK) as a control. Imported proteins were
separated by SDS-PAGE and detected by digital autoradiography. (B) Membrane potential of zim17ri
mitochondria. The electric membrane potential (∆Ψ) of isolated zim17ri mitochondria was assessed by
use of the potential-sensitive fluorescent dye 3,3’-dipropylthiadicarbocyanine iodide (diSC3(5)).
quantified and plottet against the import time. Figure 3.30A shows the result of at
least 3 independent experiments. In contrast to zim17ri mitochondria, both zim17rc-
3a and -3b showed a considerably faster import than wt mitochondria at permissive
temperature. A membrane potential measurement showed a stable electrochemical
gradient for wild type as well as respiratory-competent mutant cells (figure 3.30A).
After a high temperature treatment, the import rates of zim17rc-3a mitochondria
were reduced in comparison to wt and zim17rc-3b.
3.5.5.3. Preprotein import into wt, zim17-3a and zim17-3b mitochondria in vivo
To examine the preprotein import under in vivo conditions, protein extracts from
equal amounts of cells grown on YPD and YPG at permissive and non-permissive
temperature were prepared and analysed via SDS-PAGE and Western blot. West-
ern blot membranes were incubated with an antibody against the E.coli Hsp60
orthologue GroEL. The GroEL antibody was chosen to distinguish between mature
and unimported pre-forms of mitochondrial proteins in the cell because of its high
specifity for Hsp60 proteins and its low crossreactiviy with yeast cytosolic proteins.
At 25 ◦C, a single Hsp60 signal was detected in all cells, most likely deriving from
the mature form of Hsp60 in the mitochondrial matrix (figure 3.31, lanes 1-6). When
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Figure 3.30.: Import phenotype of zim17ri mitochondria. (A) Import of Su9(86)-DHFR. The
[35S]-labeled preprotein Su9(86)-DHFR was incubated with isolated zim17rc mitochondria as described
in section 2.6.2.1. Samples were taken at the indicated time-points, divided into halves and treated with
proteinase K or water as a control and analysed as described in figure 3.29. Each data point shows the
mean value of at least three independent experiments. (B) Membrane potential. The electric membrane
potential (∆Ψ) of isolated zim17rc mitochondria was assessed as described in figure 3.29.
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Figure 3.31.: In-vivo import phenotype of zim17 mutant integrants. Respiratory competent zim17
mutant integrants were grown to log phase in YPD and YPG medium at 25 ◦C and 37 ◦C. Protein
extracts from equal amounts of cells were prepared and analysed via SDS-PAGE, Western blot and
incubation with a GroEL/Hsp60 antibody.
grown on YPD at 37 ◦C, both zim17-3a and zim17-3b cells showed a second band
slightly above the mature Hsp60 form , presumably representing an unimported
pre-form of Hsp60 (figure 3.31, lanes 8+9). On YPG, even at elevated temperatures
only the mature Hsp60 was visible, indicating that the observed in organello import
defects of zim17rc-3a mitochondria are less severe in the living cell.
3.5.5.4. Analysis of import-related functions of Ssc1 in respiratory-competent zim17
mitochondria
3.5.5.4.1. ATP-binding properties of Ssc1
ATP-bound Ssc1 is recruited to the translocase via the scaffold protein Tim44. Hy-
drolysis of ATP occurs upon the binding of the incoming preprotein and is stimulated
by Pam18, a class III J-protein located at the matrix surface of the inner mitochon-
drial membrane. The attachment of Ssc1 to the translocase during this process
enables Ssc1 to exert an inward-directed force (’pulling’) on the incoming protein. As
zim17rc-3a mitochondria showed a diminished import at elevated temperatures, the
ability of Ssc1 to generate an inward-directed translocation force on preproteins in
transit was tested in wt and mutant mitochondria. The activity of Ssc1 is dependent
on its ability to interact with ATP. It was shown previously that Zim17 does not act
as a nucleotide exchange factor and does not stimulate the ATPase activity of Ssc1.
Therefore, its influence on the general ability of Ssc1 to bind to the nucleotide was
assessed. Zim17rc mitochondria were lysed in a Triton-X-100-containing buffer and
subjected to immobilized ATP as described in section 2.6.6.1.2. The binding to ATP
in zim17rc-3a and -3b mitochondria was indistinguishable from the wt, revealing
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that the general ability of Ssc1 to interact with ATP is not diminished in the zim17
mutants (figure 3.32A).
3.5.5.4.2. Zim17 mutants show an intact inward directed translocation force
To measure the ability of Ssc1 to generate an inward directed translocation force in
zim17rc mitochondria, import reactions applying the preprotein b2(167)∆DHFR were
carried out in the presence of the DHFR-ligand MTX as described in section 2.6.3.
The ts mutant ssc1-2 is known to display a pulling defect due to a mutation in
its substrate-binding domain (Voisine 1999) and was therefore used as a control.
Import reactions were carried out for 20min at 25 ◦C and subsequently treated with
proteinaseK. The amount of protease-resistant b2(167)∆DHFR was determined in
relation to the total amount of imported protein. As the general import efficiencies of
wild type and mutant mitochondria differed, all signals were normalized to the total
amount of imported protein that was trapped in the import channel. While ssc1-2
mitochondria showed a reduction in the pulling activity after a 15min heat treatment
at 37 ◦C, accumulated translocation intermediates remained largely protease-resistant
in all measured zim17 mutants, implying that ATP-hydrolysis and the interaction
of Ssc1 with the translocase complex of the inner mitochondrial membrane are still
intact in the zim17 mutants.
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Figure 3.32.: Ssc1 nucleotide-binding and ’pulling’ activity in zim17rc mitochondria. (A) Binding
of Ssc1 from zim17rc mitochondria to ATP-agarose. Isolated mitochondria of wild-type and zim17
mutants were lysed as described under ’experimental procedures’ and subjected to ATP-agarose. Bound
proteins were eluted with Laemmli-buffer and analysed via SDS-PAGE and immunoblotting with a Ssc1-
specific antibody. (B) Ssc1-dependent pulling activity on preproteins in transit in zim17rc mitochondria.
Radiolabeled b2(167)∆DHFR with the prebound DHFR ligand MTX was incubated with isolated
zim17rc-wt, -3a -3b and ssc1-2 mitochondria to accumulate translocation intermediates. The import
was terminated after 20min at 25 ◦C and samples were assayed as described in section 2.6.3. Protease-
resistant b2(167)∆DHFR was assayed by SDS-PAGE and digital autoradiography. The graph represents
the mean values of three independent experiments.
3.5.5.4.3. Zim17 mutants show a diminished Ssc1-interaction with newly imported sub-
strate proteins
To assess if the import defect in zim17rc-3a mitochondria is due to a diminished
substrate interaction of Ssc1, a co-immunoprecipitation experiment was performed.
Radiolabelled Su9(86)DHFR was imported 20min in zim17rc mitochondria. After
the import reaction was stopped, samples were divided into two halves. One half
was further incubated at 25 ◦C for 15min, the other half was directly subjected
to immunoprecipitation. Mitochondria were lysed under native conditions and im-
munoprecipitations were carried out. Samples were assayed by SDS-PAGE and the
signals obtained by digital autoradiography were quantified. Due to the differing
import efficiencies, the amounts of co-precipitated Su9(86)DHFR were set in rela-
tion to the total amounts of imported protein for each mutant. As both mutants
showed slightly differing levels of Ssc1 and a partial Ssc1 aggregation phenotype at
non-permissive temperature, the amounts of precipitated Ssc1 differed between the
samples. Therefore, the relative amounts of co-precipitated substrate were addition-
ally normalized to the precipitation efficiency. At permissive temperature, 5% of
newly imported Su9(86)DHFR could be co-precipitated with Ssc1 from wt mitochon-
dria (figure 3.33). As the interaction of Ssc1 with substrate proteins is transient, the
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Figure 3.33.: Interaction of Ssc1 from zim17rc mitochondria with newly imported substrate
proteins. Radiolabeled Su9(86)-DHFR was imported into isolated zim17rc mitochondria. The import was
terminated after 20min at 25 ◦C and samples were further incubated at 25 ◦C for 15min. Mitochondria
taken at the time-points indicated were lysed, and Su9(86)DHFR were co-immunoprecipitated using
Ssc1 antiserum. Co-precipitated Su9(86)DHFR was assayed by SDS-PAGE, Western blot and digital
autoradiography. Signals from at least three independent experiments were quantified and the substrate-
binding efficiency of Ssc1 was calculated as described in the text. Error bars represent the standard
errors of at least 3 independent experiments.
amounts of co-precipitated Su9(86)DHFR were reduced approximately 2-fold after
15min of post-import incubation. At non-permissive temperature, the overall yield of
co-precipitated substrate was higher than at 25 ◦C, probably due to higher metabolic
rates at elevated temperatures. The association of Ssc1 with preprotein in zim17rc-3b
mitochondria was indistinguishable from wt under permissive conditions. After
heat-treatment, zim17rc-3b mitochondria displayed a slighty reduced association of
Ssc1 with its substrate in heat shocked mitochondria, nevertheless, the substrate was
released from Ssc1 after a 15min post-import incubation in a wt-like manner. In
contrast, a significant decrease in the amount of co-precipitated Su9(86)DHFR was
measured in zim17rc-3a mitochondria already under permissive conditions. After a
16 h heat treatment at 37 ◦C, only 6% of the total amount of imported Su9(86)DHFR
could be co-precipitated with Ssc1. Taken together, zim17rc-3a shows a temperature-
independent defect in the interaction with newly imported substrate proteins at the
translocation channel that might contribute to the import deficiency observed in the
mutant.
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3.5.5.5. Analysis of matrix functions of Ssc1 in respiratory-competent zim17
mitochondria
3.5.5.5.1. Binding of Ssc1 to immobilized model substrates
To examine the interaction of Ssc1 with substrates in the mitochondrial matrix
independently from the processes that take place at the import channel, an in vitro
substrate interaction assay using the unfolded model substrate RCMLA was per-
formed section 2.6.6.2. Mitochondrial lysates were prepared under native conditions.
To exclude aggregated Ssc1 from the reaction, all lysates were subjected to a 30min
centrifugation step at 45 000 x g. Soluble fractions were incubated with immobilized
RCMLA and analysed as described in figure 3.34. Surprisingly and in contrast to its
diminished binding to newly imported substrate proteins in the zim17-3a mutant, the
interaction of Ssc1 with RCMLA was stable in the zim17rc mutants under permissive
and non-permissive conditions (figure 3.34A).
Figure 3.34.: Ssc1 substrate-binding and ’folding’ activity in zim17rc mitochondria. (A) Binding
of Ssc1 from zim17rc mitochondria to RCMLA-sepharose. Mitochondrial lysates were prepared as
described in the text and subjected to RCMLA-Sepharose. Bound proteins were eluted with excess
ATP and analysed via SDS-PAGE, Western blot and incubation with an antibody against Ssc1. (B)
Folding activity of Ssc1 in wild-type and zim17 mutants. Radiolabeled Su9(86)-DHFR was denatured
with 7M urea and imported into the indicated isolated mitochondria. The import was terminated after
5min at 25 ◦C and mitochondria were lysed and treated with proteinase K. Samples were analysed via
SDS-PAGE, autoradiography and quantification of seven independent experiments.
3.5.5.5.2. Zim17 mutants show an intact folding activity of Ssc1
To further assess the folding capacity of Ssc1 in the zim17rc mutants, a specific assay
employing the protein Su9(86)DHFR was performed. Urea-denatured Su9(86)DHFR
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was imported into isolated zim17rc mitochondria for 5min and the protease-resistance
of imported DHFR was determined as described in section 2.6.4. As expected, ssc1-2
mutant mitochondria, that were used as a control, displayed a strong folding defect
(figure 3.34B). In contrast to the Ssc1-deficiencies that were observed during the
import reaction, the folding capacities of in zim17rc mutant mitochondria were
indistinguishable from the wt.
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4. Discussion
4.1. Co-expression with Zim17 is a suitable method to purify functional
recombinant Ssc1.
The interaction of Zim17 with the main mitochondrial Hsp70 protein Ssc1 has been
characterized in several studies and most likely occurs under nucleotid-free conditions
(Blamowska 2010; Sichting 2005). Zim17 is known to prevent the aggregation of
Hsp70s in the mitochondrial matrix of S.cerevisiae (Sichting 2005) and in the cytosol
of E.coli cells (Momose 2007). Recent studies using yeast deletion mutants (zim17∆)
showed that both mitochondrial Hsp70s, Ssc1 and Ssq1, had a high tendency to
aggregate and that the ATPase domain of newly imported Ssc1 is unable to fold
properly in the absence of Zim17 (Blamowska, Neupert and Hell 2012). In this work,
the aggregation-protective character of Zim17 was utilized to study the interaction
of Zim17 with Ssc1, the main yeast mitochondrial Hsp70 protein, in an in vitro
approach. As Ssc1 is known to form insoluble aggregates when it is expressed in
E.coli cells, its recombinant expression and purification for in vitro experiments is
difficult and time-consuming. Co-expression with Zim17 could thus pave the way
for a quick and easy purification of recombinant Ssc1 from E.coli cells under native
conditions. Three different plasmids (pDB10, pIL1 and pIL2) that originate from
the vector pETDuet (Novagen) were used for the co-expression of His-tagged Ssc1
and Strep-tagged Zim17 in E.coli cells. PETDuet contains two multiple cloning sites,
each with its own T7-promotor and ribosome binding site. Expression from pDB10,
that derives from the unmodified pETDuet vector, resulted in high levels of Zim17
compared to small quantities of Ssc, probably due to the largely differing lengths of
the proteins. A modification of the plasmid by removing the T7 promotor in front of
the second multiple cloning site (pIL1) resulted in transcription of both the SSC1
and the ZIM17 gene on a single mRNA and improved the ratio of Zim17 and Ssc1.
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However, Zim17 was still overexpresed in comparison to the Hsp70 chaperone with a
Zim17-Ssc1 ratio of approximately 3:1. Additional deletion of the second ribosome
binding site upstream of the ZIM17 insert (pIL2) yielded Zim17-levels that were
lower than the amounts of Ssc1 with an approximate Zim17-Ssc1 ratio of 1:5. Thus,
expression from pIL2 closer resembled the proportions of Zim17 and Ssc1 in the
matrix of yeast mitochondria.
Expression from pIL2 resulted in a partial aggregation (approximately 50%) of Ssc1
in E.coli cells. Even when Zim17 was expressed in saturated amounts (pIL1), 50%
of the co-expressed Ssc1 was found in the insoluble fraction of the E.coli lysates.
However, the co-expression system allowed the purification of the remaining 50%
of soluble Ssc1 under native conditions. Binding assays with immobilized ATP
showed that the nucleotid-binding properties of the purified Ssc1 were preserved. It
has to be noted that Ssc1 could not be eluted from the column with excess ATP,
indicating a diminished ability to hydrolyse ATP or to release the bound ADP
from its nucleotide-binding pocket after hydrolysis. These defects, however, are
most likely derived from the lack of the nucleotide exchange factor Mge1 and the
J-protein Mdj1 that stimulates the ATP hydrolysis of Ssc1 in vivo. When an elution
with Lämmli buffer was performed, Ssc1 and Zim17 were eluted together from the
ATP column. In summary, the experiments show that the expression of Ssc1 in
the presence of Zim17 provides an efficient method to express and purify relatively
large amounts of Ssc1 from E.coli under native conditions. The purified chaperone
is still functional as its ability to interact with immobilized nucleotides is preserved.
Nevertheless, it was not possible to purify Zim17-free Ssc1 as the binding of Zim17
to the chaperone seems to be relatively stable. This, however, may not be a problem
in the presence of other components of the Ssc1 chaperone system that potentially
exclude the binding of Zim17 (Goswami, Chittoor and D’Silva 2010). Furthermore,
there is no hint that Zim17 functionally interfers with other Ssc1 cochaperones. The
Ssc1-Zim17 co-expression system is thus a suitable method to purify soluble Ssc1 for
in vitro experiments.
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4.2. Recombinant Zim17 tends to form dimers in solution but interacts
with Ssc1 as a monomer
The interaction behaviour of Zim17 and Ssc1 was studied via gel filtration analysis.
Interestingly, Zim17 eluted at the size of a dimer but seemed to interact with Ssc1
in a monomeric form. Zim17 that was expressed in the absence of Ssc1 occured
almost completely in the dimeric form, confirming that the dimerization occurs
independently of its interaction with Ssc1. The occurance of dimeric forms has
also been observed for the human Zim17-orthologue Hep1 (Zhai 2008) and the
chloroplast Zim17 orthologue HEP2 (Willmund 2008), raising the question for their
functional importance. Similarly, it was shown in a recent study (Dores-Silva 2013)
that recombinant human Hep1 eluted mainly at the size of an apparent dimer
(29.6 kDa) in FPLC experiments. However, it was pointed out that an assymetric
monomeric form of Hep1 would elute at the same size. Thus, the apparent dimeric
form of Zim17 could just represent a different conformation of the monomeric protein
in its unbound state. However, recombinant Hep1 showed the tendency to form
concentration-dependent oligomers and the structural stability of the oligomers and
the monomer was furthermore dependent on the presence of zinc (Dores-Silva 2013).
The stabilising role of the zinc atom in yeast Zim17 has been directly demonstrated
in other studies. Recombinant Zim17 mutants that were carrying a mutation in
one of the zinc-chelating cysteines and thus were unable to bind their ligand, were
aggregating in E.coli cells (Momose 2007). Furthermore, molecular dynamics (MD)
simulations showed that the Zn2+ ion stabilised the whole Zim17 molecule through
local and long range effects mediated by the coordinating cysteines C75 and C100
(Fraga 2012). Interestingly, these effects particularly affect the region around the
residues R106, H107 and D111 that have been implicated to take part in the
interaction with Hsp70 (Fraga 2012; Momose 2007; Zhai 2011). In accordance with
these results, Zim17 zinc finger mutants that were generated in this work aggregated
after recombinant expression in E.coli (section 3.2.2). However, upon import of their
precursor forms into the mitochondrial matrix, the zinc finger mutants remained
soluble (section 3.2.3), pointing towards a less severe and maybe more specific effect
of the zinc ligand under in vivo conditions.
An example for the stabilising effect of a zinc ligand in mitochondrial proteins is
represented by the small IMS-proteins Tim9 and Tim10 that assist in the import
of mitochondrial membrane proteins. In the IMS, Tim9 and Tim10 proteins form
106 4. Discussion
disulfide-bonds between their zinc-chelating cysteine residues and are found in
hexameric heterocomplexes (Lu 2004; Webb 2006). Nevertheless, the binding of zinc
seems to stabilise newly synthesised monomeric Tim10 in the cytosol to maintain it
in a reduced, import-competent state (Lu and Woodburn 2005). However, import
of Tim9 and Tim10 seems to occur preferential in their zinc free apo-form (Morgan
2009). A spontaneous cysteine oxidation in the absence of zinc, resulting in disulfide
bonds between the cysteine residues, could not be detected in Zim17 (Fraga 2012).
Moreover, while the intermembrane-space protein Mia40 assists in the folding and
complex formation of newly imported Tim9 and Tim10 (Müller 2008), a comparable
import pathway is not known to occur in the mitochondrial matrix. Thus, functional
or structural similarities of Zim17 with the small Tim proteins are unlikely. It
cannot be excluded that Zim17 is stabilised by binding to cytosolic zinc prior to
its import. However, as zinc-binding induces a stably folded conformation, it is
unlikely that Zim17 is imported in its zinc-chelated form. As the binding of zinc to
Zim17 is fast and relatively stable (Fraga 2012), the zinc atom would have to be
removed or zinc-binding would have to be prevented by a cytosolic factor prior to the
import reaction. The presence of such an unknown cytosolic factor has already been
suggested to facilitate the import of Tim9 and Tim10 (Morgan 2009) and might also
be important for the import of other metal-chelating proteins.
Apart from the special role of the zinc atom during the biogenesis pathway of the
small Tim proteins, a stabilising role of ligands has also been shown for a diversity
of other metal chelating proteins (Cunningham, Mulkerrin and Wells 1991; Maret
2005; McCall, Huang and Fierke 2000; Namuswe and Berg 2012). For some of these
proteins, the metal-binding region seems to be directly involved in dimerization
events or even forms the dimerization site itself (Chantalat 1999; Cunningham,
Mulkerrin and Wells 1991; Frankel, Bredt and Pabo 1988; Maret 2005; McIntyre
1993). However, none of those proteins shows structural or functional similarities
with Zim17, potentially excluding a role the zinc binding domain in its dimerization.
The N-terminal domain of Zim17 (amino acids 64-112, Vu 2012) involves its zinc-
chelating residues and the conserved His107 and D111 that are believed to be
part of the Ssc1-interaction site (Momose 2007; Zhai 2011). However, not much is
known about the function of the C-terminal domain of Zim17 (amino acids 112-160).
Fluorescence emission spectroscopy data of human Hep1 using the conserved W115
in its C-terminal region as an internal probe, indicated that W115 itself might be
part of the oligomerization interface of human Hep1 (Dores-Silva 2013) raising the
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question if this region might be involved in Zim17 oligomerization.
Taken together, the phenomenon of putative Zim17 oligomers and dimers and the
precise role of the zinc ligand remain to be clarified. As oligomerization of Zim17
seems to take place in the absence of a Hsp70 binding partner, it could provide an
inactive storage form of the protein. This would make sense when no zinc is available
to stabilise the monomer and to render the protein into a functional state. However,
not only the monomeric but also the oligomeric forms of Zim17 seem to display a
higher stability in the presence of the zinc ligand, raising more questions about its
functional significance. Further studies will be necessary to elucidate the relationship
between zinc-binding, oligomerization and function of Zim17.
4.3. Dependence of the Zim17-interaction on the nucleotide-binding state
of Ssc1
The interaction of Zim17 with mtHsp70s occurs most likely in the absence of nu-
cleotides (Blamowska, Neupert and Hell 2012; Sichting 2005). Nevertheless, it has
been demonstrated that the human Zim17 orthologue Hep1 can also interact with
mtHsp70 in the presence of ATP or ADP, though with reduced efficiency (Goswami,
Chittoor and D’Silva 2010; Zhai 2008). Furthermore, the human Hep1 is known to
stimulate the ATP hydrolysis activity of mtHsp70 (Zhai 2008) and thus must be
able to bind to the chaperone in the presence of ATP.
In ATP-binding experiments using FPLC-purified components, Zim17 was eluted to-
gether with Ssc1 from immobilized ATP, indicating a stable, nucleotide-independent
interaction between the two proteins. However, as other components of the Hsp70
system were missing in the experiment, it is unclear if the Zim17 binding to Ssc1
is as stable under in vitro conditons. A study on human mitochondrial Hsp70
chaperones with an impaired J-protein interaction showed enhanced binding to the
Zim17-orthologue Hep1. Moreover, the binding sites for the J-protein Tid1 and
Hep1 at the ATPase-Domain of mtHsp70 are mutually exclusive (Goswami, Chittoor
and D’Silva 2010). It is thus possible that binding of Zim17 to Ssc1 is weakend
prefrentially during a stage of the Hsp70 reaction cycle where other cochaperones
displace Zim17.
To revise the nucleotide-dependency of the Zim17-Ssc1 interaction, a Ni-NTA pull-
down experiment applying mitochondria from a yeast strain carrying a Ssc1-His
gene was performed. Zim17, like the nucleotide-exchange factor Mge1, coeluted with
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Ssc1-His under nucleotide-free conditions while the J-protein Mdj1 bound to Ssc1
in the presence of ATP. In a second approach, the binding of Ssc1 to immobilized
Zim17 was examined. Ssc1 bound to Zim17 under both ATP and nucleotide-free
conditions. However, the experiments were perturbed by a high background of Zim17
interacting with the crude column material was observed. Furthermore, it cannot be
excluded that Ssc1 interacts with the immobilized Zim17 in a substrate-like manner.
Taken together, the experiments confirm that Zim17 seems to bind to Ssc1 preferably
in the absence of nucleotides. However, as observed under in vitro conditions in
experiments with immobilized ATP, an interaction in the presence of nucleotides
seems to be generally possible and might also occur in vivo, though to a much lower
extend.
4.4. Expression of Zim17 conditional mutants in a zim17∆ genetic
background is not suitable for the direct analysis of Zim17 functions
Previous studies applying yeast deletion mutants (zim17∆) showed that both mi-
tochondrial Hsp70s, Ssc1 and Ssq1, had a high tendency to aggregate and that the
ATPase domain of newly imported Ssc1 is unable to fold properly in the absence of
Zim17 (Blamowska, Neupert and Hell 2012; Blamowska 2010). However, a direct
analysis of Zim17 functions under these conditions was difficult due to the accu-
mulation of severe secondary defects caused by the aggregation of mtHsp70s. To
overcome those difficulties, a set of temperature-sensitive mutations of the ZIM17
gene of S. cerevisiae from a library generated by random mutagenesis was cloned into
the yeast vector pFL39 and expressed in zim17∆ cells under the control of their own
promotor (Sanjuán Szklarz 2005). Yeasts were screened for temperature-sensitive
growth behaviour and the yeast strains zim17-2 (L40S/ L59S/ H107P), zim17-3
(D111G, N79S) and zim17-4 (V31A, L113P, I115T) were chosen for further analysis.
For control purposes, a corresponding wt (zim17-corrWT ) strain carrying the ZIM17
gene on the same plasmid as the mutants was generated. A subcellular fractionation
experiment and a sequence analysis of the mutants revealed that zim17-2, that was
previously analysed by Szklarz (2005), and zim17-4 carried mutations in the predicted
Zim17 pre-sequence. In case of zim17-2 the exchange of leucine with a neutral serine
at position 40 probably interferes with its import into the mitochondrial matrix,
leading to virtually undetectable amounts in the mitochondrial matrix. Zim17-4 that
carries an alanine instead of a valine at position 31 was found in the mitochondrial
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fraction, though in much lower amounts than Zim17-corrWT and Zim17-3.
PFLzim17-ts3-CEN (zim17-3 ), pFLzim17-ts4-CEN (zim17-4 ) and the corresponding
wt plasmid were transformed into a respiratory-deficient zim17∆-strain. Expression
of Zim17-corrWT in the zim17∆ background were able to rescue the temperature-
sensitive phenotype. Furthermore, zim17-3, zim17-4 and zim17-corrWT apparently
had regained their respiratory competence as they were viable under non-fermentable
(YPG) conditions. However, growth on YPD lead to a relapse of the respiratory-
incompetent phenotype in the mutants as well as in zim17-corrWT cells. As expres-
sion of wild type Zim17 did not fully rescue the respiratory-deficient phenotype of the
original zim17∆ cells, it has to be assumed that the loss of respiratory competence is
not a direct effect of the lack of Zim17 but more likely derives from an accumulation
of secondary effects due to the ZIM17 deletion.
On the molecular level, the expression of zim17-corrWT and zim17-3 lead to a
high overexpression of both proteins, probably as a response to the lack of Zim17
in the ∆ mutant. Moreover, Ssc1 showed a severe aggregation in the correspond-
ing wild type as well as the zim17-3 mutant even at a permissive temperature of
25 ◦C. The zim17-4 mutant exhibited lower expression levels of Zim17 and a more
temperature-sensitive aggregation-behaviour of Ssc1, nevertheless, also in this mutant
a considerable aggregation of Hsp70 chaperone was already observed at 25 ◦C.
Zim17∆ mutants tend to accumulate primary and secondary effects as a consequence
of mtHsp70 loss of function. These include important processes like the import of pre-
proteins and the biogenesis of Fe/S cluster proteins (Sanjuán Szklarz 2005; Sichting
2005). As these deficiencies result in the formation of dysfunctional mitochondria, the
inability of wt Zim17 to fully rescue the growth and aggregation phenotype of these
cells could be explained. The recombinant expression of conditional zim17 mutants
in the zim17∆ genetic background consequently leads to a mixture of primary and
secondary effects that are not fully distinguishable. Thus, the recombinant expression
of zim17 -mutants in zim17∆ cells is not suitable to study the direct consequences of
a Zim17 loss-of-function.
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4.5. Two novel genomic integrated zim17 mutants show a
temperature-sensitive phenotype combined with an instable
respiratory deficiency
To obviate the described accumulation of secondary effects, two conditional zim17
mutants were integrated into the genome of the S.cerevisiae YPH499 wt strain
under the addition of the LEU2 marker. The mutant zim17-3a derives from the
recombinant mutant zim17-3 and contains a mutation at residue D111 that belongs
to the conserved DNL-motif of Zim17 and is believed to be part of the interface for the
interaction with Ssc1 (Momose 2007). Similarly, the human Zim17 orthologue Hep1
showed a dependence on residue D111 in its interaction with the Hsp70 chaperone
HSP9A (Zhai 2011). The random mutagenesis thus confirms the importance of
the D111 site in Zim17. Zim17-3a carries a second mutation at the less conserved
residue N79 that is in direct neighbourhood to one the zinc-chelating residues (C78)
of Zim17. In order to distinguish the effects of the different point mutations, the
strain zim17-3b, that contains only the D111G mutation, was constructed.
Zim17-3a and -3b were successfully integrated into the yeast genome while the
integration of a third mutant, zim17-4 (V31A, LI113/115PT), did not yield any viable
positive clones. While the D111G mutation from zim17-3 has been characterized
previously (Momose 2007; Zhai 2011), the functional significance of the mutated
residues in zim17-4 is not known. It thus remains elusive if the integration of zim17-
4 failed because the respective mutations are probably lethal or due to technical
problems.
While the original zim17-3a and -3b mutant integrants were not able to grow on
non-fermentable carbon sources and thus showed a respiratory-deficient phenotype,
a random spore analysis yielded a mixture of respiratory-competent (zim17rc) and
respiratory-incompetent (zim17ri) mutant cells. The corresponding wt cells showed a
100% respiratory competence. For zim17-3b, the proportion of respiratory-competent
cells was higher (74% of tetrades) than for zim17-3a (36.6% of tetrades). Further
experiments revealed that the respiratory deficiency could be induced by growth
on a fermentable carbon source as it was already observed for the recombinant
mutants zim17-3 and zim17-4. However, a high temperature treatment did not
induce respiratory deficiency. In summary, both zim17 mutant integrants showed a
temperature-sensitive phenotype going along with an instable respiratory competence.
Thus, this data confirms that the respiratory deficiency is not a direct effect of the
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loss of functional Zim17 but derives from secondary effects that are most likely
due to the concomitant loss of functional mtHsp70s. To characterize the direct
and secondary effects of the Zim17 loss of function on yeast mtHsp70s zim17rc and
zim17ri mutants were analysed separately.
4.6. The respiratory instable phenotype of conditional zim17 mutants
derives from a deficient mitochondrial Fe/S cluster biogenesis as a
consequence of mtHsp70 loss of function
A biochemical analysis of zim17ri mutant integrants revealed defects in mtHsp70-
dependent processes. Zim17-3a and -3b were expressed in slightly higher amounts
than Zim17-wt in the zim17ri cells. Both zim17-3a and -3b showed a substantial
aggregation of the two mtHsp70 chaperones Ssc1 and Ssq1 already at a permissive
temperature of 25 ◦C. The second yeast mtHsp70 chaperone Ssq1 plays a role in the
biogenesis of mitochondrial Fe/S proteins and is believed to promote the transfer of
the Fe/S cluster from the scaffold protein Isu1 to its apo-protein in the biogenesis
of mitochondrial Fe/S cluster proteins (Dutkiewicz 2006). In mitochondria, Fe/S
clusters are found in proteins of the respiratory chain complexes and in aconitase, an
enzyme of the citric acid cycle (Lill and Mühlenhoff 2008; Lill 2006). S. cerevisiae
with defects in the Fe/S cluster biogenesis are known to display a decrease in
proteins of respiratory metabolism (Hausmann 2007, Lill 2012 and references
therein). Indeed, the levels of proteins of the respiratory chain and the citrate
cycle were downregulated to almost non-detectable amounts in the zim17ri mutant
integrants. Furthermore, a complete loss of iron-sulfur cluster containing proteins
like aconitase and Rip1 was observed. A decrease of aconitase has been shown
previously in zim17∆ cells and was linked to the loss of function of Ssq1 in these
cells (Sichting 2005). The loss of aconitase observed in this study was induced by
growth of originally respiratory-competent cells on YPD. While aconitase levels were
reduced to non-detectable amounts already after 6-12h of incubation on YPD, cells
became respiratory-deficient after 24h on the fermentable carbon source, supporting
the idea that the respiratory incompetence derives from ongoing damages in the
Ssq1-mediated steps of Fe/S biogenesis.
Analyses of the levels of other proteins in zim17ri mitochondria revealed no further
abnormalities. The expression of Ssc1 and Ssq1 themselves along with their J-proteins
Pam18, Mdj1 and Jac1 was stable in the respiratory-deficient mutants. The only
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exception was the Ssq1 substrate Isu1 that showed a substantial upregulation in
the mutants. Elevated levels of Isu1 have been observed previously in cells lacking
components of the mitochondrial Fe/S cluster assembly machinery and are caused
by an up-regulated protein expression both at a translational and posttranslational
level (Andrew 2008). The Isu1-upregulation thus further indicates a defective Fe/S
biogenesis in the zim17ri mutants.
Zim17 mutant cells displayed a respiratory-competent phenotype (zim17rc) as long
as they were forced to grow under non-fermentable conditions. In contrast to its
expression levels in zim17ri cells, Zim17 itself was expressed in lower levels in both
mutants. Similarly, the levels of Ssq1, the Fe/S biogenesis chaperone were strongly
downregulated and showed an almost complete aggregation in the zim17rc-3a mutant
at elevated temperatures. This behaviour was reflected by significant alterations in
the amounts of Isu1 and the Ssq J-domain partner Jac1 after a 37 ◦C heat treatment.
It has been shown that Jac1 is able to interact with Isu1 independently (Andrew
2006; Dutkiewicz 2006) and it is widely accepted that holo-Isu1 and Jac1 form a
complex first and are together recruited to the Hsp70 chaperone by interaction of
Jac1 and Ssq1. The Isu1-upregulation and the presence of Jac1 are critical for the
survival of yeasts in the absence of Ssq1. Hence, it is likely that growth of the zim17
mutant cells under non-fermentable conditions induces an adaptive process in the
gene expression leading to an improved conservation of mitochondrial functions, in
particular respiratory competence. The overexpression of Jac1 might be able to
enhance the substrate affinity of mtHsp70s for Isu1. Since the levels of Ssq1 are
reduced in the zim17 mutants , it is also likely that the role of Ssq1 is partially taken
over by Ssc1 under these conditions. This is corroborated by the observation that an
artificial overexpression of Jac1 is able to shift the function of Ssq1 in Fe/S cluster
biogenesis to Ssc1 and rescue the growth defects of ssq1∆ mutants (Schilke 2006).
The high temperature-dependent overexpression of Ssc1 in both zim17rc mutants
further supports this hypothesis.
In support of these results, no significant reductions in the levels of respiratory
enzymes or Fe/S proteins were observed in the respiratory-competent zim17 mutants.
However, a loss of activity of the Fe/S-protein aconitase that was going along
with a defective Fe-incorporation into the enzyme was measurable in zim17rc
mitochondria (Lewrenz et.al, submitted). In conclusion, the initial damage of
mitochondrial Fe/S biogenesis in the zim17 -mutants over time could emerge in a
respiratory-deficient phenotype on non-fermentable carbon sources where no protec-
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tive mechanisms are induced in the mutants. Taken together, this data confirms
that the respiratory instable phenotype of zim17 mutants most likely displays a
long-term effect deriving from a defective Fe/S biogenesis as a consequence of a Ssq1
loss of function. Hence, the temperature-sensitive lethal phenotype of our zim17rc
mutant cells most likely correlates with a functional defect of the main mtHsp70 Ssc1.
4.7. Zim17 exerts a direct supportive function on Hsp70 activities
independent of its aggregation-protective role
Hsp70 chaperones showed a strong aggregation even at permissive temperature in
respiratory-deficient zim17ri mutant cells. In vivo import experiments with zim17ri
cells revealed a deficient import, at an elevated temperature of 37 ◦C, favouring the
theory of a direct influence of Zim17 on the matrix-destined preprotein import. A
diminished matrix import has also been shown in zim17∆ cells. However, as both
zim17∆ and zim17ri mitochondria are known to be respiratory unstable, one has
to take into consideration, that the membrane potential ∆Ψ of these mitochondria
might be low.
As measurements confirmed that the zim17ri mutants showed a disrupted inner
membrane potential, in organello import experiments were carried out in the
presence of excess ATP and denatured preproteins. The import into both zim17ri-3a
and zim17ri-3b was diminished not only in comparison to the respiratory-competent
zim17-wt cells but also in comparison to a respiratory-incompetent, ∆Ψ-deficient
YPH499 strain (YPH499 rho−). Thus, the diminution of import seems to be a direct
effect of the zim17 mutations and is only partly deriving from the lack of ∆Ψ .
However, as large amounts of Ssc1 were aggregating in the mutants, it cannot be
excluded that the observed import defect is solely deriving from a lack of soluble
Ssc1 under these conditions.
The aggregation phenotype of zim17rc cells was temperature-dependent and less
severe than in the zim17ri mutants. Interestingly, the import into both zim17rc-3a
and -3b was increased at a permissive temperature when no Ssc1 aggregation
was detected. After a 16h heat treatment at 37 ◦C the import into zim17rc-3a
mitochondria was decreased in comparison to wild type mitochondria while the
import into zim17rc-3b was indistinguishable from wt. The zim17rc-3a mutant
showed a more severe aggregation of mtHsp70s than zim17rc-3b. The import rates
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of the mutants thus seemed to correlate with the aggregation behaviour of Ssc1.
However, as only about 30% of the total amount of Ssc1 aggregated in the zim17rc-3a
mutant after the heat-treatment leaving 70% of Ssc1 in the soluble fraction, it is
unlikely that the strong import defect solely derives from the aggregation of the
chaperone. Moreover, the Ssc1 aggregation phenotype does not explain the elevated
import into zim17rc mitochondria at permissive temperature.
Unexpectedly, an in vivo import analyis of the zim17 mutants only showed an
import defect under fermentable conditions. The alterations in the import behaviour
of isolated zim17rc mitochondria thus mirror only a slight effect that is undetectable
in vivo. Hence, the influence of Zim17 on the enzymatic cycle of Ssc1 must be
only indirectly related to the import function of the chaperone. To this end, the
behaviour of Ssc1 at different points of its enzymatic cycle that are relevant for the
import reaction was examined. Ssc1 is recruited to the translocase via the scaffold
protein Tim44. At this position, it is able to exert an inward-directed translocation
force (’pulling’) on the incoming protein that is driven by a conformational change
induced by ATP-hydrolysis. The ability of Ssc1 to generate an import-driving
force on preproteins in transit was not affected in the zim17rc mutants. Since
both mutants further showed a wild type-like interaction of Ssc1 with ATP, their
import-motor functions in general did not seem to be affected as such. Nevertheless,
co-immunoprecipitation experiments revealed a reduced interaction of Ssc1 with
newly imported proteins after the import reaction in the zim17-3a mutant. In
contrast, the interaction of Ssc1 with general Hsp70 substrates in vitro (RCMLA)
was not altered. Thus, the substrate-interaction deficiency seemed to be restricted
to import-related processes that are mediated by Ssc1.
During folding reactions in the matrix compartment, Ssc1 functionally interacts with
the J-protein Mdj1, a homolog of the bacterial DnaJ. Mdj1 belongs to the class I
J-proteins that contain a substrate-binding domain and two zinc-binding motifs
at their C-terminus. Mitochondrial Hsp70s have two more specialised J-protein
interaction partners in addition to Mdj1. Pam18, a small J-protein associated with
the inner membrane protein translocase TIM23, interacts with Ssc1 during the import
of matrix-targeted proteins. Jac1 interacts with the second mtHsp70 chaperone
Ssq1 during Fe/S cluster assembly. Both proteins are class III J-proteins and lack
the typical cysteine-rich C-terminal domain of Mdj1. It is generally assumed that
Pam18 does not have an intrinsic substrate-binding activity. However, Jac1 seems to
be able to interact with the Ssq1-substrate Isu1 through a motif in its C-terminal
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region (Ciesielski 2012). Due to its zinc finger domain, it has been presumed earlier,
that Zim17 might act as one polypeptide part of a ’fractured’ J-protein providing a
substrate-binding motif for class III J-proteins like Pam18 and Jac1 (Burri 2004).
The observed direct effect of Zim17 on the import activity of Ssc1 supports an aspect
of the ’fractured’ J-protein hypothesis. The diminished co-immunoprecipitation of
precursor proteins with soluble Ssc1 at the import channel in the zim17-3a mutant
demonstrates that Zim17 may directly support the interaction of Ssc1 with imported
substrate proteins. In the same process, the inner membrane J-protein Pam18,
consisting virtually only of a membrane-tethered J-domain, would activate the
ATPase activity of Ssc1. The combined activity of both proteins would contribute to
the full activity of the import motor with its core enzyme Ssc1.
Since a direct physical interaction of Zim17 with mtHsp70 substrate polypeptides
has not been reported so far, the question arises how Zim17 influences the substrate-
binding activity of mtHsp70s. Ssc1 is recruited to the import channel by the scaffold
protein Tim44 and thus is in close proximity to incoming substrate proteins. Hence,
the substrate-delivering properties that have been described for other J-proteins are
dispensable for Ssc1 at the import channel (Kampinga and Craig 2010). Moreover,
Jac1, the J-protein of the second Zim17-interaction partner Ssq1 is able to bind the
specific substrate Isu1 and delivers it to the chaperone. It is thus likely that Zim17
rather enhances the substrate affinity of mtHsp70s than to deliver unfolded substrates
to the Hsp70 chaperone. The upregulation of the specific Ssq1 cochaperone Jac1
in the zim17rc mutants further supports this conclusion. As mentioned earlier, the
specific binding of Jac1 to Isu1, confers the substrate specifity (Knieszner 2005).
It is therefore possible that the upregulation of Jac1 occurs as a reaction to the
diminished substrate affinity of Ssq1 in the mutants.
The interaction of Zim17 with mtHsp70s occurs most likely in the absence of nu-
cleotides. Nevertheless, it has been demonstrated that the human Zim17 orthologue
Hep1 can also interact with mtHsp70 in the presence of ATP or ADP, though with
reduced efficiency. Furthermore, the interaction of Hep1 and mtHsp70 remained
stable after addition of a model-substrate protein under both nucleotide-free and
ATP conditions (Goswami, Chittoor and D’Silva 2010). This, together with the
results of this work, would favour a model in which Zim17-binding to Ssc1 occurs
after or during the initial binding of substrate and stabilises the Hsp70-substrate
complex after ATP-hydrolysis to allow a more efficient interaction with the client
protein. A similar task has been suggested for zinc centerII in the C-terminal
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substrate-binding domain of the class I J-protein DnaJ. While zinc centerI seems to
be directly involved in the interaction with unfolded substrates, it has been proposed
that zinc centerII contributes to the high-affinity interaction of Hsp70s with client
proteins (Linke 2003). In support of this thesis Hep1 has been shown to enhance
the ATPase activity of mtHsp70s, a feature that could not be observed for the
yeast Zim17 protein and may have evolved to further support the stable binding
of substrates to mtHsp70. In conclusion, Zim17 seems to specifically influence the
function of mtHsp70 proteins in processes that involve class III J-proteins, most
likely by a mechanism that regulates the interaction of the chaperone with substrate
proteins. As class I J-protein partners contain domains for the regulation of the
Hsp70 substrate-affinity themselves, the function of Zim17 is dispensable in those
cases. Collectively, Zim17 exerts a direct effect on the import activity of Ssc1 that
differs from a simple aggregation-preventive function.
The decreased Hsp70 affinity for substrate proteins in the zim17 mutants may
also explain the elevated import into zim17rc mutant mitochondria at permissive
temperature. The faster substrate release in the mutants would consequently lead to
a faster import when the ATPase- and the pulling-activity of Ssc1 are intact. At
elevated temperatures, the temperature-sensitive zim17-3a mutant shows an even
more transient substrate-binding. This, together with a lower availability of Ssc1 at
the import channel caused by temperature-induced aggregation would consequently
lead to a decelerated import and jamming of the TIM23 translocase. One would
expect that in this situation the inward directed translocation force that Ssc1 exerts
on the incoming preprotein should be diminished. Unexpectedly, the Ssc1 pulling
activity of the mutants in organello was indistinguishable from wt. However, as the
pulling activity of Ssc1 was measured in relation to the total amount of imported
protein, a decrease of the inward-directed translocation force was probably masked
by normalization to the lower import efficiency in the zim17-3a mutant and thus
could not be detected under these conditions. A recent study on the enzymatic
cycle of Ssc1 using purified components revealed that the binding of Ssc1 to its
matrix J-protein Mdj1 is relatively stable in comparison to the binding of other
Hsp70 chaperones to their J-proteins (Mapa 2010). During the Ssc1-dependent
import-reaction, a prolonged substrate-binding due to a stable J-protein interaction
would lead to stagnation of the import process and to jamming of the translocase
(Mapa 2010). Conversely, a rapid substrate release due to insufficient substrate
affinity would lead to similar consequences, raising the question of a regulatory
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mechanism for Ssc1 chaperone system during the import of preproteins (Mapa 2010,
see above). According to the results presented in this work, it is possible that Zim17
is part of such a regulatory mechanism.
4.8. Does the zinc finger domain of Zim17 play a role in exerting its
Hsp70-supporting function?
Zim17rc-3a and -3b mutants showed a similar phenotype, however, most of the
observed effects were stronger in the 3a than in the 3b mutant. While both mutants
showed an enhanced import activity at 25 ◦C, only the import of zim17rc-3a was
decreased in comparison to the wt after a 16 h heat treatment at 37 ◦C. Furthermore,
the diminishment in the substrate-interacting activity of Ssc1 and the decrease in
the activity of the Fe/S protein aconitase were much stronger in zim17rc-3a than in
zim17rc-3b mitochondria. The aspartic acid at position 111 that is mutated in both
mutants belongs to the conserved DNL-motif of Zim17 and is believed to be part of
the interface for the interaction with Ssc1 (Momose 2007). Accordingly, the human
Zim17 orthologue Hep1 showed a dependence on residue D111 in its interaction with
the chaperone HSP9A (Zhai 2011). The additional mutation in Zim17-3a at position
79 is in direct neighbourhood to one of the four zinc-chelating cysteins in Zim17.
Furthermore, it is positioned at the end of one of the β-sheets that are flanking the
zinc-binding site. Alteration of the aspartic acid to a neutral serine at this position
could lead to changes in the secondary structure of Zim17 that probably prevent
an efficient binding of the zinc atom. It was reported recently, that zinc-free Zim17
displays an unstructured conformation and folds independently to its native stucture
after the addition of Zn2+. In particular, the coordinating cysteines C75 and C100
transmit stabilising intramolecular effects to the residues at the Hsp70 binding site
(Fraga 2012). Furthermore, it was proposed that the zinc centerII of DnaJ provides
a second site for interaction with the Hsp70 chaperone (Linke 2003). It is thus likely
that the enhanced thermolability of Zim17-3a due to a diminished binding of zinc
could be the reason for a generally more severe phenotype of zim17-3a mutant cells
that contain the additional N79S amino acid exchange.
However, the exact role of the zinc finger domain of Zim17 could not be resolved in
this work and remains elusive. Furthermore, experimental evidence if alteration of
the poorly conserved residue N79 indeed influences the zinc-binding properties of
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Zim17 is missing. Alternatively, it could be possible that the domain containing the
zinc-chelating residues of Zim17 provides an interaction site for class III J-proteins
or Hsp70-bound substrates themselves. Further investigations will need to elucidate
the importance of this site and the exact mechanism of the interplay between Zim17
and the different components of the mtHsp70 chaperone system.
4.9. Is the prevention of Hsp70 aggregation a primary Zim17 function?
Why are mtHsp70s aggregating in zim17 -mutant and zim17∆ cells? In the ATP-
bound state the substrate-binding domain (SBD) and nucleotide-binding domain
(NBD) of Ssc1 are in close proximity to each other. As soon a substrate is bound
and ATP-hydrolysis has occurred the two domains are undocked. It was therefore
proposed that mitochondrial Hsp70s represent a class of 70kDa heat shock proteins
that are particularly prone to aggregation, probably due to flexible conformers that
occur as cycle intermediates or loosely folded, de novo imported proteins (Blamowska
2010). In addition, it was shown that Zim17 is able to assist in the de novo folding
of newly imported Ssc1 to a trypsin-resistant conformation in the mitochondrial
matrix (Blamowska, Neupert and Hell 2012). However, no de novo imported Ssc1
was detectable in the aggregate pellets of zim17rc cells under both permissive and
non-permissive conditions. Thus, though newly imported Ssc1 might be less resistant
to protease-treatment in the absence of Zim17, it still seems to be able to fold into a
soluble conformation. The results of this work do not exclude the possibility that
Zim17 is able to interact with the ATPase-domain of nucleotide-free, newly imported
mtHsp70s or stays attached to intermediates in the enzymatic cycle to prevent their
misfolding and subsequent aggregation. In the zim17rc mutants, 30 and 13% of total
Ssc1 aggregated after subjection to a non-permissive temperature. Due to its reduced
substratet-affinity, aggregation of Ssc1 in the zim17 -mutant mitochondria could be
caused by an accumulation of substrate-free intermediates of the enzymatic cycle.
It thus seems to be reasonable to assume that an enhancement of substrate affinity
and the prevention of aggregation through the binding of Zim17 might just represent
aspects of the same overall function. As Zim17 seems to assist mtHsp70s during
a reaction cycle that is mediated by class III J-proteins, it is conceivable that the
binding of other cochaperones to aggregation-prone conformers also have stabilising
effects (Momose 2007).
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A. Appendix
                           = ribosome binding sites                                      = annealing sites primer
                           = ATG ZIM17*-artefact and in frame ATGs ZIM17                 = restriction sites          
                               10        20        30       40         50       60        70        80        90        100   
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       ggggaattgtgagcggataacaattcccctctagaaataattttgtttaactttaagaaggagatataccatgg-------------------------- 
pDB10                 GGGGAATTGTGAGCGGATAACAATTCCCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATACCATGGCGTCAACCAAGGTTCAAGGTTCCGTC 
pIL1 +rbs             GGGGAATTGTGAGCGGATAACAATTCCCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATACCATGGCGTCAACCAAGGTTCAAGGTTCCGTC 
Zim17*-artefact-pIL1  ---------------------------------------------------------------------------------------------------- 
pIL2 -rbs             GGGGAATTGTGAGCGGATAACAATTCCCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATACCATGGCGTCAACCAAGGTTCAAGGTTCCGTC 
zim17*-artefact-pIL2  ---------------------------------------------------------------------------------------------------- 
Ssc1*His10            -----------------------------------------------------------------------M--A--S--T--K--V--Q--G--S--V- 
Zim17*Strep           ---------------------------------------------------------------------------------------------------- 
                                                                                           NcoI
                              110       120       130       140       150       160       170       180       190       200   
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       ---------------------------------------------------------------------------------------------------- 
pDB10                 ATCGGTATCGATTTGGGTACCACCAACTCTGCGGTTGCCATTATGGAAGGTAAAGTTCCAAAAATTATTGAAAACGCCGAAGGTTCCAGAACTACTCCTT 
pIL1 +rbs             ATCGGTATCGATTTGGGTACCACCAACTCTGCGGTTGCCATTATGGAAGGTAAAGTTCCAAAAATTATTGAAAACGCCGAAGGTTCCAGAACTACTCCTT 
Zim17*-artefact-pIL1  ---------------------------------------------------------------------------------------------------- 
pIL2 -rbs             ATCGGTATCGATTTGGGTACCACCAACTCTGCGGTTGCCATTATGGAAGGTAAAGTTCCAAAAATTATTGAAAACGCCGAAGGTTCCAGAACTACTCCTT 
zim17*-artefact-pIL2  ---------------------------------------------------------------------------------------------------- 
Ssc1*His10            -I--G--I--D--L--G--T--T--N--S--A--V--A--I--M--E--G--K--V--P--K--I--I--E--N--A--E--G--S--R--T--T--P-- 
Zim17*Strep           ---------------------------------------------------------------------------------------------------- 
                              210       220       230       240       250       260       270       280       290       300   
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       ---------------------------------------------------------------------------------------------------- 
pDB10                 CTGTAGTAGCTTTCACTAAAGAGGGAGAACGTTTGGTTGGTATTCCAGCCAAGCGTCAAGCCGTAGTGAACCCAGAAAACACCCTATTTGCTACCAAGCG 
pIL1 +rbs             CTGTAGTAGCTTTCACTAAAGAGGGAGAACGTTTGGTTGGTATTCCAGCCAAGCGTCAAGCCGTAGTGAACCCAGAAAACACCCTATTTGCTACCAAGCG 
Zim17*-artefact-pIL1  ---------------------------------------------------------------------------------------------------- 
pIL2 -rbs             CTGTAGTAGCTTTCACTAAAGAGGGAGAACGTTTGGTTGGTATTCCAGCCAAGCGTCAAGCCGTAGTGAACCCAGAAAACACCCTATTTGCTACCAAGCG 
zim17*-artefact-pIL2  ---------------------------------------------------------------------------------------------------- 
Ssc1*His10            S--V--V--A--F--T--K--E--G--E--R--L--V--G--I--P--A--K--R--Q--A--V--V--N--P--E--N--T--L--F--A--T--K--R 
Zim17*Strep           ---------------------------------------------------------------------------------------------------- 
                              310       320       330       340       350       360       370       380       390       400   
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       ---------------------------------------------------------------------------------------------------- 
pDB10                 TTTGATTGGTCGTCGTTTCGAAGACGCTGAAGTGCAAAGAGATATCAAGCAAGTTCCATACAAGATCGTCAAGCACTCCAACGGGGATGCTTGGGTTGAG 
pIL1 +rbs             TTTGATTGGTCGTCGTTTCGAAGACGCTGAAGTGCAAAGAGATATCAAGCAAGTTCCATACAAGATCGTCAAGCACTCCAACGGGGATGCTTGGGTTGAG 
Zim17*-artefact-pIL1  ---------------------------------------------------------------------------------------------------- 
pIL2 -rbs             TTTGATTGGTCGTCGTTTCGAAGACGCTGAAGTGCAAAGAGATATCAAGCAAGTTCCATACAAGATCGTCAAGCACTCCAACGGGGATGCTTGGGTTGAG 
zim17*-artefact-pIL2  ---------------------------------------------------------------------------------------------------- 
Ssc1*His10            --L--I--G--R--R--F--E--D--A--E--V--Q--R--D--I--K--Q--V--P--Y--K--I--V--K--H--S--N--G--D--A--W--V--E- 
Zim17*Strep           ---------------------------------------------------------------------------------------------------- 
                              410       420       430       440       450       460       470       480       490       500   
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       ---------------------------------------------------------------------------------------------------- 
pDB10                 GCCAGAGGTCAAACTTACTCACCAGCCCAAATCGGTGGGTTCGTCTTGAACAAGATGAAGGAAACAGCTGAGGCCTACTTGGGTAAGCCAGTTAAGAATG 
pIL1 +rbs             GCCAGAGGTCAAACTTACTCACCAGCCCAAATCGGTGGGTTCGTCTTGAACAAGATGAAGGAAACAGCTGAGGCCTACTTGGGTAAGCCAGTTAAGAATG 
Zim17*-artefact-pIL1  ---------------------------------------------------------------------------------------------------- 
pIL2 -rbs             GCCAGAGGTCAAACTTACTCACCAGCCCAAATCGGTGGGTTCGTCTTGAACAAGATGAAGGAAACAGCTGAGGCCTACTTGGGTAAGCCAGTTAAGAATG 
zim17*-artefact-pIL2  ---------------------------------------------------------------------------------------------------- 
Ssc1*His10            -A--R--G--Q--T--Y--S--P--A--Q--I--G--G--F--V--L--N--K--M--K--E--T--A--E--A--Y--L--G--K--P--V--K--N-- 
Zim17*Strep           ---------------------------------------------------------------------------------------------------- 
                              510       520       530       540       550       560       570       580       590       600   
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       ---------------------------------------------------------------------------------------------------- 
pDB10                 CTGTTGTCACTGTCCCAGCTTATTTCAACGACTCTCAAAGACAAGCTACTAAAGACGCAGGCCAAATTGTTGGTTTGAACGTTTTACGTGTCGTCAATGA 
pIL1 +rbs             CTGTTGTCACTGTCCCAGCTTATTTCAACGACTCTCAAAGACAAGCTACTAAAGACGCAGGCCAAATTGTTGGTTTGAACGTTTTACGTGTCGTCAATGA 
Zim17*-artefact-pIL1  ---------------------------------------------------------------------------------------------------- 
pIL2 -rbs             CTGTTGTCACTGTCCCAGCTTATTTCAACGACTCTCAAAGACAAGCTACTAAAGACGCAGGCCAAATTGTTGGTTTGAACGTTTTACGTGTCGTCAATGA 
zim17*-artefact-pIL2  ---------------------------------------------------------------------------------------------------- 
Ssc1*His10            A--V--V--T--V--P--A--Y--F--N--D--S--Q--R--Q--A--T--K--D--A--G--Q--I--V--G--L--N--V--L--R--V--V--N--E 
Zim17*Strep           ---------------------------------------------------------------------------------------------------- 
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                              610       620       630       640       650       660       670       680       690       700   
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       ---------------------------------------------------------------------------------------------------- 
pDB10                 ACCAACCGCCGCTGCCTTAGCTTACGGTTTGGAAAAATCCGACTCTAAAGTTGTTGCCGTTTTCGATTTGGGTGGTGGTACTTTCGATATCTCCATCTTA 
pIL1 +rbs             ACCAACCGCCGCTGCCTTAGCTTACGGTTTGGAAAAATCCGACTCTAAAGTTGTTGCCGTTTTCGATTTGGGTGGTGGTACTTTCGATATCTCCATCTTA 
Zim17*-artefact-pIL1  ---------------------------------------------------------------------------------------------------- 
pIL2 -rbs             ACCAACCGCCGCTGCCTTAGCTTACGGTTTGGAAAAATCCGACTCTAAAGTTGTTGCCGTTTTCGATTTGGGTGGTGGTACTTTCGATATCTCCATCTTA 
zim17*-artefact-pIL2  ---------------------------------------------------------------------------------------------------- 
Ssc1*His10            --P--T--A--A--A--L--A--Y--G--L--E--K--S--D--S--K--V--V--A--V--F--D--L--G--G--G--T--F--D--I--S--I--L- 
Zim17*Strep           ---------------------------------------------------------------------------------------------------- 
                              710       720       730       740       750       760       770       780       790       800   
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       ---------------------------------------------------------------------------------------------------- 
pDB10                 GATATTGACAACGGTGTTTTTGAAGTTAAGTCCACTAACGGTGACACTCATTTGGGTGGTGAAGATTTCGACATCTATTTGTTGAGAGAGATTGTTTCTC 
pIL1 +rbs             GATATTGACAACGGTGTTTTTGAAGTTAAGTCCACTAACGGTGACACTCATTTGGGTGGTGAAGATTTCGACATCTATTTGTTGAGAGAGATTGTTTCTC 
Zim17*-artefact-pIL1  ---------------------------------------------------------------------------------------------------- 
pIL2 -rbs             GATATTGACAACGGTGTTTTTGAAGTTAAGTCCACTAACGGTGACACTCATTTGGGTGGTGAAGATTTCGACATCTATTTGTTGAGAGAGATTGTTTCTC 
zim17*-artefact-pIL2  ---------------------------------------------------------------------------------------------------- 
Ssc1*His10            -D--I--D--N--G--V--F--E--V--K--S--T--N--G--D--T--H--L--G--G--E--D--F--D--I--Y--L--L--R--E--I--V--S-- 
Zim17*Strep           ---------------------------------------------------------------------------------------------------- 
                              810       820       830       840       850       860       870       880       890       900   
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       ---------------------------------------------------------------------------------------------------- 
pDB10                 GTTTCAAGACCGAAACTGGTATTGATTTGGAAAATGACCGTATGGCTATCCAAAGAATTAGAGAAGCTGCTGAAAAGGCTAAGATTGAGCTATCTTCTAC 
pIL1 +rbs             GTTTCAAGACCGAAACTGGTATTGATTTGGAAAATGACCGTATGGCTATCCAAAGAATTAGAGAAGCTGCTGAAAAGGCTAAGATTGAGCTATCTTCTAC 
Zim17*-artefact-pIL1  ---------------------------------------------------------------------------------------------------- 
pIL2 -rbs             GTTTCAAGACCGAAACTGGTATTGATTTGGAAAATGACCGTATGGCTATCCAAAGAATTAGAGAAGCTGCTGAAAAGGCTAAGATTGAGCTATCTTCTAC 
zim17*-artefact-pIL2  ---------------------------------------------------------------------------------------------------- 
Ssc1*His10            R--F--K--T--E--T--G--I--D--L--E--N--D--R--M--A--I--Q--R--I--R--E--A--A--E--K--A--K--I--E--L--S--S--T 
Zim17*Strep           ---------------------------------------------------------------------------------------------------- 
                              910       920       930       940       950       960       970       980       990       1000  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       ---------------------------------------------------------------------------------------------------- 
pDB10                 CGTTTCCACTGAAATCAACCTGCCATTTATCACTGCTGATGCCTCAGGTCCAAAGCATATCAACATGAAGTTCTCCAGGGCTCAATTCGAGACTTTGACA 
pIL1 +rbs             CGTTTCCACTGAAATCAACCTGCCATTTATCACTGCTGATGCCTCAGGTCCAAAGCATATCAACATGAAGTTCTCCAGGGCTCAATTCGAGACTTTGACA 
Zim17*-artefact-pIL1  ---------------------------------------------------------------------------------------------------- 
pIL2 -rbs             CGTTTCCACTGAAATCAACCTGCCATTTATCACTGCTGATGCCTCAGGTCCAAAGCATATCAACATGAAGTTCTCCAGGGCTCAATTCGAGACTTTGACA 
zim17*-artefact-pIL2  ---------------------------------------------------------------------------------------------------- 
Ssc1*His10            --V--S--T--E--I--N--L--P--F--I--T--A--D--A--S--G--P--K--H--I--N--M--K--F--S--R--A--Q--F--E--T--L--T- 
Zim17*Strep           ---------------------------------------------------------------------------------------------------- 
                              1010      1020      1030      1040      1050      1060      1070      1080      1090      1100  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       ---------------------------------------------------------------------------------------------------- 
pDB10                 GCCCCACTAGTTAAGAGAACTGTCGACCCAGTCAAGAAGGCTTTGAAAGACGCCGGTTTGTCTACTTCAGACATATCTGAAGTCTTATTGGTCGGTGGTA 
pIL1 +rbs             GCCCCACTAGTTAAGAGAACTGTCGACCCAGTCAAGAAGGCTTTGAAAGACGCCGGTTTGTCTACTTCAGACATATCTGAAGTCTTATTGGTCGGTGGTA 
Zim17*-artefact-pIL1  ---------------------------------------------------------------------------------------------------- 
pIL2 -rbs             GCCCCACTAGTTAAGAGAACTGTCGACCCAGTCAAGAAGGCTTTGAAAGACGCCGGTTTGTCTACTTCAGACATATCTGAAGTCTTATTGGTCGGTGGTA 
zim17*-artefact-pIL2  ---------------------------------------------------------------------------------------------------- 
Ssc1*His10            -A--P--L--V--K--R--T--V--D--P--V--K--K--A--L--K--D--A--G--L--S--T--S--D--I--S--E--V--L--L--V--G--G-- 
Zim17*Strep           ---------------------------------------------------------------------------------------------------- 
                              1110      1120      1130      1140      1150      1160      1170      1180      1190      1200  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       ---------------------------------------------------------------------------------------------------- 
pDB10                 TGTCCAGAATGCCTAAGGTTGTCGAAACCGTTAAATCTTTGTTTGGTAAGGACCCATCTAAGGCCGTCAACCCAGATGAAGCTGTTGCCATTGGTGCTGC 
pIL1 +rbs             TGTCCAGAATGCCTAAGGTTGTCGAAACCGTTAAATCTTTGTTTGGTAAGGACCCATCTAAGGCCGTCAACCCAGATGAAGCTGTTGCCATTGGTGCTGC 
Zim17*-artefact-pIL1  ---------------------------------------------------------------------------------------------------- 
pIL2 -rbs             TGTCCAGAATGCCTAAGGTTGTCGAAACCGTTAAATCTTTGTTTGGTAAGGACCCATCTAAGGCCGTCAACCCAGATGAAGCTGTTGCCATTGGTGCTGC 
zim17*-artefact-pIL2  ---------------------------------------------------------------------------------------------------- 
Ssc1*His10            M--S--R--M--P--K--V--V--E--T--V--K--S--L--F--G--K--D--P--S--K--A--V--N--P--D--E--A--V--A--I--G--A--A 
Zim17*Strep           ---------------------------------------------------------------------------------------------------- 
                              1210      1220      1230      1240      1250      1260      1270      1280      1290      1300  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       ---------------------------------------------------------------------------------------------------- 
pDB10                 TGTGCAAGGTGCTGTCTTGTCCGGTGAGGTTACTGACGTCTTATTATTAGATGTTACCCCATTGTCTCTAGGTATCGAAACTTTAGGTGGTGTTTTCACA 
pIL1 +rbs             TGTGCAAGGTGCTGTCTTGTCCGGTGAGGTTACTGACGTCTTATTATTAGATGTTACCCCATTGTCTCTAGGTATCGAAACTTTAGGTGGTGTTTTCACA 
Zim17*-artefact-pIL1  ---------------------------------------------------------------------------------------------------- 
pIL2 -rbs             TGTGCAAGGTGCTGTCTTGTCCGGTGAGGTTACTGACGTCTTATTATTAGATGTTACCCCATTGTCTCTAGGTATCGAAACTTTAGGTGGTGTTTTCACA 
zim17*-artefact-pIL2  ---------------------------------------------------------------------------------------------------- 
Ssc1*His10            --V--Q--G--A--V--L--S--G--E--V--T--D--V--L--L--L--D--V--T--P--L--S--L--G--I--E--T--L--G--G--V--F--T- 
Zim17*Strep           ---------------------------------------------------------------------------------------------------- 
                              1310      1320      1330      1340      1350      1360      1370      1380      1390      1400  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       ---------------------------------------------------------------------------------------------------- 
pDB10                 AGATTGATTCCAAGAAACACTACTATTCCAACAAAGAAATCTCAAATCTTCTCCACTGCCGCTGCTGGTCAAACTTCTGTTGAAATCAGAGTTTTCCAAG 
pIL1 +rbs             AGATTGATTCCAAGAAACACTACTATTCCAACAAAGAAATCTCAAATCTTCTCCACTGCCGCTGCTGGTCAAACTTCTGTTGAAATCAGAGTTTTCCAAG 
Zim17*-artefact-pIL1  ---------------------------------------------------------------------------------------------------- 
pIL2 -rbs             AGATTGATTCCAAGAAACACTACTATTCCAACAAAGAAATCTCAAATCTTCTCCACTGCCGCTGCTGGTCAAACTTCTGTTGAAATCAGAGTTTTCCAAG 
zim17*-artefact-pIL2  ---------------------------------------------------------------------------------------------------- 
Ssc1*His10            -R--L--I--P--R--N--T--T--I--P--T--K--K--S--Q--I--F--S--T--A--A--A--G--Q--T--S--V--E--I--R--V--F--Q-- 
Zim17*Strep           ---------------------------------------------------------------------------------------------------- 
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                              1410      1420      1430      1440      1450      1460      1470      1480      1490      1500  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       ---------------------------------------------------------------------------------------------------- 
pDB10                 GTGAAAGAGAATTGGTTAGAGACAACAAATTGATTGGTAACTTCACTTTAGCCGGTATCCCACCTGCTCCAAAGGGTGTCCCACAAATCGAAGTCACTTT 
pIL1 +rbs             GTGAAAGAGAATTGGTTAGAGACAACAAATTGATTGGTAACTTCACTTTAGCCGGTATCCCACCTGCTCCAAAGGGTGTCCCACAAATCGAAGTCACTTT 
Zim17*-artefact-pIL1  ---------------------------------------------------------------------------------------------------- 
pIL2 -rbs             GTGAAAGAGAATTGGTTAGAGACAACAAATTGATTGGTAACTTCACTTTAGCCGGTATCCCACCTGCTCCAAAGGGTGTCCCACAAATCGAAGTCACTTT 
zim17*-artefact-pIL2  ---------------------------------------------------------------------------------------------------- 
Ssc1*His10            G--E--R--E--L--V--R--D--N--K--L--I--G--N--F--T--L--A--G--I--P--P--A--P--K--G--V--P--Q--I--E--V--T--F 
Zim17*Strep           ---------------------------------------------------------------------------------------------------- 
                              1510      1520      1530      1540      1550      1560      1570      1580      1590      1600  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       ---------------------------------------------------------------------------------------------------- 
pDB10                 TGACATCGATGCCGATGGTATTATTAACGTTTCTGCTAGAGACAAAGCTACAAACAAAGATTCTTCTATTACTGTTGCCGGTTCTTCTGGTTTGTCCGAA 
pIL1 +rbs             TGACATCGATGCCGATGGTATTATTAACGTTTCTGCTAGAGACAAAGCTACAAACAAAGATTCTTCTATTACTGTTGCCGGTTCTTCTGGTTTGTCCGAA 
Zim17*-artefact-pIL1  ---------------------------------------------------------------------------------------------------- 
pIL2 -rbs             TGACATCGATGCCGATGGTATTATTAACGTTTCTGCTAGAGACAAAGCTACAAACAAAGATTCTTCTATTACTGTTGCCGGTTCTTCTGGTTTGTCCGAA 
zim17*-artefact-pIL2  ---------------------------------------------------------------------------------------------------- 
Ssc1*His10            --D--I--D--A--D--G--I--I--N--V--S--A--R--D--K--A--T--N--K--D--S--S--I--T--V--A--G--S--S--G--L--S--E- 
Zim17*Strep           ---------------------------------------------------------------------------------------------------- 
                                                                                              pDB20-IL1-f        
                    
                              1610      1620      1630      1640      1650      1660      1670      1680      1690      1700  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       ---------------------------------------------------------------------------------------------------- 
pDB10                 AACGAAATTGAACAAATGGTTAACGACGCTGAAAAATTCAAGTCTCAAGATGAAGCTAGAAAACAAGCCATCGAAACTGCCAACAAGGCTGACCAATTGG 
pIL1 +rbs             AACGAAATTGAACAAATGGTTAACGACGCTGAAAAATTCAAGTCTCAAGATGAAGCTAGAAAACAAGCCATCGAAACTGCCAACAAGGCTGACCAATTGG 
Zim17*-artefact-pIL1  ---------------------------------------------------------------------------------------------------- 
pIL2 -rbs             AACGAAATTGAACAAATGGTTAACGACGCTGAAAAATTCAAGTCTCAAGATGAAGCTAGAAAACAAGCCATCGAAACTGCCAACAAGGCTGACCAATTGG 
zim17*-artefact-pIL2  ---------------------------------------------------------------------------------------------------- 
Ssc1*His10            -N--E--I--E--Q--M--V--N--D--A--E--K--F--K--S--Q--D--E--A--R--K--Q--A--I--E--T--A--N--K--A--D--Q--L-- 
Zim17*Strep           ---------------------------------------------------------------------------------------------------- 
                                                                                                                    MfeI   
                              1710      1720      1730      1740      1750      1760      1770      1780      1790      1800  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       ---------------------------------------------------------------------------------------------------- 
pDB10                 CCAACGATACTGAAAACTCCTTGAAAGAATTTGAAGGTAAGGTTGACAAGGCTGAAGCCCAAAAGGTTAGGGATCAAATCACTTCCTTGAAGGAGTTGGT 
pIL1 +rbs             CCAACGATACTGAAAACTCCTTGAAAGAATTTGAAGGTAAGGTTGACAAGGCTGAAGCCCAAAAGGTTAGGGATCAAATCACTTCCTTGAAGGAGTTGGT 
Zim17*-artefact-pIL1  ---------------------------------------------------------------------------------------------------- 
pIL2 -rbs             CCAACGATACTGAAAACTCCTTGAAAGAATTTGAAGGTAAGGTTGACAAGGCTGAAGCCCAAAAGGTTAGGGATCAAATCACTTCCTTGAAGGAGTTGGT 
zim17*-artefact-pIL2  ---------------------------------------------------------------------------------------------------- 
Ssc1*His10            A--N--D--T--E--N--S--L--K--E--F--E--G--K--V--D--K--A--E--A--Q--K--V--R--D--Q--I--T--S--L--K--E--L--V 
Zim17*Strep           ---------------------------------------------------------------------------------------------------- 
                              1810      1820      1830      1840      1850      1860      1870      1880      1890      1900  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       ---------------------------------------------------------------------------------------------------- 
pDB10                 TGCTAGAGTACAAGGTGGCGAAGAGGTTAACGCTGAGGAGTTAAAGACCAAGACCGAAGAATTGCAAACTTCCTCGATGAAATTGTTTGAACAATTATAC 
pIL1 +rbs             TGCTAGAGTACAAGGTGGCGAAGAGGTTAACGCTGAGGAGTTAAAGACCAAGACCGAAGAATTGCAAACTTCCTCGATGAAATTGTTTGAACAATTATAC 
Zim17*-artefact-pIL1  ---------------------------------------------------------------------------------------------------- 
pIL2 -rbs             TGCTAGAGTACAAGGTGGCGAAGAGGTTAACGCTGAGGAGTTAAAGACCAAGACCGAAGAATTGCAAACTTCCTCGATGAAATTGTTTGAACAATTATAC 
zim17*-artefact-pIL2  ---------------------------------------------------------------------------------------------------- 
Ssc1*His10            --A--R--V--Q--G--G--E--E--V--N--A--E--E--L--K--T--K--T--E--E--L--Q--T--S--S--M--K--L--F--E--Q--L--Y- 
Zim17*Strep           ---------------------------------------------------------------------------------------------------- 
                              1910      1920      1930      1940      1950      1960      1970      1980      1990      2000  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       ---------------------------------------------------------------------------------------------------- 
pDB10                 AAGAACGACTCTAACAACAACAACAACAACAACGGCAACAATGCCGAATCTGGTGAAACTAAGCAGCCAGGAGCTCACCACCACCACCAcCATCATCATC 
pIL1 +rbs             AAGAACGACTCTAACAACAACAACAACAACAACGGCAACAATGCCGAATCTGGTGAAACTAAGCAGCCAGGAGCTCACCACCACCACCAcCATCATCATC 
Zim17*-artefact-pIL1  -----------------------------------------M--P--N--L--V--K--L--S--S--Q--E--L--T--T--T--T--T--I--I--I- 
pIL2 -rbs             AAGAACGACTCTAACAACAACAACAACAACAACGGCAACAATGCCGAATCTGGTGAAACTAAGCAGCCAGGAGCTCACCACCACCACCAcCATCATCATC 
zim17*-artefact-pIL2  -----------------------------------------M--P--N--L--V--K--L--S--S--Q--E--L--T--T--T--T--T--I--I--I- 
Ssc1*His10            -K--N--D--S--N--N--N--N--N--N--N--G--N--N--A--E--S--G--E--T--K--Q--P--G--A--H--H--H--H--H--H--H--H-- 
Zim17*Strep           ---------------------------------------------------------------------------------------------------- 
                              2010      2020      2030      2040      2050      2060      2070      2080      2090      2100  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       ------aagcttgcggccgcataatgcttaagtcgaacagaaagtaatcgtattgtacacggccgcataatcgaaattaatacgactcactataggggaa 
pDB10                 ATcActaAGCTTGCGGCCGCATAATGCTTAAGTCGAACAGAAAGTAATCGTATTGTACACGGCCGCATAATCGAAATTAATACGACTCACTATAGGGGAA 
pIL1 +rbs             ATcActaAGCTTGCGGCCGCATAATGCTTAAGTCGAACAGAAAGTAATCGTATTGTACACGGCCGCATAATC---------------------------- 
Zim17*-artefact-pIL1  -I--T--K--L--A--A--A--* ----------------------------------------------------------------------------    
pIL2 -rbs             ATcActaAGCTTGCG------------------------------------------------------------------------------------- 
zim17*-artefact-pIL2  -I--T--K--L--A-------------------------------------------------------------------------------------- 
Ssc1*His10            H--H--* --------------------------------------------------------------------------------------------    
Zim17*Strep           ---------------------------------------------------------------------------------------------------- 
                            HindIII                                       pDB20-IL1+rbs-r/ pDB20-IL1-r
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                              2110      2120      2130      2140      2150      2160      2170      2180      2190      2200  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       ttgtgagcggataacaattccccatcttagtatattagttaagtataagaaggagatatacatatg---------------------------------- 
pDB10                 TTGTGAGCGGATAACAATTCCCCATCTTAGTATATTAGTTAAGTATAAGAAGGAGATATACATATGAATATCATCGCACATAATGAAGTGAAAAAGGACG 
pIL1 +rbs             --------------------------------------------------caggaggtatCATATGAATATCATCGCACATAATGAAGTGAAAAAGGACG 
Zim17*-artefact-pIL1  ----------------------------------------------------------------------------------------------------    
pIL2 -rbs             ------------------------------------------------------------catatgAATATCATCGCACATAATGAAGTGAAAAAGGACG 
zim17*-artefact-pIL2  -------------------------------------------------------------H--M--N--I--I--A--H--N--E--V--K--K--D-- 
Ssc1*His10            ----------------------------------------------------------------------------------------------------    
Zim17*Strep           ----------------------------------------------------------------M--N--I--I--A--H--N--E--V--K--K--D--
                                                                      rbs MCS2     NdeI        
                                                                         Shine dalgarno 
                              2210      2220      2230      2240      2250      2260      2270      2280      2290      2300  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       ---------------------------------------------------------------------------------------------------- 
pDB10                 ATAAGAAGGTTCATTTGGGGTCTTTTAAGGTAGACAAGCCTAAGATGATGATAGCTTTCACCTGCAAGAAATGTAACACCCGATCTTCACACACAATGTC 
pIL1 +rbs             ATAAGAAGGTTCATTTGGGGTCTTTTAAGGTAGACAAGCCTAAGATGATGATAGCTTTCACCTGCAAGAAATGTAACACCCGATCTTCACACACAATGTC 
Zim17*-artefact-pIL1  ----------------------------------------------------------------------------------------------------    
pIL2 -rbs             ATAAGAAGGTTCATTTGGGGTCTTTTAAGGTAGACAAGCCTAAGATGATGATAGCTTTCACCTGCAAGAAATGTAACACCCGATCTTCACACACAATGTC 
zim17*-artefact-pIL2  D--K--K--V--H--L--G--S--F--K--V--D--K--P--K--M--M--I--A--F--T--C--K--K--C--N--T--R--S--S--H--T--M--S 
Ssc1*His10            ----------------------------------------------------------------------------------------------------    
Zim17*Strep           D--K--K--V--H--L--G--S--F--K--V--D--K--P--K--M--M--I--A--F--T--C--K--K--C--N--T--R--S--S--H--T--M--S 
                              2310      2320      2330      2340      2350      2360      2370      2380      2390      2400  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       ---------------------------------------------------------------------------------------------------- 
pDB10                 CAAGCAGGCGTACGAGAAAGGTACTGTCTTGATCTCTTGTCCGCACTGCAAAGTGAGACATTTGATAGCAGACCATCTGAAAATATTCCATGATCATCAT 
pIL1 +rbs             CAAGCAGGCGTACGAGAAAGGTACTGTCTTGATCTCTTGTCCGCACTGCAAAGTGAGACATTTGATAGCAGACCATCTGAAAATATTCCATGATCATCAT 
Zim17*-artefact-pIL1  ----------------------------------------------------------------------------------------------------    
pIL2 -rbs             CAAGCAGGCGTACGAGAAAGGTACTGTCTTGATCTCTTGTCCGCACTGCAAAGTGAGACATTTGATAGCAGACCATCTGAAAATATTCCATGATCATCAT 
zim17*-artefact-pIL2  --K--Q--A--Y--E--K--G--T--V--L--I--S--C--P--H--C--K--V--R--H--L--I--A--D--H--L--K--I--F--H--D--H--H- 
Ssc1*His10            ----------------------------------------------------------------------------------------------------    
Zim17*Strep           --K--Q--A--Y--E--K--G--T--V--L--I--S--C--P--H--C--K--V--R--H--L--I--A--D--H--L--K--I--F--H--D--H--H-
 
                              2410      2420      2430      2440      2450      2460      2470      2480      2490      2500  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       ---------------------------------------------------------------------------------------------------- 
pDB10                 GTTACCGTGGAACAGTTAATGAAAGCTAACGGAGAACAAGTTAGCCAAGACGTGGGCGACTTGGAGTTTGAAGACATCCCAGATTCGCTAAAGGACGTCC 
pIL1 +rbs             GTTACCGTGGAACAGTTAATGAAAGCTAACGGAGAACAAGTTAGCCAAGACGTGGGCGACTTGGAGTTTGAAGACATCCCAGATTCGCTAAAGGACGTCC 
Zim17*-artefact-pIL1  ----------------------------------------------------------------------------------------------------    
pIL2 -rbs             GTTACCGTGGAACAGTTAATGAAAGCTAACGGAGAACAAGTTAGCCAAGACGTGGGCGACTTGGAGTTTGAAGACATCCCAGATTCGCTAAAGGACGTCC 
zim17*-artefact-pIL2  -V--T--V--E--Q--L--M--K--A--N--G--E--Q--V--S--Q--D--V--G--D--L--E--F--E--D--I--P--D--S--L--K--D--V-- 
Ssc1*His10            ----------------------------------------------------------------------------------------------------    
Zim17*Strep           -V--T--V--E--Q--L--M--K--A--N--G--E--Q--V--S--Q--D--V--G--D--L--E--F--E--D--I--P--D--S--L--K--D--V-- 
                              2510      2520      2530      2540      2550      2560      2570      2580      2590      2600  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       --------------------------------------------------------------------------------------------------ct 
pDB10                 TGGGAAAATATGCCAAGAACAACTCAGAAAATGCATCCCAGCTCCCTCACCCTTCCCAGAAAGGTAGCGCTTGGAGCCACCCGCAGTTCGAAAAATAACT 
pIL1 +rbs             TGGGAAAATATGCCAAGAACAACTCAGAAAATGCATCCCAGCTCCCTCACCCTTCCCAGAAAGGTAGCGCTTGGAGCCACCCGCAGTTCGAAAAATAACT 
Zim17*-artefact-pIL1  ----------------------------------------------------------------------------------------------------    
pIL2 -rbs             TGGGAAAATATGCCAAGAACAACTCAGAAAATGCATCCCAGCTCCCTCACCCTTCCCAGAAAGGTAGCGCTTGGAGCCACCCGCAGTTCGAAAAATAACT 
zim17*-artefact-pIL2  L--G--K--Y--A--K--N--N--S--E--N--A--S--Q--L--P--H--P--S--Q--K--G--S--A--W--S--H--P--Q--F--E--K--* --   
Ssc1*His10            ----------------------------------------------------------------------------------------------------    
Zim17*Strep           L--G--K--Y--A--K--N--N--S--E--N--A--S--Q--L--P--H--P--S--Q--K--G--S--A--W--S--H--P--Q--F--E--K--*--- 
                              2610      2620      2630      2640      2650      2660      2670      2680      2690      2700  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       cgagtctggtaaagaaaccgctgctgcgaaatttgaacgccagcacatggactcgtctactagcgcagcttaattaacctaggctgctgccaccgctgag 
pDB10                 CGAGTCTGGTAAAGAAACCGCTGCTGCGAAATTTGAACGCCAGCACATGGACTCGTCTACTAGCGCAGCTTAATTAACCTAGGCTGCTGCCACCGCTGAG 
pIL1 +rbs             CGAGTCTGGTAAAGAAACCGCTGCTGCGAAATTTGAACGCCAGCACATGGACTCGTCTACTAGCGCAGCTTAATTAACCTAGGCTGCTGCCACCGCTGAG    
pIL2 -rbs             CGAGTCTGGTAAAGAAACCGCTGCTGCGAAATTTGAACGCCAGCACATGGACTCGTCTACTAGCGCAGCTTAATTAACCTAGGCTGCTGCCACCGCTGAG 
                      XhoI                                                                                                    
                                                                                                            
                              2710      2720      2730      2740      2750      2760      2770      2780      2790      2800  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       caataactagcataaccccttggggcctctaaacgggtcttgaggggttttttgctgaaaggaggaactatatccggattggcgaatgggacgcgccctg 
pDB10                 CAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTGCTGAAAGGAGGAACTATATCCGGATTGGCGAATGGGACGCGCCCTG 
pIL1 +rbs             CAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTGCTGAAAGGAGGAACTATATCCGGATTGGCGAATGGGACGCGCCCTG    
pIL2 -rbs             CAATAACTAGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTGCTGAAAGGAGGAACTATATCCGGATTGGCGAATGGGACGCGCCCTG 
                                                                                                                
                              2810      2820      2830      2840      2850      2860      2870      2880      2890      2900  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       tagcggcgcattaagcgcggcgggtgtggtggttacgcgcagcgtgaccgctacacttgccagcgccctagcgcccgctcctttcgctttcttcccttcc 
pDB10                 TAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCAGCGTGACCGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTCTTCCCTTCC 
pIL1 +rbs             TAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCAGCGTGACCGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTCTTCCCTTCC    
pIL2 -rbs             TAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCAGCGTGACCGCTACACTTGCCAGCGCCCTAGCGCCCGCTCCTTTCGCTTTCTTCCCTTCC 
                                                                                                    
                              2910      2920      2930      2940      2950      2960      2970      2980      2990      3000  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       tttctcgccacgttcgccggctttccccgtcaagctctaaatcgggggctccctttagggttccgatttagtgctttacggcacctcgaccccaaaaaac 
pDB10                 TTTCTCGCCACGTTCGCCGGCTTTCCCCGTCAAGCTCTAAATCGGGGGCTCCCTTTAGGGTTCCGATTTAGTGCTTTACGGCACCTCGACCCCAAAAAAC 
pIL1 +rbs             TTTCTCGCCACGTTCGCCGGCTTTCCCCGTCAAGCTCTAAATCGGGGGCTCCCTTTAGGGTTCCGATTTAGTGCTTTACGGCACCTCGACCCCAAAAAAC    
pIL2 -rbs             TTTCTCGCCACGTTCGCCGGCTTTCCCCGTCAAGCTCTAAATCGGGGGCTCCCTTTAGGGTTCCGATTTAGTGCTTTACGGCACCTCGACCCCAAAAAAC 
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                              3010      3020      3030      3040      3050      3060      3070      3080      3090      3100  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       ttgattagggtgatggttcacgtagtgggccatcgccctgatagacggtttttcgccctttgacgttggagtccacgttctttaatagtggactcttgtt 
pDB10                 TTGATTAGGGTGATGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTTTTCGCCCTTTGACGTTGGAGTCCACGTTCTTTAATAGTGGACTCTTGTT 
pIL1 +rbs             TTGATTAGGGTGATGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTTTTCGCCCTTTGACGTTGGAGTCCACGTTCTTTAATAGTGGACTCTTGTT    
pIL2 -rbs             TTGATTAGGGTGATGGTTCACGTAGTGGGCCATCGCCCTGATAGACGGTTTTTCGCCCTTTGACGTTGGAGTCCACGTTCTTTAATAGTGGACTCTTGTT 
                                                         
                              3110      3120      3130      3140      3150      3160      3170      3180      3190      3200  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       ccaaactggaacaacactcaaccctatctcggtctattcttttgatttataagggattttgccgatttcggcctattggttaaaaaatgagctgatttaa 
pDB10                 CCAAACTGGAACAACACTCAACCCTATCTCGGTCTATTCTTTTGATTTATAAGGGATTTTGCCGATTTCGGCCTATTGGTTAAAAAATGAGCTGATTTAA 
pIL1 +rbs             CCAAACTGGAACAACACTCAACCCTATCTCGGTCTATTCTTTTGATTTATAAGGGATTTTGCCGATTTCGGCCTATTGGTTAAAAAATGAGCTGATTTAA    
pIL2 -rbs             CCAAACTGGAACAACACTCAACCCTATCTCGGTCTATTCTTTTGATTTATAAGGGATTTTGCCGATTTCGGCCTATTGGTTAAAAAATGAGCTGATTTAA 
                                                                                                             
                              3210      3220      3230      3240      3250      3260      3270      3280      3290      3300  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       caaaaatttaacgcgaattttaacaaaatattaacgtttacaatttctggcggcacgatggcatgagattatcaaaaaggatcttcacctagatcctttt 
pDB10                 CAAAAATTTAACGCGAATTTTAACAAAATATTAACGTTTACAATTTCTGGCGGCACGATGGCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT 
pIL1 +rbs             CAAAAATTTAACGCGAATTTTAACAAAATATTAACGTTTACAATTTCTGGCGGCACGATGGCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT    
pIL2 -rbs             CAAAAATTTAACGCGAATTTTAACAAAATATTAACGTTTACAATTTCTGGCGGCACGATGGCATGAGATTATCAAAAAGGATCTTCACCTAGATCCTTTT 
                                                                                                               
                              3310      3320      3330      3340      3350      3360      3370      3380      3390      3400  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       aaattaaaaatgaagttttaaatcaatctaaagtatatatgagtaaacttggtctgacagttaccaatgcttaatcagtgaggcacctatctcagcgatc 
pDB10                 AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATC 
pIL1 +rbs             AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATC    
pIL2 -rbs             AAATTAAAAATGAAGTTTTAAATCAATCTAAAGTATATATGAGTAAACTTGGTCTGACAGTTACCAATGCTTAATCAGTGAGGCACCTATCTCAGCGATC    
                                                                                                               
                              3410      3420      3430      3440      3450      3460      3470      3480      3490      3500  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       tgtctatttcgttcatccatagttgcctgactccccgtcgtgtagataactacgatacgggagggcttaccatctggccccagtgctgcaatgataccgc 
pDB10                 TGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGC 
pIL1 +rbs             TGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGC    
pIL2 -rbs             TGTCTATTTCGTTCATCCATAGTTGCCTGACTCCCCGTCGTGTAGATAACTACGATACGGGAGGGCTTACCATCTGGCCCCAGTGCTGCAATGATACCGC 
                                                                                                              
                              3510      3520      3530      3540      3550      3560      3570      3580      3590      3600  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       gagacccacgctcaccggctccagatttatcagcaataaaccagccagccggaagggccgagcgcagaagtggtcctgcaactttatccgcctccatcca 
pDB10                 GAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCA 
pIL1 +rbs             GAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCA    
pIL2 -rbs             GAGACCCACGCTCACCGGCTCCAGATTTATCAGCAATAAACCAGCCAGCCGGAAGGGCCGAGCGCAGAAGTGGTCCTGCAACTTTATCCGCCTCCATCCA 
                                                                                                             
                              3610      3620      3630      3640      3650      3660      3670      3680      3690      3700  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       gtctattaattgttgccgggaagctagagtaagtagttcgccagttaatagtttgcgcaacgttgttgccattgctacaggcatcgtggtgtcacgctcg 
pDB10                 GTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCG 
pIL1 +rbs             GTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCG    
pIL2 -rbs             GTCTATTAATTGTTGCCGGGAAGCTAGAGTAAGTAGTTCGCCAGTTAATAGTTTGCGCAACGTTGTTGCCATTGCTACAGGCATCGTGGTGTCACGCTCG    
                              3710      3720      3730      3740      3750      3760      3770      3780      3790      3800  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       tcgtttggtatggcttcattcagctccggttcccaacgatcaaggcgagttacatgatcccccatgttgtgcaaaaaagcggttagctccttcggtcctc 
pDB10                 TCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTC 
pIL1 +rbs             TCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTC    
pIL2 -rbs             TCGTTTGGTATGGCTTCATTCAGCTCCGGTTCCCAACGATCAAGGCGAGTTACATGATCCCCCATGTTGTGCAAAAAAGCGGTTAGCTCCTTCGGTCCTC    
                              3810      3820      3830      3840      3850      3860      3870      3880      3890      3900  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       cgatcgttgtcagaagtaagttggccgcagtgttatcactcatggttatggcagcactgcataattctcttactgtcatgccatccgtaagatgcttttc 
pDB10                 CGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTC 
pIL1 +rbs             CGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTC    
pIL2 -rbs             CGATCGTTGTCAGAAGTAAGTTGGCCGCAGTGTTATCACTCATGGTTATGGCAGCACTGCATAATTCTCTTACTGTCATGCCATCCGTAAGATGCTTTTC 
                                                                                                               
                              3910      3920      3930      3940      3950      3960      3970      3980      3990      4000  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       tgtgactggtgagtactcaaccaagtcattctgagaatagtgtatgcggcgaccgagttgctcttgcccggcgtcaatacgggataataccgcgccacat 
pDB10                 TGTGACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACAT 
pIL1 +rbs             TGTGACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACAT    
pIL2 -rbs             TGTGACTGGTGAGTACTCAACCAAGTCATTCTGAGAATAGTGTATGCGGCGACCGAGTTGCTCTTGCCCGGCGTCAATACGGGATAATACCGCGCCACAT 
                                                                                                           
                              4010      4020      4030      4040      4050      4060      4070      4080      4090      4100  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       agcagaactttaaaagtgctcatcattggaaaacgttcttcggggcgaaaactctcaaggatcttaccgctgttgagatccagttcgatgtaacccactc 
pDB10                 AGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTC 
pIL1 +rbs             AGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTC    
pIL2 -rbs             AGCAGAACTTTAAAAGTGCTCATCATTGGAAAACGTTCTTCGGGGCGAAAACTCTCAAGGATCTTACCGCTGTTGAGATCCAGTTCGATGTAACCCACTC 
                                                                                                             
                              4110      4120      4130      4140      4150      4160      4170      4180      4190      4200  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       gtgcacccaactgatcttcagcatcttttactttcaccagcgtttctgggtgagcaaaaacaggaaggcaaaatgccgcaaaaaagggaataagggcgac 
pDB10                 GTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGAC 
pIL1 +rbs             GTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGAC    
pIL2 -rbs             GTGCACCCAACTGATCTTCAGCATCTTTTACTTTCACCAGCGTTTCTGGGTGAGCAAAAACAGGAAGGCAAAATGCCGCAAAAAAGGGAATAAGGGCGAC 
                                                                                                              
138 A. Appendix
                              4210      4220      4230      4240      4250      4260      4270      4280      4290      4300  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       acggaaatgttgaatactcatactcttcctttttcaatcatgattgaagcatttatcagggttattgtctcatgagcggatacatatttgaatgtattta 
pDB10                 ACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATCATGATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTA 
pIL1 +rbs             ACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATCATGATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTA    
pIL2 -rbs             ACGGAAATGTTGAATACTCATACTCTTCCTTTTTCAATCATGATTGAAGCATTTATCAGGGTTATTGTCTCATGAGCGGATACATATTTGAATGTATTTA 
                                                                                                            
                              4310      4320      4330      4340      4350      4360      4370      4380      4390      4400  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       gaaaaataaacaaataggtcatgaccaaaatcccttaacgtgagttttcgttccactgagcgtcagaccccgtagaaaagatcaaaggatcttcttgaga 
pDB10                 GAAAAATAAACAAATAGGTCATGACCAAAATCCCTTAACGTGAGTTTTCGTTCCACTGAGCGTCAGACCCCGTAGAAAAGATCAAAGGATCTTCTTGAGA 
pIL1 +rbs             GAAAAATAAACAAATAGGTCATGACCAAAATCCCTTAACGTGAGTTTTCGTTCCACTGAGCGTCAGACCCCGTAGAAAAGATCAAAGGATCTTCTTGAGA    
pIL2 -rbs             GAAAAATAAACAAATAGGTCATGACCAAAATCCCTTAACGTGAGTTTTCGTTCCACTGAGCGTCAGACCCCGTAGAAAAGATCAAAGGATCTTCTTGAGA 
                                                                                                              
                              4410      4420      4430      4440      4450      4460      4470      4480      4490      4500  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       tcctttttttctgcgcgtaatctgctgcttgcaaacaaaaaaaccaccgctaccagcggtggtttgtttgccggatcaagagctaccaactctttttccg 
pDB10                 TCCTTTTTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCGCTACCAGCGGTGGTTTGTTTGCCGGATCAAGAGCTACCAACTCTTTTTCCG 
pIL1 +rbs             TCCTTTTTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCGCTACCAGCGGTGGTTTGTTTGCCGGATCAAGAGCTACCAACTCTTTTTCCG    
pIL2 -rbs             TCCTTTTTTTCTGCGCGTAATCTGCTGCTTGCAAACAAAAAAACCACCGCTACCAGCGGTGGTTTGTTTGCCGGATCAAGAGCTACCAACTCTTTTTCCG 
                                                                                                          
                              4510      4520      4530      4540      4550      4560      4570      4580      4590      4600  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       aaggtaactggcttcagcagagcgcagataccaaatactgtccttctagtgtagccgtagttaggccaccacttcaagaactctgtagcaccgcctacat 
pDB10                 AAGGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACTGTCCTTCTAGTGTAGCCGTAGTTAGGCCACCACTTCAAGAACTCTGTAGCACCGCCTACAT 
pIL1 +rbs             AAGGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACTGTCCTTCTAGTGTAGCCGTAGTTAGGCCACCACTTCAAGAACTCTGTAGCACCGCCTACAT    
pIL2 -rbs             AAGGTAACTGGCTTCAGCAGAGCGCAGATACCAAATACTGTCCTTCTAGTGTAGCCGTAGTTAGGCCACCACTTCAAGAACTCTGTAGCACCGCCTACAT 
                                                                                                         
                              4610      4620      4630      4640      4650      4660      4670      4680      4690      4700  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       acctcgctctgctaatcctgttaccagtggctgctgccagtggcgataagtcgtgtcttaccgggttggactcaagacgatagttaccggataaggcgca 
pDB10                 ACCTCGCTCTGCTAATCCTGTTACCAGTGGCTGCTGCCAGTGGCGATAAGTCGTGTCTTACCGGGTTGGACTCAAGACGATAGTTACCGGATAAGGCGCA 
pIL1 +rbs             ACCTCGCTCTGCTAATCCTGTTACCAGTGGCTGCTGCCAGTGGCGATAAGTCGTGTCTTACCGGGTTGGACTCAAGACGATAGTTACCGGATAAGGCGCA    
pIL2 -rbs             ACCTCGCTCTGCTAATCCTGTTACCAGTGGCTGCTGCCAGTGGCGATAAGTCGTGTCTTACCGGGTTGGACTCAAGACGATAGTTACCGGATAAGGCGCA 
                                                                                                           
                              4710      4720      4730      4740      4750      4760      4770      4780      4790      4800  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       gcggtcgggctgaacggggggttcgtgcacacagcccagcttggagcgaacgacctacaccgaactgagatacctacagcgtgagctatgagaaagcgcc 
pDB10                 GCGGTCGGGCTGAACGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAACGACCTACACCGAACTGAGATACCTACAGCGTGAGCTATGAGAAAGCGCC 
pIL1 +rbs             GCGGTCGGGCTGAACGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAACGACCTACACCGAACTGAGATACCTACAGCGTGAGCTATGAGAAAGCGCC    
pIL2 -rbs             GCGGTCGGGCTGAACGGGGGGTTCGTGCACACAGCCCAGCTTGGAGCGAACGACCTACACCGAACTGAGATACCTACAGCGTGAGCTATGAGAAAGCGCC 
                                                                                                            
                              4810      4820      4830      4840      4850      4860      4870      4880      4890      4900  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       acgcttcccgaagggagaaaggcggacaggtatccggtaagcggcagggtcggaacaggagagcgcacgagggagcttccagggggaaacgcctggtatc 
pDB10                 ACGCTTCCCGAAGGGAGAAAGGCGGACAGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCACGAGGGAGCTTCCAGGGGGAAACGCCTGGTATC 
pIL1 +rbs             ACGCTTCCCGAAGGGAGAAAGGCGGACAGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCACGAGGGAGCTTCCAGGGGGAAACGCCTGGTATC    
pIL2 -rbs             ACGCTTCCCGAAGGGAGAAAGGCGGACAGGTATCCGGTAAGCGGCAGGGTCGGAACAGGAGAGCGCACGAGGGAGCTTCCAGGGGGAAACGCCTGGTATC 
                                                                                                          
                              4910      4920      4930      4940      4950      4960      4970      4980      4990      5000  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       tttatagtcctgtcgggtttcgccacctctgacttgagcgtcgatttttgtgatgctcgtcaggggggcggagcctatggaaaaacgccagcaacgcggc 
pDB10                 TTTATAGTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATTTTTGTGATGCTCGTCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGC 
pIL1 +rbs             TTTATAGTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATTTTTGTGATGCTCGTCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGC    
pIL2 -rbs             TTTATAGTCCTGTCGGGTTTCGCCACCTCTGACTTGAGCGTCGATTTTTGTGATGCTCGTCAGGGGGGCGGAGCCTATGGAAAAACGCCAGCAACGCGGC 
                              5010      5020      5030      5040      5050      5060      5070      5080      5090      5100  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       ctttttacggttcctggccttttgctggccttttgctcacatgttctttcctgcgttatcccctgattctgtggataaccgtattaccgcctttgagtga 
pDB10                 CTTTTTACGGTTCCTGGCCTTTTGCTGGCCTTTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGATTCTGTGGATAACCGTATTACCGCCTTTGAGTGA 
pIL1 +rbs             CTTTTTACGGTTCCTGGCCTTTTGCTGGCCTTTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGATTCTGTGGATAACCGTATTACCGCCTTTGAGTGA    
pIL2 -rbs             CTTTTTACGGTTCCTGGCCTTTTGCTGGCCTTTTGCTCACATGTTCTTTCCTGCGTTATCCCCTGATTCTGTGGATAACCGTATTACCGCCTTTGAGTGA 
                                                                                                            
                              5110      5120      5130      5140      5150      5160      5170      5180      5190      5200  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       gctgataccgctcgccgcagccgaacgaccgagcgcagcgagtcagtgagcgaggaagcggaagagcgcctgatgcggtattttctccttacgcatctgt 
pDB10                 GCTGATACCGCTCGCCGCAGCCGAACGACCGAGCGCAGCGAGTCAGTGAGCGAGGAAGCGGAAGAGCGCCTGATGCGGTATTTTCTCCTTACGCATCTGT 
pIL1 +rbs             GCTGATACCGCTCGCCGCAGCCGAACGACCGAGCGCAGCGAGTCAGTGAGCGAGGAAGCGGAAGAGCGCCTGATGCGGTATTTTCTCCTTACGCATCTGT    
pIL2 -rbs             GCTGATACCGCTCGCCGCAGCCGAACGACCGAGCGCAGCGAGTCAGTGAGCGAGGAAGCGGAAGAGCGCCTGATGCGGTATTTTCTCCTTACGCATCTGT 
                                                                                                          
                              5210      5220      5230      5240      5250      5260      5270      5280      5290      5300  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       gcggtatttcacaccgcatatatggtgcactctcagtacaatctgctctgatgccgcatagttaagccagtatacactccgctatcgctacgtgactggg 
pDB10                 GCGGTATTTCACACCGCATATATGGTGCACTCTCAGTACAATCTGCTCTGATGCCGCATAGTTAAGCCAGTATACACTCCGCTATCGCTACGTGACTGGG 
pIL1 +rbs             GCGGTATTTCACACCGCATATATGGTGCACTCTCAGTACAATCTGCTCTGATGCCGCATAGTTAAGCCAGTATACACTCCGCTATCGCTACGTGACTGGG    
pIL2 -rbs             GCGGTATTTCACACCGCATATATGGTGCACTCTCAGTACAATCTGCTCTGATGCCGCATAGTTAAGCCAGTATACACTCCGCTATCGCTACGTGACTGGG 
                                                                           
                              5310      5320      5330      5340      5350      5360      5370      5380      5390      5400  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       tcatggctgcgccccgacacccgccaacacccgctgacgcgccctgacgggcttgtctgctcccggcatccgcttacagacaagctgtgaccgtctccgg 
pDB10                 TCATGGCTGCGCCCCGACACCCGCCAACACCCGCTGACGCGCCCTGACGGGCTTGTCTGCTCCCGGCATCCGCTTACAGACAAGCTGTGACCGTCTCCGG 
pIL1 +rbs             TCATGGCTGCGCCCCGACACCCGCCAACACCCGCTGACGCGCCCTGACGGGCTTGTCTGCTCCCGGCATCCGCTTACAGACAAGCTGTGACCGTCTCCGG    
pIL2 -rbs             TCATGGCTGCGCCCCGACACCCGCCAACACCCGCTGACGCGCCCTGACGGGCTTGTCTGCTCCCGGCATCCGCTTACAGACAAGCTGTGACCGTCTCCGG 
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                              5410      5420      5430      5440      5450      5460      5470      5480      5490      5500  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       gagctgcatgtgtcagaggttttcaccgtcatcaccgaaacgcgcgaggcagctgcggtaaagctcatcagcgtggtcgtgaagcgattcacagatgtct 
pDB10                 GAGCTGCATGTGTCAGAGGTTTTCACCGTCATCACCGAAACGCGCGAGGCAGCTGCGGTAAAGCTCATCAGCGTGGTCGTGAAGCGATTCACAGATGTCT 
pIL1 +rbs             GAGCTGCATGTGTCAGAGGTTTTCACCGTCATCACCGAAACGCGCGAGGCAGCTGCGGTAAAGCTCATCAGCGTGGTCGTGAAGCGATTCACAGATGTCT    
pIL2 -rbs             GAGCTGCATGTGTCAGAGGTTTTCACCGTCATCACCGAAACGCGCGAGGCAGCTGCGGTAAAGCTCATCAGCGTGGTCGTGAAGCGATTCACAGATGTCT 
                                                                                                                              
                              5510      5520      5530      5540      5550      5560      5570      5580      5590      5600  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       gcctgttcatccgcgtccagctcgttgagtttctccagaagcgttaatgtctggcttctgataaagcgggccatgttaagggcggttttttcctgtttgg 
pDB10                 GCCTGTTCATCCGCGTCCAGCTCGTTGAGTTTCTCCAGAAGCGTTAATGTCTGGCTTCTGATAAAGCGGGCCATGTTAAGGGCGGTTTTTTCCTGTTTGG 
pIL1 +rbs             GCCTGTTCATCCGCGTCCAGCTCGTTGAGTTTCTCCAGAAGCGTTAATGTCTGGCTTCTGATAAAGCGGGCCATGTTAAGGGCGGTTTTTTCCTGTTTGG    
pIL2 -rbs             GCCTGTTCATCCGCGTCCAGCTCGTTGAGTTTCTCCAGAAGCGTTAATGTCTGGCTTCTGATAAAGCGGGCCATGTTAAGGGCGGTTTTTTCCTGTTTGG    
                              5610      5620      5630      5640      5650      5660      5670      5680      5690      5700  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       tcactgatgcctccgtgtaagggggatttctgttcatgggggtaatgataccgatgaaacgagagaggatgctcacgatacgggttactgatgatgaaca 
pDB10                 TCACTGATGCCTCCGTGTAAGGGGGATTTCTGTTCATGGGGGTAATGATACCGATGAAACGAGAGAGGATGCTCACGATACGGGTTACTGATGATGAACA 
pIL1 +rbs             TCACTGATGCCTCCGTGTAAGGGGGATTTCTGTTCATGGGGGTAATGATACCGATGAAACGAGAGAGGATGCTCACGATACGGGTTACTGATGATGAACA    
pIL2 -rbs             TCACTGATGCCTCCGTGTAAGGGGGATTTCTGTTCATGGGGGTAATGATACCGATGAAACGAGAGAGGATGCTCACGATACGGGTTACTGATGATGAACA    
                              5710      5720      5730      5740      5750      5760      5770      5780      5790      5800  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       tgcccggttactggaacgttgtgagggtaaacaactggcggtatggatgcggcgggaccagagaaaaatcactcagggtcaatgccagcgcttcgttaat 
pDB10                 TGCCCGGTTACTGGAACGTTGTGAGGGTAAACAACTGGCGGTATGGATGCGGCGGGACCAGAGAAAAATCACTCAGGGTCAATGCCAGCGCTTCGTTAAT 
pIL1 +rbs             TGCCCGGTTACTGGAACGTTGTGAGGGTAAACAACTGGCGGTATGGATGCGGCGGGACCAGAGAAAAATCACTCAGGGTCAATGCCAGCGCTTCGTTAAT    
pIL2 -rbs             TGCCCGGTTACTGGAACGTTGTGAGGGTAAACAACTGGCGGTATGGATGCGGCGGGACCAGAGAAAAATCACTCAGGGTCAATGCCAGCGCTTCGTTAAT 
                                                                                                            
                              5810      5820      5830      5840      5850      5860      5870      5880      5890      5900  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       acagatgtaggtgttccacagggtagccagcagcatcctgcgatgcagatccggaacataatggtgcagggcgctgacttccgcgtttccagactttacg 
pDB10                 ACAGATGTAGGTGTTCCACAGGGTAGCCAGCAGCATCCTGCGATGCAGATCCGGAACATAATGGTGCAGGGCGCTGACTTCCGCGTTTCCAGACTTTACG 
pIL1 +rbs             ACAGATGTAGGTGTTCCACAGGGTAGCCAGCAGCATCCTGCGATGCAGATCCGGAACATAATGGTGCAGGGCGCTGACTTCCGCGTTTCCAGACTTTACG    
pIL2 -rbs             ACAGATGTAGGTGTTCCACAGGGTAGCCAGCAGCATCCTGCGATGCAGATCCGGAACATAATGGTGCAGGGCGCTGACTTCCGCGTTTCCAGACTTTACG 
                                                                                                        
                              5910      5920      5930      5940      5950      5960      5970      5980      5990      6000  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       aaacacggaaaccgaagaccattcatgttgttgctcaggtcgcagacgttttgcagcagcagtcgcttcacgttcgctcgcgtatcggtgattcattctg 
pDB10                 AAACACGGAAACCGAAGACCATTCATGTTGTTGCTCAGGTCGCAGACGTTTTGCAGCAGCAGTCGCTTCACGTTCGCTCGCGTATCGGTGATTCATTCTG 
pIL1 +rbs             AAACACGGAAACCGAAGACCATTCATGTTGTTGCTCAGGTCGCAGACGTTTTGCAGCAGCAGTCGCTTCACGTTCGCTCGCGTATCGGTGATTCATTCTG    
pIL2 -rbs             AAACACGGAAACCGAAGACCATTCATGTTGTTGCTCAGGTCGCAGACGTTTTGCAGCAGCAGTCGCTTCACGTTCGCTCGCGTATCGGTGATTCATTCTG 
                                                                                                       
                              6010      6020      6030      6040      6050      6060      6070      6080      6090      6100  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       ctaaccagtaaggcaaccccgccagcctagccgggtcctcaacgacaggagcacgatcatgctagtcatgccccgcgcccaccggaaggagctgactggg 
pDB10                 CTAACCAGTAAGGCAACCCCGCCAGCCTAGCCGGGTCCTCAACGACAGGAGCACGATCATGCTAGTCATGCCCCGCGCCCACCGGAAGGAGCTGACTGGG 
pIL1 +rbs             CTAACCAGTAAGGCAACCCCGCCAGCCTAGCCGGGTCCTCAACGACAGGAGCACGATCATGCTAGTCATGCCCCGCGCCCACCGGAAGGAGCTGACTGGG    
pIL2 -rbs             CTAACCAGTAAGGCAACCCCGCCAGCCTAGCCGGGTCCTCAACGACAGGAGCACGATCATGCTAGTCATGCCCCGCGCCCACCGGAAGGAGCTGACTGGG 
                                                                                                   
                              6110      6120      6130      6140      6150      6160      6170      6180      6190      6200  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       ttgaaggctctcaagggcatcggtcgagatcccggtgcctaatgagtgagctaacttacattaattgcgttgcgctcactgcccgctttccagtcgggaa 
pDB10                 TTGAAGGCTCTCAAGGGCATCGGTCGAGATCCCGGTGCCTAATGAGTGAGCTAACTTACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAA 
pIL1 +rbs             TTGAAGGCTCTCAAGGGCATCGGTCGAGATCCCGGTGCCTAATGAGTGAGCTAACTTACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAA    
pIL2 -rbs             TTGAAGGCTCTCAAGGGCATCGGTCGAGATCCCGGTGCCTAATGAGTGAGCTAACTTACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAA 
                                                                                                   
                              6210      6220      6230      6240      6250      6260      6270      6280      6290      6300  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       acctgtcgtgccagctgcattaatgaatcggccaacgcgcggggagaggcggtttgcgtattgggcgccagggtggtttttcttttcaccagtgagacgg 
pDB10                 ACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCCAGGGTGGTTTTTCTTTTCACCAGTGAGACGG 
pIL1 +rbs             ACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCCAGGGTGGTTTTTCTTTTCACCAGTGAGACGG    
pIL2 -rbs             ACCTGTCGTGCCAGCTGCATTAATGAATCGGCCAACGCGCGGGGAGAGGCGGTTTGCGTATTGGGCGCCAGGGTGGTTTTTCTTTTCACCAGTGAGACGG 
                                                                                                 
                              6310      6320      6330      6340      6350      6360      6370      6380      6390      6400  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       gcaacagctgattgcccttcaccgcctggccctgagagagttgcagcaagcggtccacgctggtttgccccagcaggcgaaaatcctgtttgatggtggt 
pDB10                 GCAACAGCTGATTGCCCTTCACCGCCTGGCCCTGAGAGAGTTGCAGCAAGCGGTCCACGCTGGTTTGCCCCAGCAGGCGAAAATCCTGTTTGATGGTGGT 
pIL1 +rbs             GCAACAGCTGATTGCCCTTCACCGCCTGGCCCTGAGAGAGTTGCAGCAAGCGGTCCACGCTGGTTTGCCCCAGCAGGCGAAAATCCTGTTTGATGGTGGT    
pIL2 -rbs             GCAACAGCTGATTGCCCTTCACCGCCTGGCCCTGAGAGAGTTGCAGCAAGCGGTCCACGCTGGTTTGCCCCAGCAGGCGAAAATCCTGTTTGATGGTGGT    
                              6410      6420      6430      6440      6450      6460      6470      6480      6490      6500  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       taacggcgggatataacatgagctgtcttcggtatcgtcgtatcccactaccgagatgtccgcaccaacgcgcagcccggactcggtaatggcgcgcatt 
pDB10                 TAACGGCGGGATATAACATGAGCTGTCTTCGGTATCGTCGTATCCCACTACCGAGATGTCCGCACCAACGCGCAGCCCGGACTCGGTAATGGCGCGCATT 
pIL1 +rbs             TAACGGCGGGATATAACATGAGCTGTCTTCGGTATCGTCGTATCCCACTACCGAGATGTCCGCACCAACGCGCAGCCCGGACTCGGTAATGGCGCGCATT    
pIL2 -rbs             TAACGGCGGGATATAACATGAGCTGTCTTCGGTATCGTCGTATCCCACTACCGAGATGTCCGCACCAACGCGCAGCCCGGACTCGGTAATGGCGCGCATT    
                              6510      6520      6530      6540      6550      6560      6570      6580      6590      6600  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       gcgcccagcgccatctgatcgttggcaaccagcatcgcagtgggaacgatgccctcattcagcatttgcatggtttgttgaaaaccggacatggcactcc 
pDB10                 GCGCCCAGCGCCATCTGATCGTTGGCAACCAGCATCGCAGTGGGAACGATGCCCTCATTCAGCATTTGCATGGTTTGTTGAAAACCGGACATGGCACTCC 
pIL1 +rbs             GCGCCCAGCGCCATCTGATCGTTGGCAACCAGCATCGCAGTGGGAACGATGCCCTCATTCAGCATTTGCATGGTTTGTTGAAAACCGGACATGGCACTCC    
pIL1 -rbs             GCGCCCAGCGCCATCTGATCGTTGGCAACCAGCATCGCAGTGGGAACGATGCCCTCATTCAGCATTTGCATGGTTTGTTGAAAACCGGACATGGCACTCC   
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                              6610      6620      6630      6640      6650      6660      6670      6680      6690      6700  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       agtcgccttcccgttccgctatcggctgaatttgattgcgagtgagatatttatgccagccagccagacgcagacgcgccgagacagaacttaatgggcc 
pDB10                 AGTCGCCTTCCCGTTCCGCTATCGGCTGAATTTGATTGCGAGTGAGATATTTATGCCAGCCAGCCAGACGCAGACGCGCCGAGACAGAACTTAATGGGCC 
pIL1 +rbs             AGTCGCCTTCCCGTTCCGCTATCGGCTGAATTTGATTGCGAGTGAGATATTTATGCCAGCCAGCCAGACGCAGACGCGCCGAGACAGAACTTAATGGGCC    
pIL2 -rbs             AGTCGCCTTCCCGTTCCGCTATCGGCTGAATTTGATTGCGAGTGAGATATTTATGCCAGCCAGCCAGACGCAGACGCGCCGAGACAGAACTTAATGGGCC 
                                                                                                       
                              6710      6720      6730      6740      6750      6760      6770      6780      6790      6800  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       cgctaacagcgcgatttgctggtgacccaatgcgaccagatgctccacgcccagtcgcgtaccgtcttcatgggagaaaataatactgttgatgggtgtc 
pDB10                 CGCTAACAGCGCGATTTGCTGGTGACCCAATGCGACCAGATGCTCCACGCCCAGTCGCGTACCGTCTTCATGGGAGAAAATAATACTGTTGATGGGTGTC 
pIL1 +rbs             CGCTAACAGCGCGATTTGCTGGTGACCCAATGCGACCAGATGCTCCACGCCCAGTCGCGTACCGTCTTCATGGGAGAAAATAATACTGTTGATGGGTGTC    
pIL2 -rbs             CGCTAACAGCGCGATTTGCTGGTGACCCAATGCGACCAGATGCTCCACGCCCAGTCGCGTACCGTCTTCATGGGAGAAAATAATACTGTTGATGGGTGTC 
                                                                                                        
                              6810      6820      6830      6840      6850      6860      6870      6880      6890      6900  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       tggtcagagacatcaagaaataacgccggaacattagtgcaggcagcttccacagcaatggcatcctggtcatccagcggatagttaatgatcagcccac 
pDB10                 TGGTCAGAGACATCAAGAAATAACGCCGGAACATTAGTGCAGGCAGCTTCCACAGCAATGGCATCCTGGTCATCCAGCGGATAGTTAATGATCAGCCCAC 
pIL1 +rbs             TGGTCAGAGACATCAAGAAATAACGCCGGAACATTAGTGCAGGCAGCTTCCACAGCAATGGCATCCTGGTCATCCAGCGGATAGTTAATGATCAGCCCAC    
pIL2 -rbs             TGGTCAGAGACATCAAGAAATAACGCCGGAACATTAGTGCAGGCAGCTTCCACAGCAATGGCATCCTGGTCATCCAGCGGATAGTTAATGATCAGCCCAC    
                              6910      6920      6930      6940      6950      6960      6970      6980      6990      7000  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       tgacgcgttgcgcgagaagattgtgcaccgccgctttacaggcttcgacgccgcttcgttctaccatcgacaccaccacgctggcacccagttgatcggc 
pDB10                 TGACGCGTTGCGCGAGAAGATTGTGCACCGCCGCTTTACAGGCTTCGACGCCGCTTCGTTCTACCATCGACACCACCACGCTGGCACCCAGTTGATCGGC 
pIL1 +rbs             TGACGCGTTGCGCGAGAAGATTGTGCACCGCCGCTTTACAGGCTTCGACGCCGCTTCGTTCTACCATCGACACCACCACGCTGGCACCCAGTTGATCGGC    
pIL2 -rbs             TGACGCGTTGCGCGAGAAGATTGTGCACCGCCGCTTTACAGGCTTCGACGCCGCTTCGTTCTACCATCGACACCACCACGCTGGCACCCAGTTGATCGGC 
                                                                                                        
                              7010      7020      7030      7040      7050      7060      7070      7080      7090      7100  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       gcgagatttaatcgccgcgacaatttgcgacggcgcgtgcagggccagactggaggtggcaacgccaatcagcaacgactgtttgcccgccagttgttgt 
pDB10                 GCGAGATTTAATCGCCGCGACAATTTGCGACGGCGCGTGCAGGGCCAGACTGGAGGTGGCAACGCCAATCAGCAACGACTGTTTGCCCGCCAGTTGTTGT 
pIL1 +rbs             GCGAGATTTAATCGCCGCGACAATTTGCGACGGCGCGTGCAGGGCCAGACTGGAGGTGGCAACGCCAATCAGCAACGACTGTTTGCCCGCCAGTTGTTGT    
pIL2 -rbs             GCGAGATTTAATCGCCGCGACAATTTGCGACGGCGCGTGCAGGGCCAGACTGGAGGTGGCAACGCCAATCAGCAACGACTGTTTGCCCGCCAGTTGTTGT 
                                                                                                        
                              7110      7120      7130      7140      7150      7160      7170      7180      7190      7200  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       gccacgcggttgggaatgtaattcagctccgccatcgccgcttccactttttcccgcgttttcgcagaaacgtggctggcctggttcaccacgcgggaaa 
pDB10                 GCCACGCGGTTGGGAATGTAATTCAGCTCCGCCATCGCCGCTTCCACTTTTTCCCGCGTTTTCGCAGAAACGTGGCTGGCCTGGTTCACCACGCGGGAAA 
pIL1 +rbs             GCCACGCGGTTGGGAATGTAATTCAGCTCCGCCATCGCCGCTTCCACTTTTTCCCGCGTTTTCGCAGAAACGTGGCTGGCCTGGTTCACCACGCGGGAAA    
pIL2 -rbs             GCCACGCGGTTGGGAATGTAATTCAGCTCCGCCATCGCCGCTTCCACTTTTTCCCGCGTTTTCGCAGAAACGTGGCTGGCCTGGTTCACCACGCGGGAAA 
                                                                                                  
                              7210      7220      7230      7240      7250      7260      7270      7280      7290      7300  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       cggtctgataagagacaccggcatactctgcgacatcgtataacgttactggtttcacattcaccaccctgaattgactctcttccgggcgctatcatgc 
pDB10                 CGGTCTGATAAGAGACACCGGCATACTCTGCGACATCGTATAACGTTACTGGTTTCACATTCACCACCCTGAATTGACTCTCTTCCGGGCGCTATCATGC 
pIL1 +rbs             CGGTCTGATAAGAGACACCGGCATACTCTGCGACATCGTATAACGTTACTGGTTTCACATTCACCACCCTGAATTGACTCTCTTCCGGGCGCTATCATGC    
pIL2 -rbs             CGGTCTGATAAGAGACACCGGCATACTCTGCGACATCGTATAACGTTACTGGTTTCACATTCACCACCCTGAATTGACTCTCTTCCGGGCGCTATCATGC 
                                                                                                 
                              7310      7320      7330      7340      7350      7360      7370      7380      7390      7400  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       cataccgcgaaaggttttgcgccattcgatggtgtccgggatctcgacgctctcccttatgcgactcctgcattaggaagcagcccagtagtaggttgag 
pDB10                 CATACCGCGAAAGGTTTTGCGCCATTCGATGGTGTCCGGGATCTCGACGCTCTCCCTTATGCGACTCCTGCATTAGGAAGCAGCCCAGTAGTAGGTTGAG 
pIL1 +rbs             CATACCGCGAAAGGTTTTGCGCCATTCGATGGTGTCCGGGATCTCGACGCTCTCCCTTATGCGACTCCTGCATTAGGAAGCAGCCCAGTAGTAGGTTGAG    
pIL2 -rbs             CATACCGCGAAAGGTTTTGCGCCATTCGATGGTGTCCGGGATCTCGACGCTCTCCCTTATGCGACTCCTGCATTAGGAAGCAGCCCAGTAGTAGGTTGAG 
                              7410      7420      7430      7440      7450      7460      7470      7480      7490      7500  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       gccgttgagcaccgccgccgcaaggaatggtgcatgcaaggagatggcgcccaacagtcccccggccacggggcctgccaccatacccacgccgaaacaa 
pDB10                 GCCGTTGAGCACCGCCGCCGCAAGGAATGGTGCATGCAAGGAGATGGCGCCCAACAGTCCCCCGGCCACGGGGCCTGCCACCATACCCACGCCGAAACAA 
pIL1 +rbs             GCCGTTGAGCACCGCCGCCGCAAGGAATGGTGCATGCAAGGAGATGGCGCCCAACAGTCCCCCGGCCACGGGGCCTGCCACCATACCCACGCCGAAACAA    
pIL2 -rbs             GCCGTTGAGCACCGCCGCCGCAAGGAATGGTGCATGCAAGGAGATGGCGCCCAACAGTCCCCCGGCCACGGGGCCTGCCACCATACCCACGCCGAAACAA 
                              7510      7520      7530      7540      7550      7560      7570      7580      7590      7600  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       gcgctcatgagcccgaagtggcgagcccgatcttccccatcggtgatgtcggcgatataggcgccagcaaccgcacctgtggcgccggtgatgccggcca 
pDB10                 GCGCTCATGAGCCCGAAGTGGCGAGCCCGATCTTCCCCATCGGTGATGTCGGCGATATAGGCGCCAGCAACCGCACCTGTGGCGCCGGTGATGCCGGCCA 
pIL1 +rbs             GCGCTCATGAGCCCGAAGTGGCGAGCCCGATCTTCCCCATCGGTGATGTCGGCGATATAGGCGCCAGCAACCGCACCTGTGGCGCCGGTGATGCCGGCCA    
pIL2 -rbs             GCGCTCATGAGCCCGAAGTGGCGAGCCCGATCTTCCCCATCGGTGATGTCGGCGATATAGGCGCCAGCAACCGCACCTGTGGCGCCGGTGATGCCGGCCA 
                              7610      7620      7630      7640      7650      7660          
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|
pETDuet-Novagen       cgatgcgtccggcgtagaggatcgagatcgatctcgatcccgcgaaattaatacgactcactata 
pDB10                 CGATGCGTCCGGCGTAGAGGATCGAGATCGATCTCGATCCCGCGAAATTAATACGACTCACTATA 
pIL1 +rbs             CGATGCGTCCGGCGTAGAGGATCGAGATCGATCTCGATCCCGCGAAATTAATACGACTCACTATA                                       
pIL2 -rbs             CGATGCGTCCGGCGTAGAGGATCGAGATCGATCTCGATCCCGCGAAATTAATACGACTCACTATA 
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                                                             = mutated residues (amino acid exchanges are indicated)                                     restriction sites
                                                    ATG = ZIM17-presequence (Yamamoto 2005) 
                               10        20        30        40        50        60        70        80        90        100   
                                                     ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 tcgcgcgtttcggtgatgacggtgaaaacctctgacacatgcagctcccggagacggtcacagcttgtctgtaagcggatgccgggagcagacaagcccg 
pFL-Zim17-ts2-CEN     tcgcgcgtttcggtgatgacggtgaaaacctctgacacatgcagctcccggagacggtcacagcttgtctgtaagcggatgccgggagcagacaagcccg 
pFL-Zim17-ts3-CEN     tcgcgcgtttcggtgatgacggtgaaaacctctgacacatgcagctcccggagacggtcacagcttgtctgtaagcggatgccgggagcagacaagcccg 
pFL-Zim17-ts4-CEN     tcgcgcgtttcggtgatgacggtgaaaacctctgacacatgcagctcccggagacggtcacagcttgtctgtaagcggatgccgggagcagacaagcccg 
pFL-Zim17-corrWT-CEN  tcgcgcgtttcggtgatgacggtgaaaacctctgacacatgcagctcccggagacggtcacagcttgtctgtaagcggatgccgggagcagacaagcccg 
                              110       120       130       140       150       160       170       180       190       200   
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 tcagggcgcgtcagcgggtgttggcgggtgtcggggctggcttaactatgcggcatcagagcagattgtactgagagtgcaccatatgcggtgtgaaata 
pFL-Zim17-ts2-CEN     tcagggcgcgtcagcgggtgttggcgggtgtcggggctggcttaactatgcggcatcagagcagattgtactgagagtgcaccatatgcggtgtgaaata 
pFL-Zim17-ts3-CEN     tcagggcgcgtcagcgggtgttggcgggtgtcggggctggcttaactatgcggcatcagagcagattgtactgagagtgcaccatatgcggtgtgaaata 
pFL-Zim17-ts4-CEN     tcagggcgcgtcagcgggtgttggcgggtgtcggggctggcttaactatgcggcatcagagcagattgtactgagagtgcaccatatgcggtgtgaaata 
pFL-Zim17-corrWT-CEN  tcagggcgcgtcagcgggtgttggcgggtgtcggggctggcttaactatgcggcatcagagcagattgtactgagagtgcaccatatgcggtgtgaaata 
                              210       220       230       240       250       260       270       280       290       300   
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 ccgcacagatgcgtaaggagaaaataccgcatcaggcgccattcgccattcaggctgcgcaactgttgggaagggcgatcggtgcgggcctcttcgctat 
pFL-Zim17-ts2-CEN     ccgcacagatgcgtaaggagaaaataccgcatcaggcgccattcgccattcaggctgcgcaactgttgggaagggcgatcggtgcgggcctcttcgctat  
pFL-Zim17-ts3-CEN     ccgcacagatgcgtaaggagaaaataccgcatcaggcgccattcgccattcaggctgcgcaactgttgggaagggcgatcggtgcgggcctcttcgctat 
pFL-Zim17-ts4-CEN     ccgcacagatgcgtaaggagaaaataccgcatcaggcgccattcgccattcaggctgcgcaactgttgggaagggcgatcggtgcgggcctcttcgctat 
pFL-Zim17-corrWT-CEN  ccgcacagatgcgtaaggagaaaataccgcatcaggcgccattcgccattcaggctgcgcaactgttgggaagggcgatcggtgcgggcctcttcgctat 
                              310       320       330       340       350       360       370       380       390       400   
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 tacgccagctggcgaaagggggatgtgctgcaaggcgattaagttgggtaacgccagggttttcccagtcacgacgttgtaaaacgacggccagt----- 
pFL-Zim17-ts2-CEN     tacgccagctggcgaaagggggatgtgctgcaaggcgattaagttgggtaacgccagggttttcccagtcacgacgttgtaaaacgacggccagtnnnnn 
pFL-Zim17-ts3-CEN     tacgccagctggcgaaagggggatgtgctgcaaggcgattaagttgggtaacgccagggttttcccagtcacgacgttgtaaaacgacggccagtnnnTT 
pFL-Zim17-ts4-CEN     tacgccagctggcgaaagggggatgtgctgcaaggcgattaagttgggtaacgccagggttttcccagtcacgacgttgtaaaacgacggccagtnnnTT 
pFL-Zim17-corrWT-CEN  tacgccagctggcgaaagggggatgtgctgcaaggcgattaagttgggtaacgccagggttttcccagtcacgacgttgtaaaacgacggccagtnnnnn 
                              410       420       430       440       450       460       470       480       490       500   
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 ---------------------------------------------------------------------------------------------------- 
pFL-Zim17-ts2-CEN     nnnnnnTGATCTGCTGTGAGCGGTCTTCGGCTTTTCGTTGGCGTGAACTTGGGGGAGTATTTGGCTTCTCTACAAATTTTACGGGCGATATAACAGTCAT 
pFL-Zim17-ts3-CEN     CTAGCTTGATCTGCTGTGAGCGGTCTTCGGCTTTTCGTTGGCGTGAACTTGGGGGAGTATTTGGCTTCTCTACAAATTTTACGGGCGATATAACAGTCAT 
pFL-Zim17-ts4-CEN     CTAGCTTGATCTGCTGTGAGCGGTCTTCGGCTTTTCGTTGGCGTGAACTTGGGGGAGTATTTGGCTTCTCCACAGATTTTACGGGCGATATAACAGTCAT 
pFL-Zim17-corrWT-CEN  nnnnCTTGATCTGCTGTGAGCGGTCTTCGGCTTTTCGTTGGCGTGAACTTGGGGGAGTATTTGGCTTCTCTACAAATTTTACGGGCGATATAACAGTCAT  
                              510       520       530       540       550       560       570       580       590       600   
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 ---------------------------------------------------------------------------------------------------- 
pFL-Zim17-ts2-CEN     TTTATTTGTATCATCGTGGAGAGGCTTTTTCGCAGGCGATATGGCTTCCAAAAGAGTTTTGTGGTCCTCATCAACATCTTCGGCATCCTCTCCGCTTCTT 
pFL-Zim17-ts3-CEN     TTTATTTGTATCATCGTGGAGAGGCTTTTTCGCAGGCGATATGGCTTCCAAAAGAGTTTTGTGGTCCTCATCAACATCTTCGGCATCCTCTCCGCTTCTT 
pFL-Zim17-ts4-CEN     TTTATTCGTATCATCGTGGAGAGGCTTTTTCGCAGGCGATATGGCTTCCAAAAGAGTTTTGTGGTCCTCATCAACGTCTTCGGCGTCCTCTCCGCTTCTT 
pFL-Zim17-corrWT-CEN  TTTATTTGTATCATCGTGGAGAGGCTTTTTCGCAGGCGATATGGCTTCCAAAAGAGTTTTGTGGTCCTCATCAACATCTTCGGCATCCTCTCCGCTTCTT  
                              610       620       630       640       650       660       670       680       690       700   
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 ---------------------------------------------------------------------------------------------------- 
pFL-Zim17-ts2-CEN     TTCTTTGTTGTAGAGTCCTGTTTTCGTTTTGTTGATGGGACATTACTTAAACCAAGCTTTAATTGGCGCGTCATCTGAGCCAACTCAGCTCTATGCAAAA 
pFL-Zim17-ts3-CEN     TTCTTTGTTGTAGAGTCCTGTTTTCGTTTTGTTGATGGGACATTACTTAAACCAAGCTTTAATTGGCGCGTCATCTGAGCCAACTCAGCTCTATGCAAAA 
pFL-Zim17-ts4-CEN     TTCTTTGTTGTAGAGTCCTGTTTTCGTTTTGTTGATGGGACATTACTTAAACCAAGCTTTAATTGACGCGTCATCTGAGCCAACTCAGCTCTATGCAAAA 
pFL-Zim17-corrWT-CEN  TTCTTTGTTGTAGAGTCCTGTTTTCGTTTTGTTGATGGGACATTACTTAAACCAAGCTTTAATTGACGCGTCATCTGAGCCAACTCAGCTCTATGCAAAA 
                                                                          HindIII
                              710       720       730       740       750       760       770       780       790       800   
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 ---------------------------------------------------------------------------------------------------- 
pFL-Zim17-ts2-CEN     -TCTTGGAGGCC-AATTCTTGCTCTTTTTCAGGGGACATCTGGGGTTGAGACATTTCTTGTATGCACAATGGGAACACTGATTGAAAATAGTAACGCTCT 
pFL-Zim17-ts3-CEN     ATCTTGGAGGCCCAATTCTTGCTCTTTTTCAGGGGACATCTGGGGTTGAGACATTTCTTGTATGCACAATGGGAACACTGATTGAAAATAGTAACGCTCT 
pFL-Zim17-ts4-CEN     -TCTTGGAGGCC-AATTCTTGCTCTTTTTCAGGGGACGTCTGGGGTTGAGACATTTCTTGTATGCACAATGGGAACACTGATTGAAAATAGTAACGCTCT 
pFL-Zim17-corrWT-CEN  -TCTTGGAGGCC-AATTCTTGCTCTTTTTCAGGGGACATCTGGGGTTGAGACATTTCTTGTATGCACAATGGGAACACTGATTGAAAATAGTAACGCTCT 
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                              810       820       830       840       850       860       870       880       890       900   
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 ---------------------------------------------------------------------------------------------------- 
pFL-Zim17-ts2-CEN     ACGTACTCCTTCTTTCGATGATATTTTTGGTTCCTTCTGCACTTCATAATTGTAATTTTTTTTtCTTGCATTTTCGCGTGATATCAAAATTATGAGAGGA 
pFL-Zim17-ts3-CEN     ACGTACTCCTTCTTTCGATGATATTTTTGGTTCCTTCTGCACTTCATAATTGTAATTTTTTTTTCTTGCATTTTCGCGTGATATCAAAATTATGAGAGGA 
pFL-Zim17-ts4-CEN     ACGTACTCCCTCTTTCGACGATATTTTTGGTTCCTTCTGCACTTCATAATTGTAACTTTTTTTTCTTGCATTTTCGCGTGATATCAAAATTGTGAGAGGA 
pFL-Zim17-corrWT-CEN  ACGTACTCCTTCTTTCGATGATATTTTTGGTTCCTTCTGCACTTCATAATTGTAATTTTTTTTTCTTGCATTTTCGCGTGATATCAAAATTATGAGAGGA 
                              910       920       930       940       950       960       970       980       990       1000  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 ---------------------------------------------------------------------------------------------------- 
pFL-Zim17-ts2-CEN     AAGGTGAAAGAGCGTCATGTTGGCTTCAAGGGATCAGCGATACTAAAGCAGCACCGGTGCAACTGGAATATCAAGAGACTGAACATGATTCCGAGGACTA 
pFL-Zim17-ts3-CEN     AAGGTGAAAGAGCGTCATGTTGGCTTCAGGGGATCAGCGATACTAAAGCAGCACCGGTGCAACTGGAATATCAAGAGACAGAACATGATTCCGAGGACTA 
pFL-Zim17-ts4-CEN     AAGGTGAAAGAGCGTCATGTTGGCTTCAAGGGATCAGCGATACTAAAGCAGCACCGGTGCAACTGGAATATCAAGAGACTGAACATGATTCCGAGGACTA 
pFL-Zim17-corrWT-CEN  AAGGTGAAAGAGCGTCATGTTGGCTTCAAGGGATCAGCGATACTAAAGCAGCACCGGTGCAACTGGAATATCAAGAGACTGAACATGATTCCGAGGACTA 
Zim17-coding          ------------------------------------------------------------------------------------ATGATTCCGAGGACTA 
                                                                                                                          
                              1010      1020      1030      1040      1050      1060      1070      1080      1090      1100  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 ---------------------------------------------------------------------------------------------------- 
pFL-Zim17-ts2-CEN     GAACACTACTGCAAAGTAAAATACCAATTACCAGGTACTTTGCCAGATGTTGGGCGCCTCGCGTACGCTACAACGTGTGCCGTACTCTACCCGCAGCAGC 
pFL-Zim17-ts3-CEN     GAACACTACTGCAAAGTAAAATACCAATTACCAGGTACTTTGCCAGATGTTGGGCGCCTCGCGTACGCTACAACGTGTGCCGTACTCTACCCGCAGCAGC 
pFL-Zim17-ts4-CEN     GAACACTACTGCAAAGTAAAATACCAATTACCAGGTACTTTGCCAGATGTTGGGCGCCTCGCGTACGCTACAACGCGTGCCGTACTCTACCCGCAGCAGC 
pFL-Zim17-corrWT-CEN  GAACACTACTGCAAAGTAAAATACCAATTACCAGGTACTTTGCCAGATGTTGGGCGCCTCGCGTACGCTACAACGTGTGCCGTACTCTACCCGCAGCAGC 
Zim17-coding          GAACACTACTGCAAAGTAAAATACCAATTACCAGGTACTTTGCCAGATGTTGGGCGCCTCGCGTACGCTACAACGTGTGCCGTACTCTACCCGCAGCAGC 
                                             predicted ZIM17-presequence (Yamamoto 2005)                                      
                                                                                               V31A
                              1110      1120      1130      1140      1150      1160      1170      1180      1190      1200  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 --------------------------------------------------------------------------------------- 
pFL-Zim17-ts2-CEN     GTCGCATACCAATATCATCGCACATAATGAAGTGAAGAAGGACGATAAGAAGGTTCATTCGGGGTCTTTTAAGGTAGACAAGCCTAAgatGATGATAGCT 
pFL-Zim17-ts3-CEN     GTTGCATACCAATATCATCGCACATAACGAAGTGAAAAAGGACGATAAGAAGGTTCATTTGGGGTCTTTTAAGGTAGACAAGCCTAAGATGATGATAGCT 
pFL-Zim17-ts4-CEN     GTTGCATACCAATATCATCGCACATAATGAAGTGAAAAAGGACGATAAGAAGGTTCATTTGGGGTCTTTTAAGGTAGACAAGCCTAAGATGATGATAGCT 
pFL-Zim17-corrWT-CEN  GTTGCATACCAATATCATCGCACATAATGAAGTGAAAAAGGACGATAAGAAGGTTCATTTGGGGTCTTTTAAGGTAGACAAGCCTAAGATGATGATAGCT 
Zim17-coding          GTTGCATACCAATATCATCGCACATAATGAAGTGAAAAAGGACGATAAGAAGGTTCATTTGGGGTCTTTTAAGGTAGACAAGCCTAAGATGATGATAGCT 
                                                                         
                      L40S                                                      L59S                               
  
                              1210      1220      1230      1240      1250      1260      1270      1280      1290      1300  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 ---------------------------------------------------------------------------------------------------- 
pFL-Zim17-ts2-CEN     TTCACCTGCAAGAAATGTAACACCCGATCTTCACACACAATGTCCAAGCAGGCGTACGAgaAAgGTACTGTCTTGATCTCTTGTCCGCACTGCAAAGTGa 
pFL-Zim17-ts3-CEN     TTCACCTGCAAGAAATGTAGCACCCGATCTTCACACACAATGTCCAAGCAGGCGTACGAGAAAGGTACCGTCTTGATCTCTTGTCCGCACTGTAAAGTGA 
pFL-Zim17-ts4-CEN     TTCACCTGCAAGAAATGTAACACCCGATCTTCACACACAATGTCCAAGCAGGCGTACGAGAAAGGTACTGTCTTGATCTCTTGTCCGCACTGCAAAGTGA 
pFL-Zim17-corrWT-CEN  TTCACCTGCAAGAAATGTAACACCCGATCTTCACACACAATGTCCAAGCAGGCGTACGAGAAAGGTACTGTCTTGATCTCTTGTCCGCACTGCAAAGTGA 
Zim17-coding          TTCACCTGCAAGAAATGTAACACCCGATCTTCACACACAATGTCCAAGCAGGCGTACGAGAAAGGTACTGTCTTGATCTCTTGTCCGCACTGCAAAGTGA 
                                       N79S
                              1310      1320      1330      1340      1350      1360      1370      1380      1390      1400  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 ---------------------------------------------------------------------------------------------------- 
pFL-Zim17-ts2-CEN     GACCTTTGATAGCAGACCATCTGAAAATATTCCATGATCATCATGTTACCGTGGAACAGTTAATGaAAGCTAACGGGGAACAAGTTAGCCAAGACGTGGG 
pFL-Zim17-ts3-CEN     GACATTTGATAGCAGGCCATCTGAAAATATTCCATGATCATCATGTCACCGTGGAACAGTTAATGAAAGCTAACGGGGAACAAGTTAGCCAAGACGTGGG 
pFL-Zim17-ts4-CEN     GACATTTGATAGCAGACCATCCGAAAACATTCCATGATCATCATGTTACCGTGGAACAGTTAATGAAAGCTAACGGGGAACAAGTTAGCCAAGACGTGGG 
pFL-Zim17-corrWT-CEN  GACATTTGATAGCAGACCATCTGAAAATATTCCATGATCATCATGTTACCGTGGAACAGTTAATGAAAGCTAACGGAGAACAAGTTAGCCAAGACGTGGG 
Zim17-coding          GACATTTGATAGCAGACCATCTGAAAATATTCCATGATCATCATGTTACCGTGGAACAGTTAATGAAAGCTAACGGAGAACAAGTTAGCCAAGACGTGGG 
                       H107P       D111G L114P  I115T 
                              1410      1420      1430      1440      1450      1460      1470      1480      1490      1500  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 ---------------------------------------------------------------------------------------------------- 
pFL-Zim17-ts2-CEN     CGACTTGGAGTTTGAAGACATCCCAGATTCGCTAAAGGACGTCCTGGGAAAATATGCCAAGAACAACTCAGAAAATGCATCCCAGCTCCCTCACCCTTCC 
pFL-Zim17-ts3-CEN     CGACTTGGAGTTTGAAGACATCCCCGATTCGCTAAAGGACGTCCTGGGAAAGTATGCCAAGAACAACTCAGAAAATGCATCCCAGCTCCCTCACCCTTCC 
pFL-Zim17-ts4-CEN     CGACTTGGAGTTTGAAGACATCCCAGATTCGCTAAAGGACGTCCTGGGAAAATATGCCAAGAACAACTCAGAAAATGCATCCCAGCTCCCTCACCCTTCC 
pFL-Zim17-corrWT-CEN  CGACTTGGAGTTTGAAGACATCCCAGATTCGCTAAAGGACGTCCTGGGAAAATATGCCAAGAACAACTCAGAAAATGCATCCCAGCTCCCTCACCCTTCC 
Zim17-coding          CGACTTGGAGTTTGAAGACATCCCAGATTCGCTAAAGGACGTCCTGGGAAAATATGCCAAGAACAACTCAGAAAATGCATCCCAGCTCCCTCACCCTTCC 
                              1510      1520      1530      1540      1550      1560      1570      1580      1590      1600  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 ---------------------------------------------------------------------------------------------------- 
pFL-Zim17-ts2-CEN     CAGAAATGAATGAAGAGCTCATGCACAGGCATGTACATAGGTAGATATATAACCGTTAAATAGCACGCCTTTCCAGAGACTGAGTCATGATTACTGCCAA 
pFL-Zim17-ts3-CEN     -AGAAATGAATGAAGAGCTCATGCACAGGCATGTACATAGATAGATATATAACCGTTAAATAGCACGTTTTTCCAGAGACTGAGTCATGATTACTGCCAA 
pFL-Zim17-ts4-CEN     CAGAAATGAATGAAGAGCTCATGCACAGGCATGTACATAGATAGATATATAACCGTTAAATAGCACGTTTTTCCAGAGACTGAGTCATGATTACTGCCAA 
pFL-Zim17-corrWT-CEN  CAGAAATGAATGAAGAGCTCATGCACAGGCATGTACATAGATAGATATATAACCGTTAAATAGCACGTTTTTCCAGAGACTGAGTCATGATTACTGCCAA 
Zim17-coding          CAGAAATGA ------------------------------------------------------------------------------------------    
                      frame shift
                              1610      1620      1630      1640      1650      1660      1670      1680      1690      1700  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 ---------------------------------------------------------------------------------------------------- 
pFL-Zim17-ts2-CEN     AGACCCGCACATCACATATTTTTTTGCGATAACCAGCAGAAGATTTAGGACTAGAGTACATAAAGATGAGCCACTGCTAGATATGAAAAGTTGAACCGCA 
pFL-Zim17-ts3-CEN     AAACCCGCACATCACATATTTTTTTGCGATAACCAGCAGAAGATTTAGGACTAGAGTACATAAAGATGAGCCACTGCTAGATATGAAAAGTTGAACCGCA 
pFL-Zim17-ts4-CEN     AAACCCGCACATCACATATTTTTTTGCGATAACCAGCAGAAGATTTAGGACTAGAGTACATAAAGATGAGCCACTGCTAGATATGAAAAGTTGAACCGCA 
pFL-Zim17-corrWT-CEN  AAACCCGCACATCACATATTTTTTTGCGATAACCAGCAGAAGATTTAGGACTAGAGTACATAAAGATGAGCCACTGCTAGATATGAAAAGTTGAACCGCA    
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                              1710      1720      1730      1740      1750      1760      1770      1780      1790      1800  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 ---------------------------------------------------------------------------------------------------- 
pFL-Zim17-ts2-CEN     TTTTCAAACGTTCAAACCAACCGAATCATGAAACGGTTGCAATTGTTTGGTAGGTCAAAATATTTCTCGCTGGTCTCCAGTGCTGCGAAGGAGGAAGAAG 
pFL-Zim17-ts3-CEN     TTTTCAAACGTTCAAACCAACCGAATCATGAAACGGTTGCAATTGTTTGGTAGATCAAAATATTTCTCGCTGGTCTCCAGTGCTGCGAAGGAGGAAGAAG 
pFL-Zim17-ts4-CEN     TTTTCAAACGTTCAAACCAACCGAATCATGAAACGGTTGCAATTGTTTGGTAGATCAAAATATTTCTCGCTGGTCTCCAGTGCTGCGAAGGAGGAAGAAG 
pFL-Zim17-corrWT-CEN  TTTTCAAACGTTCAAACCAACCGAATCATGAAACGGTTGCAATTGTTTGGTAGATCAAAATATTTCTCGCTGGTCTCCAGTGCTGCGAAGGAGGAAGAAG 
                                                                                                    
                              1810      1820      1830      1840      1850      1860      1870      1880      1890      1900  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 -----------------cttggcgtaatcatggtcatagctgtttcctgtgtgaaattgttatccgctcacaattccacacaacatacgagccggaagca 
pFL-Zim17-ts2-CEN     AAGAGGAAGAgcnnnnnnnnggcgtaatcatggtcatagctgtttcctgtgtgaaattgttatccgctcacaattccacacaacatacgagccggaagca 
pFL-Zim17-ts3-CEN     AAGAGGAAGAGnnnaaGCttggcgtaatcatggtcatagctgtttcctgtgtgaaattgttatccgctcacaattccacacaacatacgagccggaagca 
pFL-Zim17-ts4-CEN     AAGAGGAAGAGnnnaagcttggcgtaatcatggtcatagctgtttcctgtgtgaaattgttatccgctcacaattccacacaacatacgagccggaagca 
pFL-Zim17-corrWT-CEN  AAGAGGAAGAGnnnaagcttggcgtaatcatggtcatagctgtttcctgtgtgaaattgttatccgctcacaattccacacaacatacgagccggaagca
                                    HindIII                                                                                   
                              1910      1920      1930      1940      1950      1960      1970      1980      1990      2000  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 taaagtgtaaagcctggggtgcctaatgagtgagctaactcacattaattgcgttgcgctcactgcccgctttccagtcgggaaacctgtcgtgccagca 
pFL-Zim17-ts2-CEN     taaagtgtaaagcctggggtgcctaatgagtgagctaactcacattaattgcgttgcgctcactgcccgctttccagtcgggaaacctgtcgtgccagca 
pFL-Zim17-ts3-CEN     taaagtgtaaagcctggggtgcctaatgagtgagctaactcacattaattgcgttgcgctcactgcccgctttccagtcgggaaacctgtcgtgccagca 
pFL-Zim17-ts4-CEN     taaagtgtaaagcctggggtgcctaatgagtgagctaactcacattaattgcgttgcgctcactgcccgctttccagtcgggaaacctgtcgtgccagca 
pFL-Zim17-corrWT-CEN  taaagtgtaaagcctggggtgcctaatgagtgagctaactcacattaattgcgttgcgctcactgcccgctttccagtcgggaaacctgtcgtgccagca 
                              2010      2020      2030      2040      2050      2060      2070      2080      2090      2100  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 gatctgggcaagtgcacaaacaatacttaaataaatactactcagtaataacctatttcttagcatttttgacgaaatttgctattttgttagagtcttt 
pFL-Zim17-ts2-CEN     gatctgggcaagtgcacaaacaatacttaaataaatactactcagtaataacctatttcttagcatttttgacgaaatttgctattttgttagagtcttt 
pFL-Zim17-ts3-CEN     gatctgggcaagtgcacaaacaatacttaaataaatactactcagtaataacctatttcttagcatttttgacgaaatttgctattttgttagagtcttt 
pFL-Zim17-ts4-CEN     gatctgggcaagtgcacaaacaatacttaaataaatactactcagtaataacctatttcttagcatttttgacgaaatttgctattttgttagagtcttt 
pFL-Zim17-corrWT-CEN  gatctgggcaagtgcacaaacaatacttaaataaatactactcagtaataacctatttcttagcatttttgacgaaatttgctattttgttagagtcttt    
                              2110      2120      2130      2140      2150      2160      2170      2180      2190      2200  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 tacaccatttgtctccacacctccgcttacatcaacaccaataacgccatttaatctaagcgcatcaccaacattttctggcgtcagtccaccagctaac 
pFL-Zim17-ts2-CEN     tacaccatttgtctccacacctccgcttacatcaacaccaataacgccatttaatctaagcgcatcaccaacattttctggcgtcagtccaccagctaac 
pFL-Zim17-ts3-CEN     tacaccatttgtctccacacctccgcttacatcaacaccaataacgccatttaatctaagcgcatcaccaacattttctggcgtcagtccaccagctaac 
pFL-Zim17-ts4-CEN     tacaccatttgtctccacacctccgcttacatcaacaccaataacgccatttaatctaagcgcatcaccaacattttctggcgtcagtccaccagctaac 
pFL-Zim17-corrWT-CEN  tacaccatttgtctccacacctccgcttacatcaacaccaataacgccatttaatctaagcgcatcaccaacattttctggcgtcagtccaccagctaac    
                              2210      2220      2230      2240      2250      2260      2270      2280      2290      2300  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 ataaaatgtaaactttcggggctctcttgccttccaacccagtcagaaatcgagttccaatccaaaagttcacctgtcccacctgcttctgaatcaaaca 
pFL-Zim17-ts2-CEN     ataaaatgtaaactttcggggctctcttgccttccaacccagtcagaaatcgagttccaatccaaaagttcacctgtcccacctgcttctgaatcaaaca 
pFL-Zim17-ts3-CEN     ataaaatgtaaactttcggggctctcttgccttccaacccagtcagaaatcgagttccaatccaaaagttcacctgtcccacctgcttctgaatcaaaca 
pFL-Zim17-ts4-CEN     ataaaatgtaaactttcggggctctcttgccttccaacccagtcagaaatcgagttccaatccaaaagttcacctgtcccacctgcttctgaatcaaaca 
pFL-Zim17-corrWT-CEN  ataaaatgtaaactttcggggctctcttgccttccaacccagtcagaaatcgagttccaatccaaaagttcacctgtcccacctgcttctgaatcaaaca    
                              2310      2320      2330      2340      2350      2360      2370      2380      2390      2400  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 agggaataaacgaatgaggtttctgtgaagctgcactgagtagtatgttgcagtcttttggaaatacgagtcttttaataactggcaaaccgaggaactc 
pFL-Zim17-ts2-CEN     agggaataaacgaatgaggtttctgtgaagctgcactgagtagtatgttgcagtcttttggaaatacgagtcttttaataactggcaaaccgaggaactc 
pFL-Zim17-ts3-CEN     agggaataaacgaatgaggtttctgtgaagctgcactgagtagtatgttgcagtcttttggaaatacgagtcttttaataactggcaaaccgaggaactc 
pFL-Zim17-ts4-CEN     agggaataaacgaatgaggtttctgtgaagctgcactgagtagtatgttgcagtcttttggaaatacgagtcttttaataactggcaaaccgaggaactc 
pFL-Zim17-corrWT-CEN  agggaataaacgaatgaggtttctgtgaagctgcactgagtagtatgttgcagtcttttggaaatacgagtcttttaataactggcaaaccgaggaactc    
                              2410      2420      2430      2440      2450      2460      2470      2480      2490      2500  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 ttggtattcttgccacgactcatctccatgcagttggacgatatcaatgccgtaatcattgaccagagccaaaacatcctccttaggttgattacgaaac 
pFL-Zim17-ts2-CEN     ttggtattcttgccacgactcatctccatgcagttggacgatatcaatgccgtaatcattgaccagagccaaaacatcctccttaggttgattacgaaac 
pFL-Zim17-ts3-CEN     ttggtattcttgccacgactcatctccatgcagttggacgatatcaatgccgtaatcattgaccagagccaaaacatcctccttaggttgattacgaaac 
pFL-Zim17-ts4-CEN     ttggtattcttgccacgactcatctccatgcagttggacgatatcaatgccgtaatcattgaccagagccaaaacatcctccttaggttgattacgaaac 
pFL-Zim17-corrWT-CEN  ttggtattcttgccacgactcatctccatgcagttggacgatatcaatgccgtaatcattgaccagagccaaaacatcctccttaggttgattacgaaac    
                              2510      2520      2530      2540      2550      2560      2570      2580      2590      2600  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 acgccaaccaagtatttcggagtgcctgaactatttttatatgcttttacaagacttgaaattttccttgcaataaccgggtcaattgttctctttctat 
pFL-Zim17-ts2-CEN     acgccaaccaagtatttcggagtgcctgaactatttttatatgcttttacaagacttgaaattttccttgcaataaccgggtcaattgttctctttctat 
pFL-Zim17-ts3-CEN     acgccaaccaagtatttcggagtgcctgaactatttttatatgcttttacaagacttgaaattttccttgcaataaccgggtcaattgttctctttctat 
pFL-Zim17-ts4-CEN     acgccaaccaagtatttcggagtgcctgaactatttttatatgcttttacaagacttgaaattttccttgcaataaccgggtcaattgttctctttctat 
pFL-Zim17-corrWT-CEN  acgccaaccaagtatttcggagtgcctgaactatttttatatgcttttacaagacttgaaattttccttgcaataaccgggtcaattgttctctttctat    
                              2610      2620      2630      2640      2650      2660      2670      2680      2690      2700  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 tgggcacacatataatacccagcaagtcagcatcggaatctagagcacattctgcggcctctgtgctctgcaagccgcaaactttcaccaatggaccaga 
pFL-Zim17-ts2-CEN     tgggcacacatataatacccagcaagtcagcatcggaatctagagcacattctgcggcctctgtgctctgcaagccgcaaactttcaccaatggaccaga 
pFL-Zim17-ts3-CEN     tgggcacacatataatacccagcaagtcagcatcggaatctagagcacattctgcggcctctgtgctctgcaagccgcaaactttcaccaatggaccaga 
pFL-Zim17-ts4-CEN     tgggcacacatataatacccagcaagtcagcatcggaatctagagcacattctgcggcctctgtgctctgcaagccgcaaactttcaccaatggaccaga 
pFL-Zim17-corrWT-CEN  tgggcacacatataatacccagcaagtcagcatcggaatctagagcacattctgcggcctctgtgctctgcaagccgcaaactttcaccaatggaccaga    
                              2710      2720      2730      2740      2750      2760      2770      2780      2790      2800  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 actacctgtgaaattaataacagacatactccaagctgcctttgtgtgcttaatcacggtatatatactcacgtgctcaatagtcaccaatgccctccct 
pFL-Zim17-ts2-CEN     actacctgtgaaattaataacagacatactccaagctgcctttgtgtgcttaatcacggtatatatactcacgtgctcaatagtcaccaatgccctccct 
pFL-Zim17-ts3-CEN     actacctgtgaaattaataacagacatactccaagctgcctttgtgtgcttaatcacggtatatatactcacgtgctcaatagtcaccaatgccctccct 
pFL-Zim17-ts4-CEN     actacctgtgaaattaataacagacatactccaagctgcctttgtgtgcttaatcacggtatatatactcacgtgctcaatagtcaccaatgccctccct 
pFL-Zim17-corrWT-CEN  actacctgtgaaattaataacagacatactccaagctgcctttgtgtgcttaatcacggtatatatactcacgtgctcaatagtcaccaatgccctccct    
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                              2810      2820      2830      2840      2850      2860      2870      2880      2890      2900  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 cttggccctctccttttcttttttcgaccgaattaattcagatctgctgcattaatgaatcggccaacgcgcggggagaggcggtttgcgtattgggcgc 
pFL-Zim17-ts2-CEN     cttggccctctccttttcttttttcgaccgaattaattcagatctgctgcattaatgaatcggccaacgcgcggggagaggcggtttgcgtattgggcgc 
pFL-Zim17-ts3-CEN     cttggccctctccttttcttttttcgaccgaattaattcagatctgctgcattaatgaatcggccaacgcgcggggagaggcggtttgcgtattgggcgc 
pFL-Zim17-ts4-CEN     cttggccctctccttttcttttttcgaccgaattaattcagatctgctgcattaatgaatcggccaacgcgcggggagaggcggtttgcgtattgggcgc 
pFL-Zim17-corrWT-CEN  cttggccctctccttttcttttttcgaccgaattaattcagatctgctgcattaatgaatcggccaacgcgcggggagaggcggtttgcgtattgggcgc    
                              2910      2920      2930      2940      2950      2960      2970      2980      2990      3000  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 tcttccgcttcctcgctcactgactcgctgcgctcggtcgttcggctgcggcgagcggtatcagcatcgatgaatggaaattacgtactttcaacgcaag 
pFL-Zim17-ts2-CEN     tcttccgcttcctcgctcactgactcgctgcgctcggtcgttcggctgcggcgagcggtatcagcatcgatgaatggaaattacgtactttcaacgcaag 
pFL-Zim17-ts3-CEN     tcttccgcttcctcgctcactgactcgctgcgctcggtcgttcggctgcggcgagcggtatcagcatcgatgaatggaaattacgtactttcaacgcaag 
pFL-Zim17-ts4-CEN     tcttccgcttcctcgctcactgactcgctgcgctcggtcgttcggctgcggcgagcggtatcagcatcgatgaatggaaattacgtactttcaacgcaag 
pFL-Zim17-corrWT-CEN  tcttccgcttcctcgctcactgactcgctgcgctcggtcgttcggctgcggcgagcggtatcagcatcgatgaatggaaattacgtactttcaacgcaag    
                              3010      3020      3030      3040      3050      3060      3070      3080      3090      3100  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 agcaagacaaaagaaagcctaaaactgtcttttcgtgtcggtcgtccaatatcatcgtaaacgtgtgtagagccttaaattctaatttctaactttaaat 
pFL-Zim17-ts2-CEN     agcaagacaaaagaaagcctaaaactgtcttttcgtgtcggtcgtccaatatcatcgtaaacgtgtgtagagccttaaattctaatttctaactttaaat 
pFL-Zim17-ts3-CEN     agcaagacaaaagaaagcctaaaactgtcttttcgtgtcggtcgtccaatatcatcgtaaacgtgtgtagagccttaaattctaatttctaactttaaat 
pFL-Zim17-ts4-CEN     agcaagacaaaagaaagcctaaaactgtcttttcgtgtcggtcgtccaatatcatcgtaaacgtgtgtagagccttaaattctaatttctaactttaaat 
pFL-Zim17-corrWT-CEN  agcaagacaaaagaaagcctaaaactgtcttttcgtgtcggtcgtccaatatcatcgtaaacgtgtgtagagccttaaattctaatttctaactttaaat    
                              3110      3120      3130      3140      3150      3160      3170      3180      3190      3200  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 tttttttgctattataatactaatttctaactttcaacctattttacatcttcggaaaacaaaaactattttttctttaatttctttttttactttctat 
pFL-Zim17-ts2-CEN     tttttttgctattataatactaatttctaactttcaacctattttacatcttcggaaaacaaaaactattttttctttaatttctttttttactttctat 
pFL-Zim17-ts3-CEN     tttttttgctattataatactaatttctaactttcaacctattttacatcttcggaaaacaaaaactattttttctttaatttctttttttactttctat 
pFL-Zim17-ts4-CEN     tttttttgctattataatactaatttctaactttcaacctattttacatcttcggaaaacaaaaactattttttctttaatttctttttttactttctat 
pFL-Zim17-corrWT-CEN  tttttttgctattataatactaatttctaactttcaacctattttacatcttcggaaaacaaaaactattttttctttaatttctttttttactttctat    
                              3210      3220      3230      3240      3250      3260      3270      3280      3290      3300  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 ttttaatttatatatttatattaaaaaatttaaattatattatttttatagcacgtgatgaaaagaaatatagtcttcaaggttatattatacaggttta 
pFL-Zim17-ts2-CEN     ttttaatttatatatttatattaaaaaatttaaattatattatttttatagcacgtgatgaaaagaaatatagtcttcaaggttatattatacaggttta 
pFL-Zim17-ts3-CEN     ttttaatttatatatttatattaaaaaatttaaattatattatttttatagcacgtgatgaaaagaaatatagtcttcaaggttatattatacaggttta 
pFL-Zim17-ts4-CEN     ttttaatttatatatttatattaaaaaatttaaattatattatttttatagcacgtgatgaaaagaaatatagtcttcaaggttatattatacaggttta 
pFL-Zim17-corrWT-CEN  ttttaatttatatatttatattaaaaaatttaaattatattatttttatagcacgtgatgaaaagaaatatagtcttcaaggttatattatacaggttta    
                              3310      3320      3330      3340      3350      3360      3370      3380      3390      3400  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 tatattattttacttatttttgttgttctttttcttggagtaatttagcattaacaacttcgacccatcgcgatgacgaaattgcacgtttaaaggagaa 
pFL-Zim17-ts2-CEN     tatattattttacttatttttgttgttctttttcttggagtaatttagcattaacaacttcgacccatcgcgatgacgaaattgcacgtttaaaggagaa 
pFL-Zim17-ts3-CEN     tatattattttacttatttttgttgttctttttcttggagtaatttagcattaacaacttcgacccatcgcgatgacgaaattgcacgtttaaaggagaa 
pFL-Zim17-ts4-CEN     tatattattttacttatttttgttgttctttttcttggagtaatttagcattaacaacttcgacccatcgcgatgacgaaattgcacgtttaaaggagaa 
pFL-Zim17-corrWT-CEN  tatattattttacttatttttgttgttctttttcttggagtaatttagcattaacaacttcgacccatcgcgatgacgaaattgcacgtttaaaggagaa    
                              3410      3420      3430      3440      3450      3460      3470      3480      3490      3500  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 gtcggaatcgttgcaagaagaaataaattagtttgacgttttattccttttcttctgcacagaagtgtgtatatatatatttatatatagtcgatgtgca 
pFL-Zim17-ts2-CEN     gtcggaatcgttgcaagaagaaataaattagtttgacgttttattccttttcttctgcacagaagtgtgtatatatatatttatatatagtcgatgtgca 
pFL-Zim17-ts3-CEN     gtcggaatcgttgcaagaagaaataaattagtttgacgttttattccttttcttctgcacagaagtgtgtatatatatatttatatatagtcgatgtgca 
pFL-Zim17-ts4-CEN     gtcggaatcgttgcaagaagaaataaattagtttgacgttttattccttttcttctgcacagaagtgtgtatatatatatttatatatagtcgatgtgca 
pFL-Zim17-corrWT-CEN  gtcggaatcgttgcaagaagaaataaattagtttgacgttttattccttttcttctgcacagaagtgtgtatatatatatttatatatagtcgatgtgca    
   
                         3510      3520      3530      3540      3550      3560      3570      3580      3590      3600       
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 aaagcctacattatttttcttttgatttttatttttttgttcaagtaggttcatgccgacagtaaatccttatgccctacctaaatataaacacccaaat 
pFL-Zim17-ts2-CEN     aaagcctacattatttttcttttgatttttatttttttgttcaagtaggttcatgccgacagtaaatccttatgccctacctaaatataaacacccaaat 
pFL-Zim17-ts3-CEN     aaagcctacattatttttcttttgatttttatttttttgttcaagtaggttcatgccgacagtaaatccttatgccctacctaaatataaacacccaaat 
pFL-Zim17-ts4-CEN     aaagcctacattatttttcttttgatttttatttttttgttcaagtaggttcatgccgacagtaaatccttatgccctacctaaatataaacacccaaat 
pFL-Zim17-corrWT-CEN  aaagcctacattatttttcttttgatttttatttttttgttcaagtaggttcatgccgacagtaaatccttatgccctacctaaatataaacacccaaat    
                              3610      3620      3630      3640      3650      3660      3670      3680      3690      3700  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 atatatatatatatatatatatataaataataaaaacggaaaggaaatagaataataataataatactacacgtttacgtatgtaactcattctattatt 
pFL-Zim17-ts2-CEN     atatatatatatatatatatatataaataataaaaacggaaaggaaatagaataataataataatactacacgtttacgtatgtaactcattctattatt 
pFL-Zim17-ts3-CEN     atatatatatatatatatatatataaataataaaaacggaaaggaaatagaataataataataatactacacgtttacgtatgtaactcattctattatt 
pFL-Zim17-ts4-CEN     atatatatatatatatatatatataaataataaaaacggaaaggaaatagaataataataataatactacacgtttacgtatgtaactcattctattatt 
pFL-Zim17-corrWT-CEN  atatatatatatatatatatatataaataataaaaacggaaaggaaatagaataataataataatactacacgtttacgtatgtaactcattctattatt    
                              3710      3720      3730      3740      3750      3760      3770      3780      3790      3800  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 cagactttgatattaatagaattattactactaggtttcctcacttcaaaatctataaatataccgtcatgctctaatcgatgctcactcaaaggtcggt 
pFL-Zim17-ts2-CEN     cagactttgatattaatagaattattactactaggtttcctcacttcaaaatctataaatataccgtcatgctctaatcgatgctcactcaaaggtcggt 
pFL-Zim17-ts3-CEN     cagactttgatattaatagaattattactactaggtttcctcacttcaaaatctataaatataccgtcatgctctaatcgatgctcactcaaaggtcggt 
pFL-Zim17-ts4-CEN     cagactttgatattaatagaattattactactaggtttcctcacttcaaaatctataaatataccgtcatgctctaatcgatgctcactcaaaggtcggt 
pFL-Zim17-corrWT-CEN  cagactttgatattaatagaattattactactaggtttcctcacttcaaaatctataaatataccgtcatgctctaatcgatgctcactcaaaggtcggt 
                              3810      3820      3830      3840      3850      3860      3870      3880      3890      3900  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 aatacggttatccacagaatcaggggataacgcaggaaagaacatgtgagcaaaaggccagcaaaaggccaggaaccgtaaaaaggccgcgttgctggcg 
pFL-Zim17-ts2-CEN     aatacggttatccacagaatcaggggataacgcaggaaagaacatgtgagcaaaaggccagcaaaaggccaggaaccgtaaaaaggccgcgttgctggcg 
pFL-Zim17-ts3-CEN     aatacggttatccacagaatcaggggataacgcaggaaagaacatgtgagcaaaaggccagcaaaaggccaggaaccgtaaaaaggccgcgttgctggcg 
pFL-Zim17-ts4-CEN     aatacggttatccacagaatcaggggataacgcaggaaagaacatgtgagcaaaaggccagcaaaaggccaggaaccgtaaaaaggccgcgttgctggcg 
pFL-Zim17-corrWT-CEN  aatacggttatccacagaatcaggggataacgcaggaaagaacatgtgagcaaaaggccagcaaaaggccaggaaccgtaaaaaggccgcgttgctggcg 
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                              3910      3920      3930      3940      3950      3960      3970      3980      3990      4000  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 tttttccataggctccgcccccctgacgagcatcacaaaaatcgacgctcaagtcagaggtggcgaaacccgacaggactataaagataccaggcgtttc 
pFL-Zim17-ts2-CEN     tttttccataggctccgcccccctgacgagcatcacaaaaatcgacgctcaagtcagaggtggcgaaacccgacaggactataaagataccaggcgtttc 
pFL-Zim17-ts3-CEN     tttttccataggctccgcccccctgacgagcatcacaaaaatcgacgctcaagtcagaggtggcgaaacccgacaggactataaagataccaggcgtttc 
pFL-Zim17-ts4-CEN     tttttccataggctccgcccccctgacgagcatcacaaaaatcgacgctcaagtcagaggtggcgaaacccgacaggactataaagataccaggcgtttc 
pFL-Zim17-corrWT-CEN  tttttccataggctccgcccccctgacgagcatcacaaaaatcgacgctcaagtcagaggtggcgaaacccgacaggactataaagataccaggcgtttc 
                                                                                                     
                              4010      4020      4030      4040      4050      4060      4070      4080      4090      4100  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 cccctggaagctccctcgtgcgctctcctgttccgaccctgccgcttaccggatacctgtccgcctttctcccttcgggaagcgtggcgctttctcatag 
pFL-Zim17-ts2-CEN     cccctggaagctccctcgtgcgctctcctgttccgaccctgccgcttaccggatacctgtccgcctttctcccttcgggaagcgtggcgctttctcatag 
pFL-Zim17-ts3-CEN     cccctggaagctccctcgtgcgctctcctgttccgaccctgccgcttaccggatacctgtccgcctttctcccttcgggaagcgtggcgctttctcatag 
pFL-Zim17-ts4-CEN     cccctggaagctccctcgtgcgctctcctgttccgaccctgccgcttaccggatacctgtccgcctttctcccttcgggaagcgtggcgctttctcatag 
pFL-Zim17-corrWT-CEN  cccctggaagctccctcgtgcgctctcctgttccgaccctgccgcttaccggatacctgtccgcctttctcccttcgggaagcgtggcgctttctcatag    
                              4110      4120      4130      4140      4150      4160      4170      4180      4190      4200  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 ctcacgctgtaggtatctcagttcggtgtaggtcgttcgctccaagctgggctgtgtgcacgaaccccccgttcagcccgaccgctgcgccttatccggt 
pFL-Zim17-ts2-CEN     ctcacgctgtaggtatctcagttcggtgtaggtcgttcgctccaagctgggctgtgtgcacgaaccccccgttcagcccgaccgctgcgccttatccggt 
pFL-Zim17-ts3-CEN     ctcacgctgtaggtatctcagttcggtgtaggtcgttcgctccaagctgggctgtgtgcacgaaccccccgttcagcccgaccgctgcgccttatccggt 
pFL-Zim17-ts4-CEN     ctcacgctgtaggtatctcagttcggtgtaggtcgttcgctccaagctgggctgtgtgcacgaaccccccgttcagcccgaccgctgcgccttatccggt 
pFL-Zim17-corrWT-CEN  ctcacgctgtaggtatctcagttcggtgtaggtcgttcgctccaagctgggctgtgtgcacgaaccccccgttcagcccgaccgctgcgccttatccggt    
                              4210      4220      4230      4240      4250      4260      4270      4280      4290      4300  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 aactatcgtcttgagtccaacccggtaagacacgacttatcgccactggcagcagccactggtaacaggattagcagagcgaggtatgtaggcggtgcta 
pFL-Zim17-ts2-CEN     aactatcgtcttgagtccaacccggtaagacacgacttatcgccactggcagcagccactggtaacaggattagcagagcgaggtatgtaggcggtgcta 
pFL-Zim17-ts3-CEN     aactatcgtcttgagtccaacccggtaagacacgacttatcgccactggcagcagccactggtaacaggattagcagagcgaggtatgtaggcggtgcta 
pFL-Zim17-ts4-CEN     aactatcgtcttgagtccaacccggtaagacacgacttatcgccactggcagcagccactggtaacaggattagcagagcgaggtatgtaggcggtgcta 
pFL-Zim17-corrWT-CEN  aactatcgtcttgagtccaacccggtaagacacgacttatcgccactggcagcagccactggtaacaggattagcagagcgaggtatgtaggcggtgcta    
                              4310      4320      4330      4340      4350      4360      4370      4380      4390      4400  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 cagagttcttgaagtggtggcctaactacggctacactagaaggacagtatttggtatctgcgctctgctgaagccagttaccttcggaaaaagagttgg 
pFL-Zim17-ts2-CEN     cagagttcttgaagtggtggcctaactacggctacactagaaggacagtatttggtatctgcgctctgctgaagccagttaccttcggaaaaagagttgg 
pFL-Zim17-ts3-CEN     cagagttcttgaagtggtggcctaactacggctacactagaaggacagtatttggtatctgcgctctgctgaagccagttaccttcggaaaaagagttgg 
pFL-Zim17-ts4-CEN     cagagttcttgaagtggtggcctaactacggctacactagaaggacagtatttggtatctgcgctctgctgaagccagttaccttcggaaaaagagttgg 
pFL-Zim17-corrWT-CEN  cagagttcttgaagtggtggcctaactacggctacactagaaggacagtatttggtatctgcgctctgctgaagccagttaccttcggaaaaagagttgg 
                              4410      4420      4430      4440      4450      4460      4470      4480      4490      4500  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 tagctcttgatccggcaaacaaaccaccgctggtagcggtggtttttttgtttgcaagcagcagattacgcgcagaaaaaaaggatctcaagaagatcct 
pFL-Zim17-ts2-CEN     tagctcttgatccggcaaacaaaccaccgctggtagcggtggtttttttgtttgcaagcagcagattacgcgcagaaaaaaaggatctcaagaagatcct 
pFL-Zim17-ts3-CEN     tagctcttgatccggcaaacaaaccaccgctggtagcggtggtttttttgtttgcaagcagcagattacgcgcagaaaaaaaggatctcaagaagatcct 
pFL-Zim17-ts4-CEN     tagctcttgatccggcaaacaaaccaccgctggtagcggtggtttttttgtttgcaagcagcagattacgcgcagaaaaaaaggatctcaagaagatcct 
pFL-Zim17-corrWT-CEN  tagctcttgatccggcaaacaaaccaccgctggtagcggtggtttttttgtttgcaagcagcagattacgcgcagaaaaaaaggatctcaagaagatcct 
                              4510      4520      4530      4540      4550      4560      4570      4580      4590      4600  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 ttgatcttttctacggggtctgacgctcagtggaacgaaaactcacgttaagggattttggtcatgagattatcaaaaaggatcttcacctagatccttt 
pFL-Zim17-ts2-CEN     ttgatcttttctacggggtctgacgctcagtggaacgaaaactcacgttaagggattttggtcatgagattatcaaaaaggatcttcacctagatccttt 
pFL-Zim17-ts3-CEN     ttgatcttttctacggggtctgacgctcagtggaacgaaaactcacgttaagggattttggtcatgagattatcaaaaaggatcttcacctagatccttt 
pFL-Zim17-ts4-CEN     ttgatcttttctacggggtctgacgctcagtggaacgaaaactcacgttaagggattttggtcatgagattatcaaaaaggatcttcacctagatccttt 
pFL-Zim17-corrWT-CEN  ttgatcttttctacggggtctgacgctcagtggaacgaaaactcacgttaagggattttggtcatgagattatcaaaaaggatcttcacctagatccttt    
                              4610      4620      4630      4640      4650      4660      4670      4680      4690      4700  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 taaattaaaaatgaagttttaaatcaatctaaagtatatatgagtaaacttggtctgacagttaccaatgcttaatcagtgaggcacctatctcagcgat 
pFL-Zim17-ts2-CEN     taaattaaaaatgaagttttaaatcaatctaaagtatatatgagtaaacttggtctgacagttaccaatgcttaatcagtgaggcacctatctcagcgat 
pFL-Zim17-ts3-CEN     taaattaaaaatgaagttttaaatcaatctaaagtatatatgagtaaacttggtctgacagttaccaatgcttaatcagtgaggcacctatctcagcgat 
pFL-Zim17-ts4-CEN     taaattaaaaatgaagttttaaatcaatctaaagtatatatgagtaaacttggtctgacagttaccaatgcttaatcagtgaggcacctatctcagcgat 
pFL-Zim17-corrWT-CEN  taaattaaaaatgaagttttaaatcaatctaaagtatatatgagtaaacttggtctgacagttaccaatgcttaatcagtgaggcacctatctcagcgat 
                              4710      4720      4730      4740      4750      4760      4770      4780      4790      4800  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 ctgtctatttcgttcatccatagttgcctgactccccgtcgtgtagataactacgatacgggagggcttaccatctggccccagtgctgcaatgataccg 
pFL-Zim17-ts2-CEN     ctgtctatttcgttcatccatagttgcctgactccccgtcgtgtagataactacgatacgggagggcttaccatctggccccagtgctgcaatgataccg 
pFL-Zim17-ts3-CEN     ctgtctatttcgttcatccatagttgcctgactccccgtcgtgtagataactacgatacgggagggcttaccatctggccccagtgctgcaatgataccg 
pFL-Zim17-ts4-CEN     ctgtctatttcgttcatccatagttgcctgactccccgtcgtgtagataactacgatacgggagggcttaccatctggccccagtgctgcaatgataccg 
pFL-Zim17-corrWT-CEN  ctgtctatttcgttcatccatagttgcctgactccccgtcgtgtagataactacgatacgggagggcttaccatctggccccagtgctgcaatgataccg    
                              4810      4820      4830      4840      4850      4860      4870      4880      4890      4900  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 cgagacccacgctcaccggctccagatttatcagcaataaaccagccagccggaagggccgagcgcagaagtggtcctgcaactttatccgcctccatcc 
pFL-Zim17-ts2-CEN     cgagacccacgctcaccggctccagatttatcagcaataaaccagccagccggaagggccgagcgcagaagtggtcctgcaactttatccgcctccatcc 
pFL-Zim17-ts3-CEN     cgagacccacgctcaccggctccagatttatcagcaataaaccagccagccggaagggccgagcgcagaagtggtcctgcaactttatccgcctccatcc 
pFL-Zim17-ts4-CEN     cgagacccacgctcaccggctccagatttatcagcaataaaccagccagccggaagggccgagcgcagaagtggtcctgcaactttatccgcctccatcc 
pFL-Zim17-corrWT-CEN  cgagacccacgctcaccggctccagatttatcagcaataaaccagccagccggaagggccgagcgcagaagtggtcctgcaactttatccgcctccatcc 
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                              4910      4920      4930      4940      4950      4960      4970      4980      4990      5000  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 agtctattaattgttgccgggaagctagagtaagtagttcgccagttaatagtttgcgcaacgttgttgccattgctacaggcatcgtggtgtcacgctc 
pFL-Zim17-ts2-CEN     agtctattaattgttgccgggaagctagagtaagtagttcgccagttaatagtttgcgcaacgttgttgccattgctacaggcatcgtggtgtcacgctc 
pFL-Zim17-ts3-CEN     agtctattaattgttgccgggaagctagagtaagtagttcgccagttaatagtttgcgcaacgttgttgccattgctacaggcatcgtggtgtcacgctc 
pFL-Zim17-ts4-CEN     agtctattaattgttgccgggaagctagagtaagtagttcgccagttaatagtttgcgcaacgttgttgccattgctacaggcatcgtggtgtcacgctc 
pFL-Zim17-corrWT-CEN  agtctattaattgttgccgggaagctagagtaagtagttcgccagttaatagtttgcgcaacgttgttgccattgctacaggcatcgtggtgtcacgctc    
                              5010      5020      5030      5040      5050      5060      5070      5080      5090      5100  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 gtcgtttggtatggcttcattcagctccggttcccaacgatcaaggcgagttacatgatcccccatgttgtgcaaaaaagcggttagctccttcggtcct 
pFL-Zim17-ts2-CEN     gtcgtttggtatggcttcattcagctccggttcccaacgatcaaggcgagttacatgatcccccatgttgtgcaaaaaagcggttagctccttcggtcct 
pFL-Zim17-ts3-CEN     gtcgtttggtatggcttcattcagctccggttcccaacgatcaaggcgagttacatgatcccccatgttgtgcaaaaaagcggttagctccttcggtcct 
pFL-Zim17-ts4-CEN     gtcgtttggtatggcttcattcagctccggttcccaacgatcaaggcgagttacatgatcccccatgttgtgcaaaaaagcggttagctccttcggtcct 
pFL-Zim17-corrWT-CEN  gtcgtttggtatggcttcattcagctccggttcccaacgatcaaggcgagttacatgatcccccatgttgtgcaaaaaagcggttagctccttcggtcct    
                              5110      5120      5130      5140      5150      5160      5170      5180      5190      5200  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 ccgatcgttgtcagaagtaagttggccgcagtgttatcactcatggttatggcagcactgcataattctcttactgtcatgccatccgtaagatgctttt 
pFL-Zim17-ts2-CEN     ccgatcgttgtcagaagtaagttggccgcagtgttatcactcatggttatggcagcactgcataattctcttactgtcatgccatccgtaagatgctttt 
pFL-Zim17-ts3-CEN     ccgatcgttgtcagaagtaagttggccgcagtgttatcactcatggttatggcagcactgcataattctcttactgtcatgccatccgtaagatgctttt 
pFL-Zim17-ts4-CEN     ccgatcgttgtcagaagtaagttggccgcagtgttatcactcatggttatggcagcactgcataattctcttactgtcatgccatccgtaagatgctttt 
pFL-Zim17-corrWT-CEN  ccgatcgttgtcagaagtaagttggccgcagtgttatcactcatggttatggcagcactgcataattctcttactgtcatgccatccgtaagatgctttt    
                              5210      5220      5230      5240      5250      5260      5270      5280      5290      5300  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 ctgtgactggtgagtactcaaccaagtcattctgagaatagtgtatgcggcgaccgagttgctcttgcccggcgtcaatacgggataataccgcgccaca 
pFL-Zim17-ts2-CEN     ctgtgactggtgagtactcaaccaagtcattctgagaatagtgtatgcggcgaccgagttgctcttgcccggcgtcaatacgggataataccgcgccaca 
pFL-Zim17-ts3-CEN     ctgtgactggtgagtactcaaccaagtcattctgagaatagtgtatgcggcgaccgagttgctcttgcccggcgtcaatacgggataataccgcgccaca 
pFL-Zim17-ts4-CEN     ctgtgactggtgagtactcaaccaagtcattctgagaatagtgtatgcggcgaccgagttgctcttgcccggcgtcaatacgggataataccgcgccaca 
pFL-Zim17-corrWT-CEN  ctgtgactggtgagtactcaaccaagtcattctgagaatagtgtatgcggcgaccgagttgctcttgcccggcgtcaatacgggataataccgcgccaca    
                              5310      5320      5330      5340      5350      5360      5370      5380      5390      5400  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 tagcagaactttaaaagtgctcatcattggaaaacgttcttcggggcgaaaactctcaaggatcttaccgctgttgagatccagttcgatgtaacccact 
pFL-Zim17-ts2-CEN     tagcagaactttaaaagtgctcatcattggaaaacgttcttcggggcgaaaactctcaaggatcttaccgctgttgagatccagttcgatgtaacccact 
pFL-Zim17-ts3-CEN     tagcagaactttaaaagtgctcatcattggaaaacgttcttcggggcgaaaactctcaaggatcttaccgctgttgagatccagttcgatgtaacccact 
pFL-Zim17-ts4-CEN     tagcagaactttaaaagtgctcatcattggaaaacgttcttcggggcgaaaactctcaaggatcttaccgctgttgagatccagttcgatgtaacccact 
pFL-Zim17-corrWT-CEN  tagcagaactttaaaagtgctcatcattggaaaacgttcttcggggcgaaaactctcaaggatcttaccgctgttgagatccagttcgatgtaacccact    
                              5410      5420      5430      5440      5450      5460      5470      5480      5490      5500  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 cgtgcacccaactgatcttcagcatcttttactttcaccagcgtttctgggtgagcaaaaacaggaaggcaaaatgccgcaaaaaagggaataagggcga 
pFL-Zim17-ts2-CEN     cgtgcacccaactgatcttcagcatcttttactttcaccagcgtttctgggtgagcaaaaacaggaaggcaaaatgccgcaaaaaagggaataagggcga 
pFL-Zim17-ts3-CEN     cgtgcacccaactgatcttcagcatcttttactttcaccagcgtttctgggtgagcaaaaacaggaaggcaaaatgccgcaaaaaagggaataagggcga 
pFL-Zim17-ts4-CEN     cgtgcacccaactgatcttcagcatcttttactttcaccagcgtttctgggtgagcaaaaacaggaaggcaaaatgccgcaaaaaagggaataagggcga 
pFL-Zim17-corrWT-CEN  cgtgcacccaactgatcttcagcatcttttactttcaccagcgtttctgggtgagcaaaaacaggaaggcaaaatgccgcaaaaaagggaataagggcga 
                              5510      5520      5530      5540      5550      5560      5570      5580      5590      5600  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 cacggaaatgttgaatactcatactcttcctttttcaatattattgaagcatttatcagggttattgtctcatgagcggatacatatttgaatgtattta 
pFL-Zim17-ts2-CEN     cacggaaatgttgaatactcatactcttcctttttcaatattattgaagcatttatcagggttattgtctcatgagcggatacatatttgaatgtattta 
pFL-Zim17-ts3-CEN     cacggaaatgttgaatactcatactcttcctttttcaatattattgaagcatttatcagggttattgtctcatgagcggatacatatttgaatgtattta 
pFL-Zim17-ts4-CEN     cacggaaatgttgaatactcatactcttcctttttcaatattattgaagcatttatcagggttattgtctcatgagcggatacatatttgaatgtattta 
pFL-Zim17-corrWT-CEN  cacggaaatgttgaatactcatactcttcctttttcaatattattgaagcatttatcagggttattgtctcatgagcggatacatatttgaatgtattta    
                              5610      5620      5630      5640      5650      5660      5670      5680      5690      5700  
                      ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
pFL39                 gaaaaataaacaaataggggttccgcgcacatttccccgaaaagtgccacctgacgtctaagaaaccattattatcatgacattaacctataaaaatagg 
pFL-Zim17-ts2-CEN     gaaaaataaacaaataggggttccgcgcacatttccccgaaaagtgccacctgacgtctaagaaaccattattatcatgacattaacctataaaaatagg 
pFL-Zim17-ts3-CEN     gaaaaataaacaaataggggttccgcgcacatttccccgaaaagtgccacctgacgtctaagaaaccattattatcatgacattaacctataaaaatagg 
pFL-Zim17-ts4-CEN     gaaaaataaacaaataggggttccgcgcacatttccccgaaaagtgccacctgacgtctaagaaaccattattatcatgacattaacctataaaaatagg 
pFL-Zim17-corrWT-CEN  gaaaaataaacaaataggggttccgcgcacatttccccgaaaagtgccacctgacgtctaagaaaccattattatcatgacattaacctataaaaatagg    
                              5710      5720 
                      ....|....|....|....|..
pFL39                 cgtatcacgaggccctttcgtc 
pFL-Zim17-ts2-CEN     cgtatcacgaggccctttcgtc 
pFL-Zim17-ts3-CEN     cgtatcacgaggccctttcgtc 
pFL-Zim17-ts4-CEN     cgtatcacgaggccctttcgtc 
pFL-Zim17-corrWT-CEN  cgtatcacgaggccctttcgtc 
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                                    10        20        30        40        50        60        70        80       90        
                          ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|                      
ZIM17-LEU2-Insert         ----------------------------------------------------------------------------------------AC 
LEU2-Marker               ------------------------------------------------------------------------------------------ 
LEU2-coding (rev.compl.)  ------------------------------------------------------------------------------------------ 
Zim17 coding sequence     ATGATTCCGAGGACTAGAACACTACTGCAAAGTAAAATACCAATTACCAGGTACTTTGCCAGATGTTGGGCGCCTCGCGTACGCTACAAC 
                                                                                                                    
                                  100       110       120       130       140       150       160       170       180        
                          ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
ZIM17-LEU2-Insert         GTGTGCCGTACTCTACCCGCAGCAGCGTTGCATACCAATATCATCGCACATAATGAAGTGAAAAAGGACGATAAGAAGGTTCATTTGGGG 
LEU2-Marker               ------------------------------------------------------------------------------------------ 
LEU2-coding (rev.compl.)  ------------------------------------------------------------------------------------------ 
Zim17 coding sequence     GTGTGCCGTACTCTACCCGCAGCAGCGTTGCATACCAATATCATCGCACATAATGAAGTGAAAAAGGACGATAAGAAGGTTCATTTGGGG 
                          A1-fw             
                                  190       200       210       220       230       240       250       260       270        
                          ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
ZIM17-LEU2-Insert         TCTTTTAAGGTAGACAAGCCTAAGATGATGATAGCTTTCACCTGCAAGAAATGTAACACCCGATCTTCACACACAATGTCCAAGCAGGCG 
LEU2-Marker               ------------------------------------------------------------------------------------------ 
LEU2-coding (rev.compl.)  ------------------------------------------------------------------------------------------ 
Zim17 coding sequence     TCTTTTAAGGTAGACAAGCCTAAGATGATGATAGCTTTCACCTGCAAGAAATGTAACACCCGATCTTCACACACAATGTCCAAGCAGGCG 
                                                               A1b-fw                 
                                  280       290       300       310       320       330       340       350       360        
                          ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
ZIM17-LEU2-Insert         TACGAGAAAGGTACTGTCTTGATCTCTTGTCCGCACTGCAAAGTGAGACATTTGATAGCAGACCATCTGAAAATATTCCATGATCATCAT 
LEU2-Marker               ------------------------------------------------------------------------------------------ 
LEU2-coding (rev.compl.)  ------------------------------------------------------------------------------------------ 
Zim17 coding sequence     TACGAGAAAGGTACTGTCTTGATCTCTTGTCCGCACTGCAAAGTGAGACATTTGATAGCAGACCATCTGAAAATATTCCATGATCATCAT 
                                  370       380       390       400       410       420       430       440       450        
                          ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
ZIM17-LEU2-Insert         GTTACCGTGGAACAGTTAATGAAAGCTAACGGAGAACAAGTTAGCCAAGACGTGGGCGACTTGGAGTTTGAAGACATCCCAGATTCGCTA 
LEU2-Marker               ------------------------------------------------------------------------------------------ 
LEU2-coding (rev.compl.)  ------------------------------------------------------------------------------------------ 
Zim17 coding sequence     GTTACCGTGGAACAGTTAATGAAAGCTAACGGAGAACAAGTTAGCCAAGACGTGGGCGACTTGGAGTTTGAAGACATCCCAGATTCGCTA 
                                  460       470       480       490       500       510       520       530       540        
                          ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
ZIM17-LEU2-Insert         AAGGACGTCCTGGGAAAATATGCCAAGAACAACTCAGAAAATGCATCCCAGCTCCCTCACCCTTCCCAGAAATGAATGAAGAGCTCATGC 
LEU2-Marker               ------------------------------------------------------------------------------------------ 
LEU2-coding (rev.compl.)  ------------------------------------------------------------------------------------------ 
Zim17 coding sequence     AAGGACGTCCTGGGAAAATATGCCAAGAACAACTCAGAAAATGCATCCCAGCTCCCTCACCCTTCCCAGAAATGA--------------- 
                                  550       560       570       580       590       600       610       620       630        
                          ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
ZIM17-LEU2-Insert         ACAGGCATGTACATAGATAGATATATAACCGTTAAATAGCACGTTTTTCCAGAGACTGAGTCATGATTACTGCCAAAAACCCGCACATCA 
LEU2-Marker               ------------------------------------------------------------------------------------------ 
LEU2-coding (rev.compl.)  ------------------------------------------------------------------------------------------ 
Zim17 coding sequence     ------------------------------------------------------------------------------------------ 
                                  640       650       660       670       680       690       700       710       720        
                          ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
ZIM17-LEU2-Insert         CATATTTTTTTGCGATAACCAGCAGAAGATTAGATTGTACTGAGAGTGCACCATATCGACTACGTCGTAAGGCCGTTTCTGACAGAGTAA 
LEU2-Marker               -------------------------------AGATTGTACTGAGAGTGCACCATATCGACTACGTCGTAAGGCCGTTTCTGACAGAGTAA 
LEU2-coding (rev.compl.)  ------------------------------------------------------------------------------------------ 
Zim17 coding sequence     ------------------------------------------------------------------------------------------ 
                                    B1-fw              
                                     A2-rev                                    
                                  730       740       750       760       770       780       790       800       810        
                          ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
ZIM17-LEU2-Insert         AATTCTTGAGGGAACTTTCACCATTATGGGAAATGGTTCAAGAAGGTATTGACTTAAACTCCATCAAATGGTCAGGTCATTGAGTGTTTT 
LEU2-Marker               AATTCTTGAGGGAACTTTCACCATTATGGGAAATGGTTCAAGAAGGTATTGACTTAAACTCCATCAAATGGTCAGGTCATTGAGTGTTTT 
LEU2-coding (rev.compl.)  ------------------------------------------------------------------------------------------ 
Zim17 coding sequence     ------------------------------------------------------------------------------------------ 
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                                  820       830       840       850       860       870       880       890       900        
                          ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
ZIM17-LEU2-Insert         TTATTTGTTGTATTTTTTTTTTTTTAGAGAAAATCCTCCAATATCAAATTAGGAATCGTAGTTTCATGATTTTCTGTTACACCTAACTTT 
LEU2-Marker               TTATTTGTTGTATTTTTTTTTTTTTAGAGAAAATCCTCCAATATCAAATTAGGAATCGTAGTTTCATGATTTTCTGTTACACCTAACTTT 
LEU2-coding (rev.compl.)  ------------------------------------------------------------------------------------------ 
Zim17 coding sequence     ------------------------------------------------------------------------------------------ 
              
                                  910       920       930       940       950       960       970       980       990        
                          ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
ZIM17-LEU2-Insert         TTGTGTGGTGCCCTCCTCCTTGTCAATATTAATGTTAAAGTGCAATTCTTTTTCCTTATCACGTTGAGCCATTAGTATCAATTTGCTTAC 
LEU2-Marker               TTGTGTGGTGCCCTCCTCCTTGTCAATATTAATGTTAAAGTGCAATTCTTTTTCCTTATCACGTTGAGCCATTAGTATCAATTTGCTTAC 
LEU2-coding (rev.compl.)  ------------------------------------------------------------------------------------------ 
Zim17 coding sequence     ------------------------------------------------------------------------------------------ 
                                  1000      1010      1020      1030      1040      1050      1060      1070      1080       
                          ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
ZIM17-LEU2-Insert         CTGTATTCCTTTACTATCCTCCTTTTTCTCCTTCTTGATAAATGTATGTAGATTGCGTATATAGTTTCGTCTACCCTATGAACATATTCC 
LEU2-Marker               CTGTATTCCTTTACTATCCTCCTTTTTCTCCTTCTTGATAAATGTATGTAGATTGCGTATATAGTTTCGTCTACCCTATGAACATATTCC 
LEU2-coding (rev.compl.)  ------------------------------------------------------------------------------------------ 
Zim17 coding sequence     ------------------------------------------------------------------------------------------ 
                                  1090      1100      1110      1120      1130      1140      1150      1160      1170       
                          ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
ZIM17-LEU2-Insert         ATTTTGTAATTTCGTGTCGTTTCTATTATGAATTTCATTTATAAAGTTTATGTACAAATATCATAAAAAAAGAGAATCTTTTTAAGCAAG 
LEU2-Marker               ATTTTGTAATTTCGTGTCGTTTCTATTATGAATTTCATTTATAAAGTTTATGTACAAATATCATAAAAAAAGAGAATCTTTTTAAGCAAG 
LEU2-coding (rev.compl.)  ---------------------------------------------------------------------------------TTAAGCAAG 
Zim17 coding sequence     ------------------------------------------------------------------------------------------ 
                                  1180      1190      1200      1210      1220      1230      1240      1250      1260       
                          ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
ZIM17-LEU2-Insert         GATTTTCTTAACTTCTTCGGCGACAGCATCACCGACTTCGGTGGTACTGTTGGAACCACCTAAATCACCAGTTCTGATACCTGCATCCAA 
LEU2-Marker               GATTTTCTTAACTTCTTCGGCGACAGCATCACCGACTTCGGTGGTACTGTTGGAACCACCTAAATCACCAGTTCTGATACCTGCATCCAA 
LEU2-coding (rev.compl.)  GATTTTCTTAACTTCTTCGGCGACAGCATCACCGACTTCGGTGGTACTGTTGGAACCACCTAAATCACCAGTTCTGATACCTGCATCCAA 
Zim17 coding sequence     ------------------------------------------------------------------------------------------ 
                                  1270      1280      1290      1300      1310      1320      1330      1340      1350       
                          ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
ZIM17-LEU2-Insert         AACCTTTTTAACTGCATCTTCAATGGCCTTACCTTCTTCAGGCAAGTTCAATGACAATTTCAACATCATTGCAGCAGACAAGATAGTGGC 
LEU2-Marker               AACCTTTTTAACTGCATCTTCAATGGCCTTACCTTCTTCAGGCAAGTTCAATGACAATTTCAACATCATTGCAGCAGACAAGATAGTGGC 
LEU2-coding (rev.compl.)  AACCTTTTTAACTGCATCTTCAATGGCCTTACCTTCTTCAGGCAAGTTCAATGACAATTTCAACATCATTGCAGCAGACAAGATAGTGGC 
Zim17 coding sequence     ------------------------------------------------------------------------------------------ 
                                  1360      1370      1380      1390      1400      1410      1420      1430      1440       
                          ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
ZIM17-LEU2-Insert         GATAGGGTCAACCTTATTCTTTGGCAAATCTGGAGCAGAACCGTGGCATGGTTCGTACAAACCAAATGCGGTGTTCTTGTCTGGCAAAGA 
LEU2-Marker               GATAGGGTCAACCTTATTCTTTGGCAAATCTGGAGCAGAACCGTGGCATGGTTCGTACAAACCAAATGCGGTGTTCTTGTCTGGCAAAGA 
LEU2-coding (rev.compl.)  GATAGGGTTGACCTTATTCTTTGGCAAATCTGGAGCAGAACCGTGGCATGGTTCGTACAAACCAAATGCGGTGTTCTTGTCTGGCAAAGA 
Zim17 coding sequence     ------------------------------------------------------------------------------------------ 
                                  1450      1460      1470      1480      1490      1500      1510      1520      1530       
                          ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
ZIM17-LEU2-Insert         GGCCAAGGACGCAGATGGCAACAAACCCAAGGAACCTGGGATAACGGAGGCTTCATCGGAGATGATATCACCAAACATGTTGCTGGTGAT 
LEU2-Marker               GGCCAAGGACGCAGATGGCAACAAACCCAAGGAACCTGGGATAACGGAGGCTTCATCGGAGATGATATCACCAAACATGTTGCTGGTGAT 
LEU2-coding (rev.compl.)  GGCCAAGGACGCAGATGGCAACAAACCCAAGGAACCTGGGATAACGGAGGCTTCATCGGAGATGATATCACCAAACATGTTGCTGGTGAT 
Zim17 coding sequence     ------------------------------------------------------------------------------------------ 
                                  1540      1550      1560      1570      1580      1590      1600      1610      1620       
                          ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
ZIM17-LEU2-Insert         TATAATACCATTTAGGTGGGTTGGGTTCTTAACTAGGATCATGGCGGCAGAATCAATCAATTGATGTTGAACCTTCAATGTAGGGAATTC 
LEU2-Marker               TATAATACCATTTAGGTGGGTTGGGTTCTTAACTAGGATCATGGCGGCAGAATCAATCAATTGATGTTGAACCTTCAATGTAGGGAATTC 
LEU2-coding (rev.compl.)  TATAATACCATTTAGGTGGGTTGGGTTCTTAACTAGGATCATGGCGGCAGAATCAATCAATTGATGTTGAACCTTCAATGTAGGGAATTC 
Zim17 coding sequence     ------------------------------------------------------------------------------------------ 
                                  1630      1640      1650      1660      1670      1680      1690      1700      1710       
                          ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
ZIM17-LEU2-Insert         GTTCTTGATGGTTTCCTCCACAGTTTTTCTCCATAATCTTGAAGAGGCCAAAACATTAGCTTTATCCAAGGACCAAATAGGCAATGGTGG 
LEU2-Marker               GTTCTTGATGGTTTCCTCCACAGTTTTTCTCCATAATCTTGAAGAGGCCAAAACATTAGCTTTATCCAAGGACCAAATAGGCAATGGTGG 
LEU2-coding (rev.compl.)  GTTCTTGATGGTTTCCTCCACAGTTTTTCTCCATAATCTTGAAGAGGCCAAAACATTAGCTTTATCCAAGGACCAAATAGGCAATGGTGG 
Zim17 coding sequence     ------------------------------------------------------------------------------------------ 
                                  1720      1730      1740      1750      1760      1770      1780      1790      1800       
                          ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
ZIM17-LEU2-Insert         CTCATGTTGTAGGGCCATGAAAGCGGCCATTCTTGTGATTCTTTGCACTTCTGGAACGGTGTATTGTTCACTATCCCAAGCGACACCATC 
LEU2-Marker               CTCATGTTGTAGGGCCATGAAAGCGGCCATTCTTGTGATTCTTTGCACTTCTGGAACGGTGTATTGTTCACTATCCCAAGCGACACCATC 
LEU2-coding (rev.compl.)  CTCATGTTGTAGGGCCATGAAAGCGGCCATTCTTGTGATTCTTTGCACTTCTGGAACGGTGTATTGTTCACTATCCCAAGCGACACCATC 
Zim17 coding sequence     ------------------------------------------------------------------------------------------ 
                                  1810      1820      1830      1840      1850      1860      1870      1880      1890       
                          ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
ZIM17-LEU2-Insert         ACCATCGTCTTCCTTTCTCTTACCAAAGTAAATACCTCCCACTAATTCTCTGACAACAACGAAGTCAGTACCTTTAGCAAATTGTGGCTT 
LEU2-Marker               ACCATCGTCTTCCTTTCTCTTACCAAAGTAAATACCTCCCACTAATTCTCTGACAACAACGAAGTCAGTACCTTTAGCAAATTGTGGCTT 
LEU2-coding (rev.compl.)  ACCATCGTCTTCCTTTCTCTTACCAAAGTAAATACCTCCCACTAATTCTCTGACAACAACGAAGTCAGTACCTTTAGCAAATTGTGGCTT 
Zim17 coding sequence     ------------------------------------------------------------------------------------------ 
150 A. Appendix
                                  1900      1910      1920      1930      1940      1950      1960      1970      1980       
                          ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
ZIM17-LEU2-Insert         GATTGGAGATAAGTCTAAAAGAGAGTCGGATGCAAAGTTACATGGTCTTAAGTTGGCGTACAATTGAAGTTCTTTACGGATTTTTAGTAA 
LEU2-Marker               GATTGGAGATAAGTCTAAAAGAGAGTCGGATGCAAAGTTACATGGTCTTAAGTTGGCGTACAATTGAAGTTCTTTACGGATTTTTAGTAA 
LEU2-coding (rev.compl.)  GATTGGAGATAAGTCTAAAAGAGAGTCGGATGCAAAGTTACATGGTCTTAAGTTGGCGTACAATTGAAGTTCTTTACGGATTTTTAGTAA 
Zim17 coding sequence     ------------------------------------------------------------------------------------------ 
                                  1990      2000      2010      2020      2030      2040      2050      2060      2070       
                          ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
ZIM17-LEU2-Insert         ACCTTGTTCAGGTCTAACACTACCGGTACCCCATTTAGGACCACCCACAGCACCTAACAAAACGGCATCAACCTTCTTGGAGGCTTCCAG 
LEU2-Marker               ACCTTGTTCAGGTCTAACACTACCGGTACCCCATTTAGGACCACCCACAGCACCTAACAAAACGGCATCAACCTTCTTGGAGGCTTCCAG 
LEU2-coding (rev.compl.)  ACCTTGTTCAGGTCTAACACTACCGGTACCCCATTTAGGACCACCCACAGCACCTAACAAAACGGCATCAGCCTTCTTGGAGGCTTCCAG 
Zim17 coding sequence     ------------------------------------------------------------------------------------------ 
                                  2080      2090      2100      2110      2120      2130      2140      2150      2160       
                          ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
ZIM17-LEU2-Insert         CGCCTCATCTGGAAGTGGGACACCTGTAGCATCGATAGCAGCACCACCAATTAAATGATTTTCGAAATCGAACTTGACATTGGAACGAAC 
LEU2-Marker               CGCCTCATCTGGAAGTGGGACACCTGTAGCATCGATAGCAGCACCACCAATTAAATGATTTTCGAAATCGAACTTGACATTGGAACGAAC 
LEU2-coding (rev.compl.)  CGCCTCATCTGGAAGTGGAACACCTGTAGCATCGATAGCAGCACCACCAATTAAATGATTTTCGAAATCGAACTTGACATTGGAACGAAC 
Zim17 coding sequence     ------------------------------------------------------------------------------------------ 
                                  2170      2180      2190      2200      2210      2220      2230      2240      2250       
                          ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
ZIM17-LEU2-Insert         ATCAGAAATAGCTTTAAGAACCTTAATGGCTTCGGCTGTGATTTCTTGACCAACGTGGTCACCTGGCAAAACGACGATCTTCTTAGGGGC 
LEU2-Marker               ATCAGAAATAGCTTTAAGAACCTTAATGGCTTCGGCTGTGATTTCTTGACCAACGTGGTCACCTGGCAAAACGACGATCTTCTTAGGGGC 
LEU2-coding (rev.compl.)  ATCAGAAATAGCTTTAAGAACCTTAATGGCTTCGGCTGTGATTTCTTGACCAACGTGGTCACCTGGCAAAACGACGATCTTCTTAGGGGC 
Zim17 coding sequence     ------------------------------------------------------------------------------------------ 
                                  2260      2270      2280      2290      2300      2310      2320      2330      2340       
                          ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
ZIM17-LEU2-Insert         AGACATAGGGGCAGACATTAGAATGGTATATCCTTGAAATATATATATATATTGCTGAAATGTAAAAGGTAAGAAAAGTTAGAAAGTAAG 
LEU2-Marker               AGACATAGGGGCAGACATTAGAATGGTATATCCTTGAAATATATATATATATTGCTGAAATGTAAAAGGTAAGAAAAGTTAGAAAGTAAG 
LEU2-coding (rev.compl.)  AGACAT------------------------------------------------------------------------------------ 
Zim17 coding sequence     ------------------------------------------------------------------------------------------ 
                                  2350      2360      2370      2380      2390      2400      2410      2420      2430       
                          ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
ZIM17-LEU2-Insert         ACGATTGCTAACCACCTATTGGAAAAAACAATAGGTCCTTAAATAATATTGTCAACTTCAAGTATTGTGATGCAAGCATTTAGTCATGAA 
LEU2-Marker               ACGATTGCTAACCACCTATTGGAAAAAACAATAGGTCCTTAAATAATATTGTCAACTTCAAGTATTGTGATGCAAGCATTTAGTCATGAA 
LEU2-coding (rev.compl.)  ------------------------------------------------------------------------------------------ 
Zim17 coding sequence     ------------------------------------------------------------------------------------------ 
                                  2440      2450      2460      2470      2480      2490      2500      2510      2520       
                          ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
ZIM17-LEU2-Insert         CGCTTCTCTATTCTATATGAAAAGCCGGTTCCGGCCTCTCACCTTTCCTTTTTCTCCCAATTTTTCAGTTGAAAAAGGTATATGCGTCAG 
LEU2-Marker               CGCTTCTCTATTCTATATGAAAAGCCGGTTCCGGCCTCTCACCTTTCCTTTTTCTCCCAATTTTTCAGTTGAAAAAGGTATATGCGTCAG 
LEU2-coding (rev.compl.)  ------------------------------------------------------------------------------------------ 
Zim17 coding sequence     ------------------------------------------------------------------------------------------ 
                                  2530      2540      2550      2560      2570      2580      2590      2600      2610       
                          ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
ZIM17-LEU2-Insert         GCGACCTCTGAAATTAACAAAAAATTTCCAGTCATCGAATTTGATTCTGTGCGATAGCGCCCCTGTGTGTTCTCGTTATGTTGAGGAAAA 
LEU2-Marker               GCGACCTCTGAAATTAACAAAAAATTTCCAGTCATCGAATTTGATTCTGTGCGATAGCGCCCCTGTGTGTTCTCGTTATGTTGAGGAAAA 
LEU2-coding (rev.compl.)  ------------------------------------------------------------------------------------------ 
Zim17 coding sequence     ------------------------------------------------------------------------------------------ 
                                  2620      2630      2640      2650      2660      2670      2680      2690      2700       
                          ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
ZIM17-LEU2-Insert         AAATAATGGTTGCTAAGAGATTCGAACTCTTGCATCTTACGATACCTGAGTATTCCCACAGTTAACTGCGGTCAAGATATTTCTTGAATC 
LEU2-Marker               AAATAATGGTTGCTAAGAGATTCGAACTCTTGCATCTTACGATACCTGAGTATTCCCACAGTTAACTGCGGTCAAGATATTTCTTGAATC 
LEU2-coding (rev.compl.)  ------------------------------------------------------------------------------------------ 
Zim17 coding sequence     ------------------------------------------------------------------------------------------ 
                                  2710      2720      2730      2740      2750      2760      2770      2780      2790       
                          ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
ZIM17-LEU2-Insert         AGGCGCCTTAGACCGCTCGGCCAAACAACCAATTACTTGTTGAGAAATAGAGTATAATTATCCTATAAATATAACGTTTTTGAACACACA 
LEU2-Marker               AGGCGCCTTAGACCGCTCGGCCAAACAACCAATTACTTGTTGAGAAATAGAGTATAATTATCCTATAAATATAACGTTTTTGAACACACA 
LEU2-coding (rev.compl.)  ------------------------------------------------------------------------------------------ 
Zim17 coding sequence     ------------------------------------------------------------------------------------------ 
                                  2800      2810      2820      2830      2840      2850      2860      2870      2880       
                          ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
ZIM17-LEU2-Insert         TGAACAAGGAAGTACAGGACAATTGATTTTGAAGAGAATGTGGATTTTGATGTAATTGTTGGGATTCCATTTTTAATAAGGCAATAATAT 
LEU2-Marker               TGAACAAGGAAGTACAGGACAATTGATTTTGAAGAGAATGTGGATTTTGATGTAATTGTTGGGATTCCATTTTTAATAAGGCAATAATAT 
LEU2-coding (rev.compl.)  ------------------------------------------------------------------------------------------ 
Zim17 coding sequence     ------------------------------------------------------------------------------------------ 
                                  2890      2900      2910      2920      2930      2940      2950      2960      2970       
                          ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|
ZIM17-LEU2-Insert         TAGGTATGTGGATATACTAGAAGTTCTCCTCGACCGTCGATATGCGGTGTGAAATACCGCACAGTAGGACTAGAGTACATAAAGATGAGC 
LEU2-Marker               TAGGTATGTGGATATACTAGAAGTTCTCCTCGACCGTCGATATGCGGTGTGAAATACCGCACAG-------------------------- 
LEU2-coding (rev.compl.)  ----------------------------------------------------------------                           
Zim17 coding sequence     ------------------------------------------------------------------------------------------
                                                                      B2-rev              
                                                                      C-rev                                          
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                                  2980      2990      
                          ....|....|....|....|....|....
ZIM17-LEU2-Insert         CACTGCTAGATATGAAAAGTTGAACCGCA 
LEU2-Marker               ----------------------------- 
LEU2-coding (rev.compl.)                                
Zim17 coding sequence     ----------------------------- 
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A.2. Vector maps
A.2.1. pDB10
Plasmid map of pDB10. SSC1 -His and ZIM17 -Strep were cloned into multiple cloning sites (MCS)
I and II of the pETDuet Vector (Novagen) via the NcoI/HindIII and NdeI/XhoI restriction sites. The
restriction enzymes MfeI and NdeI were used to remove the T7-promotor and ribosome binding site
(rbs) of MCS II to create the vectors pIL1 and pIL2.
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A.2.2. pIL1
Plasmid map of pIL1. The T7-promotor and ribosome-binding site (rbs) in front of the ZIM17 -insert
of pDB10 were removed via an MfeI/NdeI restriction digest. The 3’end of SSC1 and the ribosome
binding site were amplified using the primer pair pDB10-IL1-f and pDB10-IL1+rbs-r table 2.8 and
re-inserted into the plasmid.
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A.2.3. pIL2
Plasmid map of pIL2. The T7-promotor and ribosome-binding site (rbs) in front of the ZIM17 -insert
of pDB10 were removed via an MfeI/NdeI restriction digest. The 3’end of SSC1 site was amplified
using the primer pair pDB10-IL1-f and pDB10-IL2-r table 2.8 and re-inserted into the plasmid. Zim17*
= Zim17-artefact derived from an additional ATG in the SSC1-His gene
156 A. Appendix
A.2.4. pIL4
Plasmid map of pIL4. ZIM17 was cloned into MCS II of the pETDuet vector (Novagen) via the
NdeI/XhoI restriction sites.
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A.2.5. pIL6/ pIL7
Plasmid map of pIL6 and pIL7. The zinc finger mutants zim17-C78S and -C100S were cloned into
MCS II of the pETDuet vector (Novagen) via the NdeI/XhoI restriction sites.
158 A. Appendix
A.2.6. pRS415
Plasmid map of pRS415. pRS415 (Sikorski and Hieter 1989) was used for the amplification of the
Leu2 marker via the primer pair B1-fw and B2-rev (table 2.8). The LEU2 gene was used as a selection
marker for genomic integration of zim17-3a, -3b and -4.
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A.2.7. pFL-zim17-ts-CEN
Plasmid map of pFL-Zim17-ts-CEN at the example of Zim17-corrWT. The vector pFL39 was used
for cloning and expression of zim17-2,-3, and -4 in yeast. The HindIII restriction sites were used for the
cloning of the corresponding wild type.
160 A. Appendix
A.2.8. pFL39
Plasmid map of pFL39 (Bonneaud 1991). pFL39 that was used to create the pFL-zim17-ts-CEN
plasmids (Sanjuán Szklarz 2005).
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